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The prevention and treatment of cognitive impairment in the elderly has assumed 
increasing importance given the ageing population. Mild Cognitive Impairment (MCI) is 
considered as a transitional state between healthy ageing and dementia. The primary aim 
of the current study was to develop a cognitive intervention for MCI that encourages 
participation in a variety of complex and novel cognitive activities, and to examine its 
efficacy. Furthermore, these cognitive activities were developed to influence multiple 
brain networks, particularly the default mode network (DMN). A secondary aim was to 
assess the diagnostic utility of a number of screening measures in discriminating MCI. 
 
In the Cognitive Screening Study, 609 individuals (age range 65-97 years old) 
were evaluated using brief cognitive tests, including the Montreal Cognitive Assessment 
(MoCA), Rey Complex Figure Test (RCFT; copy and 3-min recall), and Trail Making 
Test-Part A (TMT-A). After the initial evaluation, 222 were excluded, the remaining 
were classified as Probable MCI (n = 75), Possible MCI (n = 72) and Probable Healthy 
Control (HC; n = 240). A portion of these individuals were followed-up with detailed 
cognitive assessment, and their performance on the detailed assessment determined which 
cognitive group they were assigned to. As a result, 17 individuals were classified as 




each individual screening measure was examined using the standard receiver operating 
characteristic curve (ROC). Multivariate logistic regression analysis was conducted to 
investigate whether combinations of the screening instruments improved the detection of 
MCI. Simultaneous discriminations among the three cognitive classes were examined 
using three-dimensional ROC. The results revealed that both MoCA and RCFT (copy and 
3-min recall) demonstrated good discrimination of MCI, however, the combination of the 
two tests showed even better discriminatory power.  
 
Thirteen MCI participants were included in the Cognitive Enrichment Study, 
these individuals were randomly allocated to either the intervention (n = 6) or waitlist 
group (n = 7). Those in the intervention group received the 4-month-long Cognitive 
Enrichment Programme. Although the neuropsychological results were generally non-
significant, we found a significant pre-post-effect on a measure of long-term memory 
retrieval. Furthermore, this study also used functional magnetic resonance imaging (fMRI) 
to examine the effect of enrichment on the DMN in MCI. DMN activity and connectivity 
were recorded pre- and post-enrichment. An increase in resting-state DMN connectivity 
was found in intervention participants, while the waitlist group showed a reduced 
connectivity. The changes in DMN connectivity were associated with an improvement on 
tests of executive function. However, there were no enrichment-related changes in DMN 
activation and deactivation. In conclusion, these results suggest some beneficial effects of 
cognitive enrichment on cognitive abilities, as well as DMN connectivity. Results from 
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CHAPTER 1 - General Introduction 
 
 Cognitive Decline in Older People 1.1
The lifespan of the general population is increasing as a result of advances in medical 
science and the availability of better healthcare services. The proportion of elderly 
persons is therefore also rising. New Zealand, like many other countries, has an ageing 
population. The proportion of people aged 65 and over has doubled since 1980, and is 
likely to double again by 2036 (StatisticsNewZealand, 2014). This rapidly ageing 
demographic, however, has a major downside, namely age-associated cognitive decline 
and dementia. Alzheimer’s disease (AD), the most common cause of dementia, is a major 
source of caregiver burden, disability, institutionalisation and mortality in old age 
(Goedert & Spillantini, 2006; Jorm & Jolley, 1998). Moreover, it has emerged as a 
critical public health emergency in many countries, as the number of older adults living 
with the disease is predicted to increase from the current 44 million to more than 132 
million by 2050 globally (Alzheimer'sAssociation, 2014).  
 
Another concern is that AD is probably the most expensive condition for our 
current health system (Alzheimer'sAssociation, 2014). Indeed, it is uncertain whether it 
will be possible to care for and treat all persons with dementia in the coming century 
(Lovestone, 2002). The societal need and fiscal costs have driven significant research 




toward developing successful remedies for AD. Unfortunately, the progressive course of 
the disorder has yet to be significantly impacted by any of the developed therapeutic 
strategies to date. 
 
 The Need for Early Identification  1.2
AD is an insidious disorder that progressively worsens brain structure and function 
(Almkvist & Winblad, 1999; Braak & Braak, 1991). By the time AD is typically 
diagnosed, substantial neuronal loss and neuropathological changes have damaged 
numerous brain regions. Although it may be possible to reverse some aspects of this 
damage, it would be ideal to initiate intervention at a time when, or even before, AD is 
mildly symptomatic, and ideally prior to dementia. Thus, the detection of an early stage 
of partial symptomatology may then offer an opportunity for early intervention. Mild 
cognitive impairment (MCI) may represent this incipient stage. Individuals with MCI 
usually show cognitive deficits that are more severe than expected, based on age and 
educational background, and which do not as yet cause significant impairment in their 
everyday activities. Confirming the view that MCI represents a transition between normal 
ageing and dementia, these individuals are at increased risk for dementia. The annual rate 
of progression from MCI to AD is approximately 14%, which is markedly greater than 
the expected 1% to 2% annual incidence of AD (Petersen, 2004; Petersen et al., 1999).  
 




Given this clinical significance, it is essential to differentiate MCI from normal 
cognition and AD. Cognitive screening provides an indication of the likely presence of 
clinically meaningful cognitive impairment and is usually the first step in the 
identification of MCI, prior to more elaborate assessments. Cognitive screening tests that 
are commonly used in clinical and research setting have been developed for the diagnosis 
of dementia and may not show adequate discrimination of MCI individuals. The Montreal 
Cognitive Assessment (MoCA) is a brief cognitive test specifically developed to screen 
for mild cognitive deficits and has been regarded as a suitable screen for people with 
suspected MCI (Lam et al., 2013; Nasreddine et al., 2005). While studies have 
demonstrated the MoCA as a sensitive measure for the detection of MCI, others have 
reported that MoCA is associated with a relatively poor specificity (Larner, 2012; T. 
Smith, Gildeh, & Holmes, 2007). The diagnostic accuracy of the MoCA can be improved 
with other supportive diagnostic techniques, such as the measurement of AD-related 
biomarkers in cerebrospinal fluid and/or structural and functional neuroimaging (Hoglund 
et al., 2015; Toledo et al., 2014; Willette, Calhoun, Egan, Kapogiannis, & Alzheimers 
Disease Neuroimaging, 2014). However, these techniques are often restricted to 
specialised settings and are not appropriate for large-scale screening of cognitive 
impairment. An alternative solution is the use of two or three brief cognitive tests in 
addition to the MoCA to improve the discriminatory power of the screening process. The 
rationale for this strategy is that different tests may provide supplementary information 
about the cognitive functioning of a given patient, increasing the probability of 
identifying those with mild deficits. 




 Treatment Options for MCI 1.3
There are currently no specific treatments for MCI, and both pharmacological agents and 
non-pharmacological intervention programmes have been examined as potential 
treatment options. The use of pharmacological treatment in persons with MCI has been a 
controversial topic. A recent systematic review demonstrated that the use of 
cholinesterase inhibitors (approved for AD treatment) have largely been unsuccessful in 
delaying disease progression or conversion to dementia in MCI patients (Karakaya, 
Fusser, Schroder, & Pantel, 2013). Additionally, factors such as cost and both immediate 
side effects such as gastrointestinal symptoms and vivid dreaming and longer term side 
effects such as bradycardia or syncope have also generated concerns with the use of 
cholinesterase inhibitors in MCI.  
 
As there is currently no clear evidence of any benefits of pharmacological 
treatment, non-pharmacological interventions especially cognitive intervention, have 
attracted a lot of attention as a potential therapeutic approach for the MCI population. 
Persons with MCI are ideal targets for cognitive intervention, as these individuals are 
usually aware of, and often worried about, their cognitive changes, which is likely to 
increase their motivation to engage in treatment (La Rue, 2011). Perhaps more 
importantly, MCI individuals retain a large range of cognitive capacities. Previous 
research has demonstrated limited efficacy of cognitive intervention in AD patients 
(Sitzer, Twamley, & Jeste, 2006), possibly as a result of substantial neuronal loss and 
reduced brain plasticity. Brain plasticity is an important aspect in cognitive intervention 




because it describes the brain’s ability to change structurally and functionally in response 
to changes in the external environment and/or its integrity (Lovden, Backman, 
Lindenberger, Schaefer, & Schmiedek, 2010; Simos et al., 2000). Brain plasticity is still 
evident in MCI individuals, as measured by their abilities to learn new information and 
adapt their behaviour (Akhtar, Moulin, & Bowie, 2006; Schreiber & Schneider, 2007), 
making them ideal candidates for cognitive intervention.  
 
Several lines of evidence from both animal and human studies have provided 
support for the hypothesis that participation in cognitive activities in humans, as well as 
environmental enrichment in animals, can lead to increased compensatory pathways in 
the brain and resilience to brain injury (Nithianantharajah & Hannan, 2006; Valenzuela, 
2008; Verghese et al., 2003; Will, Galani, Kelche, & Rosenzweig, 2004). Furthermore, it 
is now clear that cognitive functions reflect the operation of complex and widely 
distributed brain networks over and above the influence of individual brain regions 
(Andrews-Hanna et al., 2007; Bressler, 1995; Bressler & Menon, 2010). In addition, 
recent evidence suggests that ageing-related cognitive decline is a result of alternations in 
functionally connected brain regions (Greicius, Srivastava, Reiss, & Menon, 2004; 
Mevel, Chetelat, Eustache, & Desgranges, 2011). Using functional magnetic resonance 
imaging (fMRI), multiple large-scale functional brain networks have been identified and 
described. Among them, the default mode network (DMN) has received most attention, 
because it contains brain areas associated with multiple higher-order functions and 
undergoes critical changes upon ageing as well as in neurodegenerative diseases, 




particularly AD (Grady, Springer, Hongwanishkul, McIntosh, & Winocur, 2006; Greicius 
et al., 2004; Gusnard, Raichle, & Raichle, 2001; Rombouts, Barkhof, Goekoop, Stam, & 
Scheltens, 2005). Regions of the DMN have consistently been found to show high levels 
of amyloid deposition even early in the course of AD (Leech & Sharp, 2014; Sheline et 
al., 2010). Thus, intervention programmes that engage a variety of cognitive processes, in 
the form of cognitive enrichment, would stimulate many large-scale brain networks and 
perhaps maximise efficacy than cognitive training programmes that focused primarily on 
memory function alone.  
 
 Aims of the Current Study  1.4
The main aim of the current study was to develop a cognitive intervention that 
encourages participation in a variety of novel cognitive activities for individuals with 
MCI (Chapter 5-7). A noticeable difference between the current study and former studies 
would be that the Cognitive Enrichment Programme was designed to influence multiple 
large-scale networks, but include a focus on the DMN, given its importance in the 
pathological processes in AD. Additionally, we sought to investigate the feasibility and 
efficacy of the Cognitive Enrichment Programme in MCI, and examine whether the 
beneficial effects relate to functional changes in the DMN. A secondary aim was to 
provide recommendations on the screening of MCI through the use of brief 




CHAPTER 2 - Mild Cognitive Impairment 
 
 Introduction  2.1
It is probable that there are indicators of future dementia occurring up to several years 
before the onset of the full dementia syndrome. Neurochemical and neuroimaging 
evidence suggests that neuropathological changes associated with dementia, and 
Alzheimer’s disease (AD) in particular, may begin even decades before the onset of 
symptoms (Bookheimer et al., 2000; Braak & Braak, 1998). The growing emphasis on 
the importance of early identification of and interventions in dementia has led to attempts 
to define a distinct group of elderly with cognitive problems that exceed what is expected 
for their age, and educational and occupational attainment, but are not severe enough to 
cause everyday functional impairments to warrant a dementia diagnosis. This group of 
people are commonly referred to as mild cognitively impaired (MCI). The objectives of 
this chapter are to review relevant historical research on MCI, discuss how MCI is 
identified, and describe the effects of differing diagnostic criteria on its prevalence and 
rate of dementia conversion.  
 
 Historical Background 2.2
Over the last 50 years, several terms have emerged to describe and conceptualise the 
spectrum of conditions between normal ageing and pathological cognitive decline. These 




terms include benign senescent forgetfulness (Kral, 1962), age-associated memory 
impairment (Crook et al., 1986), and late-life forgetfulness (Blackford & La Rue, 1989). 
These early constructs implied that such changes are part of ‘normal ageing’, and that 
many of these individuals are exhibiting normal age-related changes and are not expected 
to undergo significant further decline or harbour neuropathological changes. These terms 
are now recognised as inadequate. By the early 1980s it was clear that many individuals 
in this group are exhibiting prodromal symptoms of dementia and would progress to 
frank dementia eventually. It was in this historical context that the term MCI became 
widely accepted in the ageing and dementia literature (Flicker, Ferris, & Reisberg, 1991). 
During the 1990s and early 2000s, MCI increasingly gained acceptance as a pathological 
entity (i.e., not a manifestation of normal aging; Petersen, Doody, et al., 2001; Winblad et 
al., 2004). More recent work reflects variability in the use of the concept and recognises 
that a population of these cases may not develop dementia (Koepsell & Monsell, 2012; 
Mitchell & Shiri-Feshki, 2009; Prestia et al., 2013).  
 
 Diagnostic Definition and Clinical Subtypes 2.3
The diagnostic term MCI refers to cognitive impairment beyond that expected for age and 
education, but does not meet criteria for dementia (Petersen, 2004; Petersen, Doody, et 
al., 2001). Diagnostic criteria for MCI have undergone periodic revision since the original 
criteria published by Petersen et al. (1999). The original criteria conceptualised MCI as 
an amnestic condition. However, as the literature on MCI expanded, there have been 




some observations that some individuals with MCI show a decline in memory only, while 
others show selective decline in other cognitive domains, such as executive function or 
visuospatial ability. In other MCI cases, mild decline is evident across multiple cognitive 
domains. Criteria for MCI have thus broadened to include both non-amnestic 
presentations and impairments in multiple cognitive domains. Although many researchers 
have suggested and used a variety of criteria for defining MCI, the general concepts in 
diagnosing MCI are (Petersen, 2004; Winblad et al., 2004): 
 subjective cognitive complaints, or by a close informant; 
 objective evidence of cognitive deficits lower than expected for age and 
educational background;  
 preserved basic activities of daily living, and complex instrumental activities are 
either intact or mildly impaired; 
 and do not meet criteria for a diagnosis of dementia. 
 
 With the advent of the revised criteria, clinical subgroups were also proposed to 
recognise that MCI is a heterogeneous diagnostic entity. An assumption has been that 
each subtype may be associated with different etiology, clinical presentation and 
prognosis. The most commonly used classification scheme is that recommended by 
Petersen et al. (2004). Four subtypes have been described and distinctions have been 
drawn between subtypes of MCI based on cognitive dysfunction: 
 amnestic MCI single domain, where memory alone is affected;  




 amnestic MCI multiple domain, where memory and at least one other area of 
cognition are affected;  
 non-amnestic MCI single domain, where one cognitive domain other than 
memory is affected; and  
 non-amnestic MCI multiple domain, where multiple domains of cognitive 
processes other than memory are affected. 
 
In addition, Petersen and colleagues (2005) provided a flowchart illustrating a 
two-step process on how to differentiate between the subtypes (Figure 2-1). First, two 
primary subtypes were delineated, based on whether a predominant memory deficit was 
present (amnestic MCI) or absent (non-amnestic MCI). Second, it acknowledged the 
possibility that more than one cognitive domain may be impaired with each of the two 
primary subtypes (e.g., single or multiple domain impaired). Even though this 
classification is drawn from the neuropsychological tests administered for evaluating 
objective cognitive impairments, each subtype is presumed to reflect different etiologies 












Figure 2-1. Flowchart for MCI diagnosis and subtyping. 
 
Amnestic MCI (aMCI) has received the most attention among researchers, 
because it has been considered to be the most common form of MCI, and the most likely 
subtype to progress to AD (Petersen & Morris, 2005). Non-amnestic (naMCI) types were 
suggested as more likely to become dementia types such as Dementia with Lewy Bodies, 
Frontotemporal dementia or have a predominately vascular etiology (Petersen & Morris, 
2005). Yaffe, Petersen, Lindquist, Kramer, and Miller (2006) examined the longitudinal 
trajectory of 327 MCI individuals after a 3.1 year follow-up. It was reported that among 
the participants who progressed to AD, 76% has a prior classification of aMCI and all 
participants who progressed to frontotemporal dementia had been previously classified as 




naMCI. In a more recent longitudinal study, where the MCI participants were followed 
up for a longer period of time (7.5 years), the authors confirmed that the proportion of 
incident AD in aMCI individuals was significantly higher than in subjects with naMCI 
(Jungwirth, Zehetmayer, Hinterberger, Tragl, & Fischer, 2012). Furthermore, 
neuroimaging studies have shown that aMCI is associated with greater hippocampal and 
medial temporal atrophy than naMCI, and these biomarkers are assumed to be especially 
sensitive to AD pathology (Clerx et al., 2013; Duara et al., 2008). Studies of brain 
metabolism showed greater medial temporal hypometabolism in aMCI than naMCI 
(Clerici et al., 2009; Mosconi et al., 2008). Positron emission tomography (PET) studies 
using Pittsburgh Compound B (PiB), an amyloid probe, found significantly higher 
percentages of aMCI individuals were PiB-positive than individuals with naMCI (Pike et 
al., 2007; Wolk et al., 2009). Thus, AD-related neurodegenerative process has been 
suggested as the main etiology of individuals with aMCI. However, memory impairment 
could also evolve as a result of other conditions such as ischemia, cardiovascular and 
cerebrovascular diseases. Vascular risk factors are common among MCI, and the concept 
of vascular cognitive impairment (vMCI) has been introduced to emphasise the high 
prevalence of cognitive impairment when there is vascular damage to the brain, such as 
stroke or small vessel disease (Davis & Rockwood, 2004; Roman & Royall, 2004; 
Roman et al., 2004). However, many of these individuals show the same pattern of 
cognitive decline as aMCI (Loewenstein et al., 2006), and is likely that their cognitive 
deficits are often caused by mixture of AD pathology and cerebrovascular disease (Davis 
& Rockwood, 2004).  




 Epidemiology  2.4
The incidence of MCI and its subtypes ranges from 1% to 6% per year with a prevalence 
from 3% to 22% in the population older than 65 years (Bennett et al., 2002; Bozoki, 
Giordani, Heidebrink, Berent, & Foster, 2001; DeCarli, 2003; J. E. Graham et al., 1997; 
Lopez et al., 2003; Petersen et al., 1999). The prevalence of MCI increases with age, 
similar to prevalence trends in AD shown in other studies (Lopez et al., 2003). 
Individuals with MCI have a 4 to 10 times higher risk of developing dementia in 
comparison to cognitively normal elderly persons (Petersen, Stevens, et al., 2001). 
Depending on the study, the overall annual conversion rate from MCI to dementia is 
between 10% to 15% per year (Bruscoli & Lovestone, 2004). So clearly not everyone 
with MCI goes on to develop dementia; some MCI individuals remain stable and other 
cases revert to a normal cognitive function (Bruscoli & Lovestone, 2004; Perri, 
Carlesimo, Serra, & Caltagirone, 2009). Concerns have been expressed over the 
‘reverted’ MCI cases, which have led some to argue that MCI is an unstable diagnostic 
category (Larrieu et al., 2002; Ritchie, Artero, & Touchon, 2001). In contrast, a recent 
longitudinal study demonstrated that the ‘reverted’ MCI are still at greater risk for 
progression to dementia compared with persons who never were considered to have MCI. 
Roberts et al. (2014) identified 534 MCI at baseline, these individuals were subsequently 
examined every 15 months. They found that almost 40% of people with MCI reverted to 
cognitively normal during follow-up examinations. However, 65% of the ‘reverts’ 
developed dementia over a 5-year follow-up, which was 6 times the percentage of 




cognitive normal subjects. This finding suggests that although MCI show fluctuations in 
cognition, the diagnosis of MCI at any time carries important prognostic implications.  
 
 Neuropsychological Evaluation  2.5
The diagnosis of MCI and its subtypes is mainly based on an individual’s performance on 
standardised neuropsychological tests. Complaints such as subtle forgetfulness, problems 
in remembering names and common words, misplacing objects, and a lack of attention 
are very common among elderly people and may not necessarily be a sign of cognitive 
disorders (Lenehan, Klekociuk, & Summers, 2012; Mendes et al., 2008). Hence 
standardised neuropsychological assessment is considered to be optimal for objectively 
assessing the degree of cognitive impairment for an individual. However, specific 
neuropsychological measures included in the diagnosis varied widely from one study to 
the other. Many of the earlier studies have taken an amnestic-centred approach in the 
assessment of MCI. In these studies, memory functions are usually assessed by tests of 
episodic memory function, but non-memory functions are often neglected or inadequately 
assessed with measures of global cognitive function, which typically do not provide 
detailed information regarding functional abilities in any cognitive domains 
(Alexopoulos, Grimmer, Perneczky, Domes, & Kurz, 2006; Brodaty et al., 2013; Gavett 
et al., 2009; Jungwirth et al., 2012; Lonie, Herrmann, Donaghey, & Ebmeier, 2008).  
 




 Researchers taking a broader view of neuropsychological assessment have argued 
against the amnestic-centred approach, in saying that, such approach is likely to miss a 
sizeable proportion of MCI cases and contribute to the inaccurate identification of MCI 
subtypes (Alladi, Arnold, Mitchell, Nestor, & Hodges, 2006; Busse, Hensel, Guhne, 
Angermeyer, & Riedel-Heller, 2006). Obviously, these consequences are of significant 
concern, given findings that individuals with MCI are at increased risk for AD, and MCI 
subtypes differ in diagnostic outcomes and likelihood of progression to AD. The National 
Institute on Ageing have recommended for MCI studies to include a comprehensive 
assessment of memory and non-memory functions (Albert et al., 2011; Klekociuk, 
Summers, Vickers, & Summers, 2014; Mitchell, Arnold, Dawson, Nestor, & Hodges, 
2009; Summers & Saunders, 2012). A detailed assessment of non-memory functions 
would ideally include measures of executive function, visuospatial function, attention and 
processing speed, and language abilities (Ghosh, Libon, & Lippa, 2013; Summers & 
Saunders, 2012). In addition, the diagnosis of MCI necessitates an abnormal change from 
baseline cognitive ability. Thus, estimation of premorbid baseline is important to gauge 
the significance of obtained test results. Table 2-1 provides an overview of the types of 
tests, grouped by cognitive domains, that may be used in the neuropsychological 
assessment to identify MCI. It is important to note that cognitive domains are not discrete 
entities. Even though a test may be designed to focus on one aspect of cognition, more 
often than not, test performance is influenced by multiple cognitive domains.  
 
 





Neuropsychological Tests, Grouped by Cognitive Domains, Commonly Used in the Assessment of MCI 
Assessment of Baseline Intelligence  
 National Adult Reading Test  
 Wechsler Test of Adult Reading 
 Advanced Clinical Solutions – Test of Premorbid IQ 
Measures of Global Cognitive Function  
 Mini-Mental Status Exam 
 Montreal Cognitive Assessment  
 Dementia Rating Scale-2 
 Clinical Rating Scale 
 Alzheimer's Disease Assessment Scale – Cognitive Subscale 
Memory  
Word-List Recall  
 Hopkin Verbal Learning Test  
 California Verbal Learning Test 
 Rey Auditory Verbal Learning Test 
 Selective Reminding Test 
Narrative Memory   
 Wechsler Memory Scale – Logical Memory  
 Rivermead Behavioural Memory Test – Story Recall  
Non-Verbal 
 Wechsler Memory Scale – Visual Reproduction 
 Rey Complex Figure Test 
 Brief Visuospatial Memory Test 
Executive Function  
 Delis–Kaplan Executive Function System  – Trail Making, Verbal Fluency, Design Fluency, 
Colour-Word Interference, Sorting, Tower 
 Wisconsin Card Sorting Test 
Visuospatial Function 
 Wechsler Adult Intelligence Scale – Matrix Reasoning, Block Design 
 Judgement of Line Orientation  
 Clock Drawing Test 
 Rey Complex Figure Test – Copy  
 Clock Drawing Test 
 Visual Object and Space Perception Battery 
 Birmingham Object Recognition Battery 
Attention and Processing Speed  
 Wechsler Adult Intelligence Scale – Digit Span, Symbol Search, Coding 
 Digit Symbol Modalities Test 
 Cancellation Test  
 Trail Making Test-Part A 
 Wechsler Memory Scale – Symbol Span 
Language 
 Boston Naming Test 
 Controlled Oral Word Association Test 
 Token Test 
  




 Measures of Global Cognitive Status  2.5.1
Brief mental status examinations, such as the Mini-Mental State Examination (MMSE), 
are often insensitive to the detection of early impairment. In contrast, the Montreal 
Cognitive Assessment has been suggested as a more useful measure of MCI. The Clinical 
Dementia Rating (CDR) scale, a semi-structured interview with the patient and the 
caregiver, is another scale that is commonly used for individuals with MCI. In addition, 
the Alzheimer’s disease Assessment Scale – Cognitive Subscale (ADAS-Cog) has also 
increasingly been used for MCI, and shown good sensitivity and specificity for 
differentiating MCI from healthy controls and AD (Verma et al., 2015). In contrast, the 
Dementia Rating Scale-2 (DRS-2) has a ceiling effect in MCI, making it difficult to 
distinguish normal ageing form early cognitive decline (De Jager & Budge, 2005), but 
has demonstrated excellent discrimination of patients of advanced dementia (Jurica, 
Leitten, & Mattis, 2001). These instruments are often used as screening instruments and 
will invariably need to be supplemented by more detailed testing to differentiate MCI 
from dementia and health controls.  
 
 Memory  2.5.2
As notes earlier in this chapter, impairment in memory is most commonly seen in MCI 
patients who subsequently progress to a diagnosis of AD dementia. Research studies have 
shown that there are a variety of memory tests that are useful for identifying those MCI 
patients who have a high likelihood of progressing to AD dementia within a few years 




(Nelson & O'Connor, 2008; Rabin et al., 2009). These tests vary in complexity (i.e., short 
stories vs. word lists; simple visual designs vs. complicated visual figures), modality of 
presentation (i.e., visual vs. auditory) and linguistic demand (i.e., geometric shapes vs. 
words). Tests of episodic memory often consist of an immediate and delayed recall 
conditions, making it possible to determine retention over a delay. Word-list learning 
tests, involving learning across multiple trials, has been suggested as perhaps the most 
challenging and sensitive measures of episodic memory when used to assess early 
cognitive changes in MCI and AD (Rabin et al., 2009). A different type of verbal memory 
test focuses on memory for narrative information (e.g., Logical Memory, Story Recall), 
and in these tests participants are asked to learn and retain a short story. Tests of non-
verbal memory may require the participant to study and later reproduce figural drawings 
and/or to study (e.g., Rey Complex Figure Test).  
 
 Executive Function 2.5.3
Executive functions comprise interference control, initiation/inhibition, set-shifting, 
cognitive flexibility, planning, organisation, and abstract reasoning. Some studies have 
suggested that poor initial performance on measures of executive function were better 
predictors of AD than tests of episodic memory (Rapp & Reischies, 2005). Recent results 
from the Alzheimer’s disease Neuroimaging Initiative indicated that executive 
impairments (Trail Making Test B-A difference score, and Digit Symbol Coding) 
predicated impairments in activities of daily living and in MCI who progressed to AD 




(Marshall et al., 2011). More recently, Clark et al. (2012) showed that measures of 
executive function differentiated between MCI participants who displayed cognitive 
decline over 12 months from those who did not decline.  
 
 Visuospatial Function 2.5.4
Visuospatial impairments are often among the first symptoms noted in AD (Mandal, 
Joshi, & Saharan, 2012; Weintraub, Wicklund, & Salmon, 2012) and can be manifested 
by individuals as getting lost in familiar environments, forgetting where they placed their 
personal items, or difficulty driving or parking a car (Quental, Brucki, & Bueno, 2013). 
Visuospatial assessment often includes measures of visual orientation (e.g., Judgement of 
Line Orientation), visual perception (e.g., Silhouettes), visual analysis and synthesis (e.g., 
Matrix Reasoning), and visuoconstructive skills (e.g., Block Design, Rey Complex Figure 
Test - Copy) (Possin, 2010; Rizzo, Anderson, Dawson, & Nawrot, 2000; Salmon & 
Bondi, 2009).  
 
 
 Attention and Processing Speed  2.5.5
Attention and processing speed are basic cognitive processes that sub-serve many other 
higher-order cognitive domains. Tasks of attention and processing speed vary widely in 
length and complexity. The most basic aspect of attention pertains to attention span – the 
amount of information that an individual can hold in mind at one time. Auditory attention 




span is often assessed by having the patient repeat progressively longer series of digits 
(e.g., Digit Span), whereas visual attention span is assessed by having the participant 
point to a series of locations indicated by the examiner on a spatial array (e.g, Symbol 
Span). Other tasks of attention focus on capacity of sustained vigilance or continuous 
performance (e.g., Cancellation). Processing speed tests typically involve the ability to 
quickly perform relatively easy or over-learned cognitive tasks. Johnson, Storandt, 
Morris, and Galvin (2009) reported that tests of attention and processing speed (Digit 
Symbol and Trail Making Test-Part A) demonstrated an inflection point 3 years before 
clinical diagnosis of AD, whereas the inflection point for verbal memory was not seen 
until 1 year before clinical diagnosis, suggests that perhaps attention and processing 
speed deficits occur before episodic memory deficits.  
 
 Language 2.5.6
A core component of the evaluation of the MCI individuals is the assessment of language.  
Language abilities can be assessed formally using standardised neuropsychological tests 
or informally throughout the assessment. Conversation speech is rated in terms of 
fluency, comprehension, and word findings problems (Graham, Cully, Snow, Massman, 
& Doody, 2004). Standardised cognitive tests are often in the form of confrontation 
naming (e.g., Boston Naming) and language comprehension (e.g., Token Test) (Nelson & 
O'Connor, 2008).  
 




 Defining Impairment  2.5.7
More recently, MCI studies have begun to explore the requirement used to define 
'impairment', specifically the number of impaired test results required to meet criteria in a 
given cognitive domain (e.g.,1 test vs. 2 tests) and the predetermined cut-off points to 
identify cognitive impairment (e.g., 1.0, 1.5 or 2SD below the normative mean). In the 
original MCI criteria, Petersen et al. (1999) suggested a cut-off of at least 1.5SD below 
the age- and education-adjusted values. However, a number of studies have defined MCI 
on the basis of cognitive impairment of 1.0SD below the average score of normal elderly 
subjects (Lonie et al., 2010; Ritchie et al., 2001), while others used the 10
th
 percentile 
(equivalent to -1.3SD) as the cut-off (Mitchell et al., 2009; Summers & Saunders, 2012). 
Some studies used a more conservative cut-off of 2SD lower than the norm (De Ronchi et 
al., 2005). Several studies have indicated that those with more severe cognitive deficits, 
defined by either the number of impaired tests or level of performance, are at increased 
risk for developing dementia. Loewenstein et al. (2009) provided compelling data that 
MCI diagnoses based on the requirement of two or more tests within a single domain, are 
superior to those based on a single impaired score. These authors reported that if one test 
was used to diagnose MCI, 56% of the individuals improved, 25% remained stable, and 
19% decline over a two- to three-year period. In contrast, if two impaired scores in a 
domain were required, none of these individuals showed improvements over the same 
follow-up period, 50% remained stable, and 50% declined. The ‘two tests within a single 
domain’ approach was further validated by Jak et al. (2009). In their study, 73 non-
demented, neurologically normal, community-dwelling older adults were followed up for 




18 months. At baseline and follow-up participants were classified as either normal or as 
having MCI by means of different diagnostic criteria, which varied on the number of 
neuropsychological tests considered in the diagnosis and the cut-off for objective 
cognitive impairment. Examination of classification agreement across time with different 
strategies revealed that the most conservative strategy examined for diagnosing MCI, that 
is, requiring performance on two measures within one cognitive domain equal to or 
greater than 1.5SD below the normative mean on two measures within a domain, had the 
greatest reliability and stability of diagnosis (Jak et al., 2009). Remarkably, the 
conservative strategy (two tests at -1.5SD) showed significant associations with 
apolipoprotein E (APOE) genotype and medial temporal atrophy (Schinka et al., 2010). 
The studies reviewed suggest that a more comprehensive approach in neuropsychological 
assessment coupled with a lower cut-off value may be the better choice for researchers 
looking for a more stable diagnostic strategy.  
 
 The Current Study  2.6
The overarching goal of the current study was to slow down the progression to AD, thus 
amnestic subtype became the obvious subtype to focus on, given its higher conversion 
rate to AD compared with the non-amnestic subtype. To accurately identify aMCI, a 
comprehensive battery of neuropsychological tests was adopted by the current study. 
Tests were classified into five board cognitive domains (memory, attention and 
processing speed, language, visuospatial skills, and executive function) each with at least 




two tests within each domain. The 1.5SD below normative data was adopted as the cut-
off value to indicate impairment, alongside the requirement that two or more tests within 






CHAPTER 3 - Cognitive Screening for MCI 
 
 Introduction 3.1
As mentioned earlier, it is of value to detect and diagnose MCI because people with this 
condition are at increased risk for AD and other types of dementia compared with 
similarly aged individuals in the general population (Petersen & Morris, 2005). One of 
the major challenges in cognitive testing is to provide abbreviated tests to differentiate 
MCI from normal cognition. As mentioned in Chapter 2, the diagnosis of MCI requires a 
comprehensive assessment of cognition (Winblad et al., 2004). However, time and 
resources are often limited in clinical and research settings, and comprehensive 
neuropsychological assessment is not always feasible. The usefulness of a particular 
screening tool lies in its diagnostic and statistical robustness – ideally, high sensitivity 
and specificity along with high accuracy for positive predictive value (PPV) and negative 
predicative value (NPV). Sensitivity refers to the ability of a test to correctly classify an 
individual as impaired; specificity refers to ability of a test to correctly classify an 
individual as unimpaired (Florkowski, 2008). PPV refers to the proportion of people with 
a positive test who actually have the disorder; and NPV refers to the proportion of those 
with a negative test who do not have the disease (Florkowski, 2008). Sensitivity and 
specificity of a particular measure may vary depending on the mix of participants and in 
particular the inclusion of people who are difficult to diagnose, while PPV and NPV are 




directly related to the prevalence of the disease in the population. Assuming sensitivity 
and specificity remain the constant, the PPV will increase with increasing prevalence; and 
NPV decreases with increase in prevalence (Florkowski, 2008). 
 
 A number of screening instruments have been used in clinical care and research to 
identify global cognitive impairment. The Montreal Cognitive Assessment (MoCA) is 
becoming one of the most widely used cognitive screens to assess cognitive status. While 
prior research has demonstrated the superiority of MoCA over Mini-Mental State 
Examination (MMSE) in differentiating the MCI cases, the specificity of the MoCA for 
MCI in the general population has been reported by some studies as poor (McLennan, 
Mathias, Brennan, & Stewart, 2011; T. Smith et al., 2007). Hence, additional tools may 
be valuable to screen for MCI.  
 
 Longitudinal studies suggest that AD is preceded by decline in multiple cognitive 
functions (R. S. Wilson, Leurgans, Boyle, & Bennett, 2011). Decline in visuospatial 
function and speeded psychomotor skills, in addition to episodic memory deficits, have 
been suggested as the earliest signs of prodromal AD (Backman, Jones, Berger, Laukka, 
& Small, 2005; Grober et al., 2008; R. S. Wilson et al., 2011). One longitudinal study 
compared individuals who became demented during follow-up and people who remained 
non-demented and reported that tests of speeded processing of visual information were 
the most significant predictors of which individuals will subsequently develop dementia 
(Johnson et al., 2009). Therefore, in addition to the MoCA, the current study included the 




Rey Complex Figure Test (RCFT) and the Trail Making Test Part A (TMT-A) as part of a 
brief cognitive screen. The RCFT was chosen because it measures both visuospatial 
abilities and visuospatial memory. Although not a screening instrument, its copy and 
immediate recall (3min) component takes minimal time to administer. Part A of the TMT 
is another brief test of visuospatial skills combined with speed of processing. Galvin et al. 
(2005) demonstrated in their longitudinal study that TMT-A was the only baseline 
cognitive measure that predicted dementia, with individuals who were slower on this 
measure developing dementia sooner. 
 
The objective of this chapter was to compare the diagnostic utility of the MoCA, 
RCFT and TMT-A in identifying people with MCI, and whether additional diagnostic 
value is achieved by combining these measures.  
 
 Method  3.2
 Brief Cognitive Screening  3.2.1
Between 2010 and 2011, 609 people aged 65 or older were recruited in the Canterbury 
region through newspaper advertisements, and through public seminars made to 
community groups, residential homes and through the New Zealand Brain Research 
Institute (NZBRI) database. These community volunteers were given a short screen at the 
participant’s home or at the NZBRI, in a single 30-minute session. Participants were 
assessed by psychology students, including the author, trained in administering the 




neuropsychological tests. The screen consisted of the MoCA (Nasreddine et al., 2005), 
RCFT Copy (Meyers & Meyers, 1995), RCFT Recall (3-min delay) (Meyers & Meyers, 
1995), and TMT-A (Mitrushina, Boone, Razani, & D'Elia, 2005). Demographic 
characteristics of the screening sample are presented in Table 3-1.  
 
Table 3-1 
Demographic Characteristics of the Screening Sample; Mean (SD) 
 Screening Participants (n = 609) 
Age 74.2 (6.2) 
Gender (F:M) 387: 222 
Education  12.9 (2.6) 
Ethnicity 605 NZ European;  
4 Maori, two of whom indicated both Maori and NZ European ethnicity 
 
Of the 609 assessed participants, 222 were excluded on the basis of: aged 85 years 
or older; previous or current medical complications (i.e., multiple sclerosis, Parkinson’s 
disease, major coronary disease, stroke, cancer); developmental disorders (i.e., learning 
disability, autistic spectrum disorder); major psychiatric conditions (i.e., schizophrenia, 
bipolar); or current medications (i.e., antidepressants, benzodiazepines) that are likely to 
affect cognitive functioning. Other reasons for exclusion are provided in Figure 3-1. 
 
 Initial Participant Classification 3.2.2
The remaining 387 participants were classified into three categories: Probable MCI (n = 
75), Possible MCI (n = 72) and Probable Healthy Control (Probable HC; n = 240) based 
on their performance on the MoCA, TMT-A, RCFT Copy and RCFT Recall (Table 3-2). 
As progression to AD is associated with both memory impairment and decline in non-




memory domains, participants in the Probable MCI group had to meet one of the 
following criteria: either a MoCA score of < 28, but an impaired score on RCFT Recall 
(< -1.5SD; 0.7
th
 percentile) or a poor performance on the MoCA (< 26; Nasreddine et al., 
2005) plus a borderline impaired or worse score on any one of the three measures (< -
1.3SD; 10
th
 percentile). People in the Probable HC group were deemed likely to be 
ageing normally, if they either attained a MoCA score of > 25 and above ‘borderline’ 
performance on all other tests (> -1.3SD; 10
th
 percentile) or had relatively poor 
performance on MoCA (< 26), but ‘normal’ performance on all other tests (> 0.7SD; 25
th
 
percentile). The Possible MCI group consisted of individuals with variable test 
performance who did not meet either the Probable HC or Probable MCI criteria.  
 
Table 3-2 
Preliminary Classification Criteria Based on the Brief Neuropsychological Screen 
Group Specific criteria 
Probable 
MCI 
MoCA <26; any z-score <-1.3SD (n = 64); or 




MoCA <26; all z-scores > -1.3SD, but <-0.7SD (n = 28); or 
MoCA >25 but <28; any z-score <-1.3SD, but RCFT Recall >-1.5SD (n = 20); or 




MoCA >25; all z-scores >-1.3SD (n = 103); or 
MoCA <26; all z-scores >-0.7SD (n = 137) 
 
Note. A z-score of -1.3 is equivalent to the 10
th
 percentile which is often used to indicate ‘borderline’ 
performance. A z-score of -0.7 is equivalent to the 25
th
 percentile which is often used to indicate the 
beginning of ‘low average’ range. MoCA = Montreal Cognitive Assessment; RCFT = Rey Complex Figure 





Figure 3-1. Flow diagram of participation. HC = Healthy Controls; MCI = Mild Cognitive Impariment. 
*Final MCI = 17, including one MCI from the Probable HC group. 
# Probable HC indiviudals (n = 33) were aged and education matched to the 35 individuals of the Probable MCI group.




 Detailed Neuropsychological Assessment 3.2.3
Subsequent to the cognitive screen, all Probable MCI who could be examined (n = 35) 
and, for comparison, an age and education matched subgroup of Probable HC (n = 20) 
received detailed neuropsychological assessment at NZBRI to confirm their cognitive 
status (Figure 3-1). Neuropsychological tests were administered in a fixed sequence with 
tests divided across two sessions. Verbal tests were intermingled with non-verbal tests in 
each session to reduce fatigue and test contamination. For example, non-verbal (non-
memory) tests were administered between the immediate and delayed recall trials of 
verbal memory test, and vice versa. For each neuropsychological test, age-matched 
normative data were used to ascertain whether performance was within the normal range 
or below the normal range. Three postgraduate psychology students including the author 
administered the tests.  
 
The tests included measures of (1) premorbid IQ (Advanced Clinical Solution; 
Wechsler, 2009); (2) global cognitive functioning – MoCA (Nasreddine et al., 2005); 
Dementia Rating Scale (DRS-2; Jurica et al., 2001); Alzheimer’s Disease Assessment 
Scale-Cognition (ADAS-cog; D. P. Graham et al., 2004; Mohs et al., 1997); (3) learning 
and memory – California Verbal Learning Test-II Short Form (CVLT-II SF; Delis, 
Kramer, Kaplan, & Ober, 2000); Brief Visuospatial Memory Test-Revised (BVMT-R; 
Benedict, 1997); RCFT Immediate and Delayed Recall (Meyers & Meyers, 1995); Story 
Recall (Wilson et al., 2008); Rappel Indice 48 Items (RI-48; Adam et al., 2007); Visual 




Association Test (Lindeboom & Schmand, 2003; Lindeboom, Schmand, Tulner, Walstra, 
& Jonker, 2002); (4) executive function – Stroop Interference (Delis et al., 2000); Letter 
Fluency (Delis et al., 2000); Category Fluency (Delis et al., 2000); Category Switching 
(Delis et al., 2000); Action Fluency (Piatt, Fields, Paolo, & Troster, 2004); Design 
Fluency (Delis et al., 2000); TMT-B (Mitrushina et al., 2005); (5) attention and 
processing speed – Digit Span Test (Wechsler, 2008a, 2008b); Stroop Word Reading 
(Delis et al., 2000); Stroop Colour Naming (Delis et al., 2000); Symbol Digit Modality 
Test (SDMT; Smith, 1982); TMT-A (Mitrushina et al., 2005); (6) visuospatial skills – 
RCFT Copy (Meyers & Meyers, 1995); Matrix Reasoning (Wechsler, 2008a, 2008b); 
Judgement of Line Orientation (Benton, Hamsher, Varney, & Spreen, 1983); Silhouettes 
(Warrington & James, 1991); and (7) language – Boston Naming (Lansing, Ivnik, 
Cullum, & Randolph, 1999); Token Test (Unverzagt et al., 1999). Subjective cognitive 
impairment was determined by asking the participant and informant “Do you have 
problems with memory or thinking?” Activities of daily living were measured using the 
Clinical Dementia Rating (CDR; Morris, 1993). The CDR and DRS-2 were used to 
exclude dementia. Tests used in the detailed neuropsychological assessment are described 
in Appendix A.  
 
 Final Participant Classification  3.2.4
Following the flowchart described in Figure 3-1, participants were assigned to their final 
groups, adjusted on the basis of performance on the detailed neuropsychological 




assessment where available. As a result, 17 individuals were classified as MCI using 
Petersen recommendations (Petersen, Doody, et al., 2001): the presence of (1) objective 
evidence of cognitive decline on two or more memory tests, defined as lower than age 
adjusted norms at 1.5SD below the standardised mean or an equivalent ‘impaired score’ 
on the Story Recall – a borderline profile score of 1 (borderline) or a score of < 19 on RI-
48 delayed recall; (2) a global cognitive score of either MoCA < 26 or DRS-2 scaled 
score < 9; (3) subjective memory complaint, by participant or informant; and (4) 
essentially preserved activities of daily as shown by a total CDR of 0 or 0.5.  
 
Participants who received detailed assessment but failed to meet these 
confirmatory MCI criteria either remained as Probable HC or were reclassified as 
Possible MCI. Reclassification to Possible MCI was necessary when their performance 
on the standardised neuropsychological tests was not sufficient for a classification of 
Probable HC. All participants who did not receive detailed neuropsychological testing 
remained with the classification given after screening. Table 3-3 provides the 
demographic characteristics of the three cognitive groups, there were no significant 
differences across the three groups in terms of age, gender, education or ethnicity.  
 
Table 3-3 
Demographics Characteristics of the Three Cognitive Groups 
 Confirmed MCI  (n = 17) Possible MCI  (n = 91) Probable HC (n = 275) 
Age 74.5 (4.6) 74.0 (6.1) 72.8 (5.4) 
Gender 7 : 10 59 : 32 139 : 88 
Education  12.9 (2.8) 13.1 (2.7) 13.4 (2.6) 
Ethnicity  1 Maori (both Maori & NZ European) All NZ European 2 Maori 
Note. MCI = Mild Cognitive Impairment; HC = Healthy Control. No significant differences. 




 Diagnostic Utility of Individual Screening Tests 3.2.5
The initial receiver operating characteristic (ROC) analyses examined the diagnostic 
utility of each individual screening measure, namely the MoCA, RCFT Copy, RCFT 
Recall, and TMT-A. The cut-off that produced the highest Youden index (sensitivity + 
specificity – 1) was identified. A prevalence rate of 15% for MCI was chosen to compute 
positive and negative predictive values (Ritchie, 2004). These univariate ROC analyses 
were performed with MedCalc version 13.1.2 (www.medcalc.be). Three separate ROC 
analyses were carried out: 
1. For the first analysis, the Possible MCI and the Probable HC were treated as a 
single non-MCI group (n = 317) and compared with the Confirmed MCI group (n 
= 17). Individuals included in this analysis provided a good representation of the 
general elderly population, where individuals exhibited a range of cognitive 
functioning. Therefore, cut-off values generated from this analysis should be 
considered when making MCI diagnosis in the general elderly population.  
2. The second analysis compared the Confirmed MCI group (n = 17) with the 
Probable HC group (n = 226). This analysis provides the cut-off values for 
diagnosing MCI from normal cognition.  
3. The third analysis compared the Confirmed MCI group (n = 17) with the Possible 
MCI group (n = 91). Results from this analysis should be considered when 
diagnosing MCI from individuals with some cognitive impairments but not 
sufficient for a diagnosis of MCI.  
 




 Diagnostic Utility of Combination of Screening Tests 3.2.6
Multivariate logistic regression analysis was then conducted to investigate whether 
combinations of the screening instruments improved the detection of MCI. These 
analyses were carried out in consultation with Associate Professor Christos Nakas at 
Laboratory of Biometry, University of Thessaly, Magnesia, Greece. For each of the three 
analysis listed above, a logistic regression model was developed using the four screening 
measures, and adding demographic variables to adjust for their influence. After model 
building, the predicted probabilities of each model (referred to as Pscores in Figure 3-3) 
were used to plot an ROC curve that was tested against the ROC of each individual 
screening measure. The models were validated using a leave-one-out analysis.  
 
 Comparisons across Three Groups 3.2.7
Three-Dimensional ROC analysis addresses the performance of a screening measure 
when making simultaneous discriminations among three groups (Nakas, 2014), in this 
instance Confirmed MCI, Possible MCI, and Probable HC. ROC surfaces were plotted on 
three-dimensional coordinates, and the volume under the ROC surface (VUS) indicates 
the discriminatory power of the screening instruments across all three groups 
simultaneously. The VUS is a logical extension of the traditional two-dimensional area 
under the curve in the two-group comparison and is appropriate when the dependent 
variable can be expected to produce an ordinal arrangement across the three groups. 
These analyses were conducted by Associate Professor Christos Nakas, in consultation 




with the current author, and the results were assessed through ROC surface analysis along 
the lines described in Nakas (2014) and J. L. Li and Zhou (2009). 
 
 Results  3.3
 Confirmed MCI vs. non-MCI (Possible MCI and Probable HC combined) 3.3.1
The first set of analyses was conducted to examine the diagnostic utility of the different 
screening tests to differentiate confirmed MCI from non-MCI (Possible MCI and 
Probable HC combined). The optimal cut-off point, sensitivity, specificity, PPV and NPV 
for each screening instrument are listed in Table 3-4. The MoCA, RCFT Copy and RCFT 
Recall produced high AUCs in discriminating individuals with MCI from those without 
MCI, and were significantly superior in this regard compared to the AUC for TMT-A 
(AUC difference of 26.1% for the MoCA, p < 0.001; AUC difference of 23.5% for the 
RCFT Copy, p < 0.01; and AUC difference of 34.4% for the RCFT recall, p < 0.001). 
The RCFT Recall appeared to perform better than the MoCA and the RCFT Copy in the 
discriminating MCI from non-MCI. The AUC for the RCFT Recall was significantly 
larger than that shown by the MoCA (AUC difference = 8.25%, p <0.05), but just failed 
to reach significance when compared to RCFT Copy (AUC difference = 10.9%, p = 
0.05). The AUC difference between the MoCA and RCFT Copy did not reach 
significance (AUC difference = 2.64%, p = 0.58). 
 
 





Confirmed MCI vs. non-MCI: Diagnostic Performance of MoCA, RCFT Copy, RCFT Recall, TMT-A  















(63.6 to 98.5) 
67.51 
(62.0 to 72.6) 
32.4 
(24.6 to 40.9) 
97.0 
(93.6 to 98.9) 
0.83  






(44.0 to 89.7) 
78.55 
(73.6 to 82.9) 
36.7 
(27.1 to 47.2) 
93.8 
(89.9 to 96.5) 
0.80  






(56.6 to 96.2) 
86.12 
(81.8 to 89.7) 
51.1 
(39.8 to 62.4) 
96.5 
(93.4 to 98.4) 
0.91  






(63.6 to 98.5) 
33.86 
(28.7 to 39.4) 
19.1 
(14.2 to 24.7) 
94.2 
(87.8 to 97.9) 
0.57  






(71.3 to 99.9) 
89.59 
(85.7 to 92.7) 
61.5 
(49.7 to 72.4) 
98.9 
(96.7 to 99.8) 
0.94  
(0.91 to 0.96) 
<0.001 
Note. MoCA = Montreal Cognitive Assessment; RCFT = Rey Complex Figure Test; TMT = Trail Making 
Test; Combined Model = MoCA + RCFT Copy + RCFT Recall; cut-off = the value that produced the 
highest Youden index; PPV = Positive Predictive Value; NPV = Negative Predictive Value; AUC = Area 
Under the Curve; CI = Confidence Interval.  
 
Logistic regression determined the combination of tests that produced the best 
discriminant ability of the Confirmed MCI and the non-MCI. This analysis suggested that 
the optimal combination was produced by the inclusion of the MoCA, RCFT Copy and 
RCFT Recall (but not TMT-A). As illustrated in Figure 3-2, the AUC for the combination 
model was higher than the AUC obtained by using a single measure, with a significant 
difference relative to the MoCA (AUC difference = 11.0%; p < 0.001) and the RCFT 
Copy (AUC difference = 13.7%; p < 0.001). However, the difference failed to reach 
significance when compared to the RCFT Recall (AUC difference = 2.78%; p = 0.22), 
although sensitivity and PPV were increased by the combination model compared to the 
RCFT Recall.  
 





Figure 3-2. ROC curves for MoCA, RCFT Copy, RCFT Recall, TMT-A and the combination model to 
detect Confirmed MCI vs. non-MCI. 
 
The logistic regression model was then used to determine the cut-off values for 
differentiating the Confirmed MCI from non-MCI, using the combination of MoCA, 
RCFT Copy and RCFT Recall. MoCA is often used by itself in previous literature, but 
here cut-offs of the added RCFT measures for different MoCA scores are presented. 
Figure 3-3 provides the visual representations of four example of MoCA scores and the 
respective cut-off values for RCFT Copy and RCFT Recall for diagnosing Confirmed 
MCI vs. non-MCI. Refer to Appendix B for more detailed information on cut-off scores. 
For simplicity, cut-off values were presented as cross-tabulation tables of RCFT Copy 
and RCFT Recall for relevant MoCA scores of 15 through to 30. For example, a person 




with a MoCA of 28, RCFT Copy of -1.5SD and RCFT Recall of -1.5SD would be 
classified as MCI. In Contrast, a person with a lower MoCA score of 19, but a RCFT 




Figure 3-3. Three-dimensional logistic regression graphs showing cut-off values for RCFT Copy and 
Recall for a range of MoCA scores. Figure courtesy of Associated Professor Christos Nakas. P-scores on 
the z-axis represents the predicted probabilities based on the logistic regression model according to the 
MoCA score on the title and the RCFT Copy and Recall scores on the x and y axes, respectively. x-axis 
represents the z-score range for RCFT Recall, and y-axis represent the z-score range for RCFT Copy. Red = 









 Confirmed MCI vs. Probable HC  3.3.2
When discriminating Confirmed MCI from Probable HC, a similar profile emerged, with 
the MoCA, RCFT Copy and RCFT Recall producing high AUCs that were superior to the 
TMT-A in discriminating MCI from Probable HC. The optimal cut-off point, sensitivity 
and specificity, PPV and NPV for each screening instrument are listed in Table 3-5. The 
AUC for the RCFT recall was significantly higher than that shown by the MoCA (AUC 
difference of 10.1%; p < 0.01), but failed to reach significance when compared with 
RCFT Copy (AUC difference of 8.31%; p= 0.07). The MoCA and the RCFT Copy had 
similar AUCs (AUC difference of 1.78%, p = 0.68); while the MoCA appeared to be a 
more sensitive measure, the RCFT Copy was more specific and had a higher PPV than 
the MoCA (Table 3-5).  
 
Table 3-5 
Confirmed MCI vs. Probable HC: Diagnostic Performance of MoCA, RCFT Copy, RCFT Recall, TMT-A  















(63.6 to 98.5) 
73.01 
(66.7 to 78.7) 
36.6 
(26.6 to 47.5) 
97.2 
(93.3 to 99.2) 
0.86  






(44.0 to 89.7) 
94.25 
(90.4 to 96.9) 
68.4 
(51.2 to 82.6) 
94.8 
(90.8 to 97.4) 
0.88  






(56.6 to 96.2) 
97.35 
(94.3 to 99.0) 
84.6 
(68.5 to 94.4) 
96.9 
(93.5 to 98.8) 
0.96  






(63.6 to 98.5) 
34.67 
(28.5 to 41.3) 
19.2 
(13.6 to 26.1) 
94.3 
(86.5 to 98.4) 
0.58  






(71.3 to 99.9) 
100 
(98.4 to 100) 
100 
(89.8 to 100) 
99.0 
(96.5 to 99.9) 
0.97 
(0.94 to 0.99) 
<0.001 
Note. MoCA = Montreal Cognitive Assessment; RCFT = Rey Complex Figure Test; TMT = Trail Making 
Test; Combined Model = MoCA + RCFT Copy + RCFT Recall; Cut-off = the value that produced the 
highest Youden index; PPV = Positive Predictive Value; NPV = Negative Predictive Value; AUC = Area 
Under the Curve; CI = Confidence Interval.  
 




The combination model showed excellent AUC, sensitivity, specificity, PPV and 
NPV. Consistent with the Confirmed MCI vs. non-MCI comparisons, the AUC for the 
Confirmed MCI vs. Probable HC produced by the combination model was excellent and 
higher than the AUC obtained by using single measures (Figure 3-4). A significant 
improvement of the combined model was found relative to the MoCA (AUC difference = 
10.8%; p < 0.001) and the RCFT Copy (AUC difference = 9.01%; p < 0.01). Once again, 
the AUCs for the combined model and the RCFT Recall were similar (AUC difference = 
6.93%, p = 0.68). Cut-off values for differentiating Confirmed MCI from Probable HC 
are presented as cross-tabulation tables in Appendix C. 
 
 
Figure 3-4. ROC curves for MoCA, RCFT Copy, RCFT Recall, TMT-A and the combination model to 
detect Confirmed MCI vs. Probably HC.  




 Confirmed MCI vs. Possible MCI  3.3.3
Given this more difficult discrimination, the AUCs were smaller than for the previous 
comparisons. When discriminating the Confirmed MCI from Possible MCI, only the 
MoCA and RCFT Recall produced significant AUCs. In contrast to previous 
comparisons, the RCFT Copy provided non-significant AUC (Table 3-6). The AUC for 
the MoCA and RCFT Recall were significant higher than that shown by the TMT-A 
(AUC difference = 20% for the MoCA, p < 0.01; AUC difference = 23.7%, p < 0.01), but 
the failed to reach significance when compared to RCFT Copy (AUC difference of 13.6% 
for MoCA, p = 0.10; AUC difference of 17.3% for RCFT Recall, p = 0.11). While RCFT 
Recall and the MoCA showed similar AUC values (AUC difference of 3.68%; p = 0.61), 
the RCFT was a more specific measure than the MoCA.  
 
Table 3-6 
Confirmed MCI vs. Possible MCI: Diagnostic Performance of MoCA, RCFT Copy, RCFT Recall, TMT-A  















(63.6 to 98.5) 
53.85 
(43.1 to 64.4) 
25.2 
(14.6 to 38.5) 
96.3 
(86.9 to 99.6) 
0.74  






(27.8 to 77.0) 
73.63 
(63.3 to 82.3) 
26.2 
(12.4 to 44.4) 
89.9 
(80.7 to 95.6) 
0.61  






(44.0 to 89.7) 
82.42 
(73.0 to 89.6) 
41.5 
(23.2 to 61.7) 
94.1 
(86.5 to 98.1) 
0.78  






(63.6 to 98.5) 
31.87 
(22.5 to 42.5) 
18.6 
(10.6 to 29.1) 
93.9 
(79.1 to 99.3) 
0.54  






(44.0 to 89.7) 
92.31 
(84.8 to 96.9) 
61.8 
(36.8 to 83.0) 
94.7 
(87.8 to 98.3) 
0.86  
(0.78 to 0.92) 
<0.001 
Note. MoCA = Montreal Cognitive Assessment; RCFT = Rey Complex Figure Test; TMT = Trail Making 
Test; Combination Model = MoCA + RCFT Copy + RCFT Recall; Cut-off = the value that produced the 
highest Youden index; PPV = Positive Predictive Value; NPV = Negative Predictive Value; AUC = Area 
Under the Curve; CI = Confidence Interval.  




The combination model performed better than the individual screening measures (Figure 
3-5). The combined model was significantly superior to the MoCA (AUC difference of 
11.8%; p <0.05). A significant difference was also observed between the combined model 
and the RCFT Copy (AUC difference of 25.4%, p <0.001). Unlike the previous 
comparisons, the combination model now produced an AUC difference that approached 
significance for the RCFT Recall (AUC difference of 8.14%, p =0.09), suggesting that an 
increased sample size might confirm the benefit of the combination model for this 
discrimination. Cut-off values for are presented in Appendix D. 
 
 
Figure 3-5. ROC curves for MoCA, RCFT Copy, RCFT Recall, TMT-A and the combination model to 
detect Confirmed MCI vs. Possible MCI.  
 




 Three-Dimensional ROC Results 3.3.4
Simultaneous discrimination of the three classes (MCI, Possible MCI, Probable HC) 
provided further evidence for the superiority of the combined model (VUS = 0.77; 95% 
CI = 0.64-0.89; Figure 3-6) over the MoCA (VUS = 0.39; 95% CI = 0.31-0.48), the 
RCFT copy (VUS = 0.48; 95% CI = 0.33-0.62), and now also the RCFT recall (VUS = 
0.60; 95% CI = 0.48-0.72; Figure 3-7). 
 
 
Figure 3-6. Three-dimensional receiver operating characteristic surfaces for the combination model. Figure 
courtesy of Associated Professor Christos Nakas. MCI = Confirmed MCI; possMCI = Possible MCI; HC = 
Probable Healthy Control; TFC = True Class Fraction.  
 
 




Pairwise comparisons showed that each of the individual measures was able to 
successfully differentiate between the three classes of participants (Table 3-7). The 
combined model was superior to the individual measures in discriminating the three 
groups, indicated by good pairwise AUCs when discriminating the otherwise more 








Figure 3-7. Visual representations of the VUS for the MoCA, RCFT Copy and RCFT Recall. Figure courtesy of Associated Professor Christos Nakas. MCI = Confirmed 



















Results for the Pairwise Comparisons 
 Confirmed MCI vs. Possible MCI  Possible MCI vs. Probable HC  Confirmed MCI vs. Probable HC 








Cut-off Sensitivity Specificity  AUC  
(p-value) 







<27 0.73 0.46 0.63 
(p<0.001) 
 <27 0.73 0.88 0.86 
(p<0.001) 









<-0.8 0.94 0.71 0.88 
(p<0.001) 
RCFT Recall <-1.4 0.82 0.71 0.77 
(p<0.01) 
 
 <-0.4 0.86 0.67 0.81 
(p<0.001) 













 0.99 0.94 0.96 
(p<0.001) 
Note. MCI = Mild Cognitive Impairment; HC = Healthy Control; MoCA = Montreal Cognitive Assessment; RCFT = Rey Complex Figure Test; Combination Model = 
MoCA + RCFT Copy + RCFT Recall. 
 
 




 Discussion  3.4
The primary purpose of the current study was to determine whether a combination of a 
brief cognitive screening test (MoCA) along with measures of specific cognitive 
functions would effectively discriminate between cognitive normal elderly, those with 
Possible MCI, and those with clearly defined MCI. The current study provided strong 
evidence that the MoCA and RCFT, particularly its recall trial, produced good 
discrimination of MCI cases, whereas TMT-A showed relatively poor discrimination. 
Moreover, the results demonstrated that combining the MoCA with the RCFT Copy and 
RCFT Recall provided better discrimination of MCI than using single measures. This 
added benefit of the combination model may be because the RCFT measures a wide 
range of cognitive abilities including memory, visuospatial and visuoconstruction 
abilities, as well as more frontal lobe functions, such as planning. In a recent study, Miller 
et al. (2014) also demonstrated that the addition of the RCFT to the MMSE improved the 
detection of MCI in the screening process. The MMSE independently correctly classified 
88.8% of cognitively normal and 53.4% of MCI, and when supplemented with the RCFT 
(copy, recall and retention) the percentage increased to 92.5% and 74.1% for cognitively 
normal and MCI, respectively. Therefore, researchers and clinicians should consider 
adding the RCFT as an adjunct test to the more routinely used MoCA when screening for 
cognitive impairment, given that its copy and the immediate recall trial can be completed 
in less than 10 minutes.  
 




The current study recognised that cognitive decline associated with ageing is a 
gradual progressive process that exists on a continuum, and that a definable intermediate 
state may exist between normal cognition and MCI (Duara et al., 2011). Many 
researchers have referred this state as the Pre-MCI, similar to the Possible MCI in the 
present study, where individuals do not fully meet formal MCI criteria but they are not 
‘cognitively normal’ either. Duara et al. (2011) examined 275 participants over a 2-3 year 
period, with annual follow-ups. At baseline, Pre-MCI showed cognitive, functional, 
motor behavioural and imagining features that were intermediate between normal 
cognition and MCI states. Over the follow up period, Pre-MCI subjects showed 
accelerated rates of progression to MCI as compared to cognitively normal subjects, but 
slower rates of progression to dementia than MCI subjects. Given that Pre-MCI 
represents an intermediate state between normal cognitive and MCI, it becomes 
especially valuable to diagnostically separate the three cognitive classes, for tracking 
progression of cognitive symptoms over time, following up on borderline changes in 
cognition, and to assess the rate of deterioration in progressive condition. In addition any 
benefit that can be gained from AD intervention may be most apparent in the earlier 
stages, thus early detection (i.e., in the MCI or even Pre-MCI stages) is extremely 
important. The traditional dichotomous ROC approach appears inadequate when one 
wants to compare and contrast three cognitive classes simultaneously. Hence, the present 
study employed three-way ROC analysis, which allows concurrent discriminations for the 
three cognitive classes. Results from the three-way ROC analyses also confirmed a clear 
benefit of the combination model relative to each individual test. The combination model 




not only showed excellent AUC when distinguishing Possible MCI vs. Probable HC, and 
Confirmed MCI vs. Probable HC, it also provided added diagnostic utility when 
discriminating Confirmed MCI vs. Possible MCI, concurrently.  
 
A major contribution of the current study is the provision of the cross-tabulation 
tables containing the cut-off values for each test generated by the combination model 
(refer to Appendix B, C, and D). Clinicians and other health professional are unlikely to 
refer to logistic regression equations for clinical decision-making. Hence, cross-tabulation 
tables have been generated using the logistic regression equation, which enables the 
examination of the relationships within the range of cut-off points for each test. Unlike 
previous studies, where a single score is used as the criterion for cut-off, the tables 
employed by the current study would allow the clinicians to take into account patients 
score on the MoCA along with their score on the RCFT Copy and RCFT Recall when 
determining cognitive status. These tables can be simply looked up and are easy to use by 
health professionals.  
 
There are several limitations to the current study. First, cognitive status was 
confirmed in relatively few individuals by comprehensive neuropsychological 
assessment. This small proportion may have caused some classification errors, thus 
affecting the sensitivity and specificity values generated by ROC analysis. Second, there 
is a possible circularity effect of using the MoCA, RCFT Copy, RCFT Recall, and TMT-
A in both the screening battery and the detailed neuropsychological battery. An ideal 




approach to eliminate the circularity effect would be to employ different tests in the 
detailed neuropsychological battery. However, in addition to the RCFT, we used a 
number of other tests to define the domain of memory. Therefore, the circularity effect is 
mitigated by the inclusion of multiple tests in the detailed neuropsychological assessment 
for each cognitive domain. In any case the proposed combination of scores is relatively 
independent of the individualised a priori cut-offs used for Probable MCI, Possible MCI 
and Probable HC. Third, there is by necessity a relative imbalance of sample size between 
the three cognitive classes, which may have prevented the elucidation of statically 
significant effects. Larger sample sizes for MCI and Possible MCI may be required for 
future studies. 
 
 Summary and Conclusion 3.5
The current study shows that the MoCA and RCFT demonstrated good discrimination of 
MCI, and the combination of the two tests showed even better discriminatory power. 
Given the copy and the immediate recall trial of the RCFT can be completed in less than 
10 minutes, researchers and clinicians should consider adding this as an adjunct test to the 
more routinely used MoCA when screening for cognitive impairment. However, it is 
important to note the primary purpose of screening is not to provide a diagnosis but to 
establish the need for an in-depth assessment. Thus, a comprehensive neuropsychological 
assessment is recommended, particularly given that MCI is a heterogeneous condition 
and its subtypes may indicate different prognosis, it is necessary to follow up any positive 




results with a comprehensive neuropsychological assessment to obtain more information 







CHAPTER 4 - Non-Pharmacological Interventions 
in MCI  
 
 Introduction  4.1
It is an international priority to develop preventative strategies for AD. One major 
approach to reduce the prevalence of AD is to develop strategies to delay its onset in 
those at risk of developing dementia. MCI represents a transitional stage between normal 
ageing and dementia. This prodromal phase of dementia is recognised as a key period to 
establish interventions to promote cognitive reserve and counter worsening cognitive 
symptoms (Albert et al., 2011). The limited efficacy of the current drug therapies in MCI 
has stimulated growing interest in the use of cognitive intervention for MCI. This chapter 
reviews the effects of non-pharmacological interventions in the cognitive functions in 
older people with MCI, but more importantly provides the theoretical basis for the 
Cognitive Enrichment Programme.  
 
 Non-pharmacological interventions for MCI  4.2
In the past few decades, a number of studies have been conducted to examine the 
potential effects benefits of non-pharmacological interventions in MCI. Chief among 
these interventions are cognitively based interventions that can be broadly classified as 




cognitive interventions, physical exercise may also be protective against cognitive decline 
(Ohman, Savikko, Strandberg, & Pitkala, 2014; Rodakowski, Saghafi, Butters, & 
Skidmore, 2015; Teixeira et al., 2012). Although the data are limited, physical exercise 
has been associated with improvements in cognitive function in older adults with MCI. 
The frequent rationale for physical exercise programs were based on the vascular 
hypothesis, in that physical activity acts as a protective factor of cognitive decline by 
reducing the risk of cardiovascular disease often associated with dementia by maintaining 
healthy blood flow (Orgeta, Regan, & Orrell, 2010). In a recent meta-analytic review of 
non-pharmacological interventions for MCI, cognitive-based interventions were 
associated with significant improvements in global cognitive function (effect size = 0.37, 
95% CI = 0.07 – 0.68), executive function (effect size = 0.8, 95% CI = 0.09 – 1.5), and 
delayed memory recall (effect size = 0.31, 95% CI = 0.01 – 0.61), whereas physic 
exercise was only associated with an improvement in the global cognitive function (effect 
size = 0.25, 95% CI = 0.08 – 0.41) (Wang et al., 2014). In addition, unlike cognitive 
activities, physical activities are less likely to directly influence various brain networks, 
thus only briefly reviewed in the current chapter. Table 4-1 provides an overview of the 





Physical Exercise in Individuals with MCI  
Author  
(Year) 
Format / Components of 
Intervention 




Outcome Measures Results 
Scherder et al. 
(2005) 
Individual Intervention: 
walking or hand/face exercise  




CG: 15 MCI  
 
RCT Six 30-min sessions 
 
3/week  
Memory, executive function Between Group Comparisons: 
a trend of TGs performing better than the 
CG on tests of executive function, but did 
not reach significance 
no beneficial effect on memory processes 
van Uffelen et al. 
(2008) 
Group Intervention:  
TG 1: aerobic walking and 
vitamin B supplementation 
TG 2: placebo activity and 
vitamin B supplementation  
TG3: aerobic walking and 
placebo supplementation  
CG: placebo activity and  
 
TG 1: 71 MCI  
TG 2: 75 MCI 
TG 3: 78 MCI  
CG: 74 MCI  





Memory, global cognitive 
function, executive function, 
processing speed, attention 
Between Group Comparisons:  
no improvement in global cognitive 
function or executive function  
women with good attendance in aerobic 
walking improved attention  
men with good attendance in aerobic 
walking improved attention 
Baker et al.  
(2010) 
Group Intervention: 
high intensity exercise 
(treadmill, stationary bicycle, 
elliptical trainer) 
or stretching control group  
 
TG: 23 MCI  
CG: 10 MCI  
RCT Ninety-six 45-60-
min sessions  
 
4/week 
Memory, processing speed, 
executive function 
Between Group Comparisons: 
TG improved in executive function, 
intervention effects were more prominent 







Varela et al.  
(2012) 
Group Intervention:  
TG 1: aerobic exercise, cycling, 
40% of the heart rate reserve 
TG 2: aerobic exercise, cycling, 
60% of the heart rate reserve  
CG: recreational activity 
 
TG 1: 17 
MCI  





min sessions  
 
3/week 
Global cognitive function, 
functional autonomy  
Pre-Post Comparisons: 
no significant intervention effects in either TG groups 
 
Suzuki et al.  
(2013) 
Group Intervention:  
TG: aerobic exercise, strength 
training, balance, dual tasking; 








min sessions  
 
2/week   
Memory, global cognitive 
function, executive function  
Between Group Comparisons: 
TG improved in global cognitive function, immediate 
memory, and letter fluency   
Nagamatsu et al.  
(2013) 
  
Group Intervention:  
TG 1: resistance training  
TG2: aerobic training  
CG: balance and tone exercises 
TG 1: 28 
MCI  








Memory, reaction time Between Group Comparisons:  
TG groups showed greater improvements in reaction times 
for a spatial memory task when compared to CG 
 
Note. RCT = Randomised Controlled Trial; TG = Treatment Group; CG = Control Group; = MCI = Mild Cognitive Impairment; AD = Alzheimer’s Disease. 




 Cognitive-Based Interventions 4.2.1
Given the primacy of memory deficit in most cases of MCI, many of the early cognitive 
intervention studies concentrated exclusively or largely on the amelioration of memory 
difficulties (a summary of results from studies of memory training are presented in Table 
4-2). These studies focused on teaching memory strategies, using either compensatory 
and/or restorative type of approaches. Commonly applied compensatory strategies 
included categorisation, chunking, visual imagery, cueing, elaboration (e.g., Kurz, Pohl, 
Ramsenthaler, & Sorg, 2009; Londos et al., 2008; S. Rapp, Brenes, & Marsh, 2002). 
Restorative strategies included spaced retrieval, errorless learning, vanishing cues and 
reality orientation (e.g., Jean et al., 2010; Troyer, Murphy, Anderson, Moscovitch, & 
Craik, 2008). While some studies focused on the utility of a particular memory strategy 
(e.g., Hampstead, Sathian, Moore, Nalisnick, & Stringer, 2008; Jean et al., 2010), most 
studies applied these techniques simultaneously. Memory strategies are usually delivered 
in group settings directed by a trainer, over multiple training sessions. These sessions are 
typically highly structured with segments of the session devoted to teaching the 
strategies, and practice using the strategies with feedback from the trainer. Besides the 
memory training component some programmes also offered education about memory, 
relaxation skills, physical rehabilitation, and life-style education as part of a 
comprehensive intervention programme (Kurz et al., 2009; Troyer et al., 2008).  
 
More recent cognitive intervention studies have adopted a more global perspective 
on cognitive functioning. These studies follow the reasonable assumption that cognitive 




functions should work together and therefore should be stimulated in concert (a summary 
of results from multi-domain studies are presented in Table 4-3). Although the memory 
training component remained as the primary target of these intervention programmes, 
language, calculation, executive function and construction praxis are also stimulated 
(Belleville et al., 2006; Buschert et al., 2011; Kinsella et al., 2009; Olazaran et al., 2004; 
Olchik, Farina, Steibel, Teixeira, & Yassuda, 2013; Tsolaki et al., 2011; Wenisch et al., 
2007). 
 
Most of the reviewed studies, whether memory strategy training studies or multi-
domain cognitive training studies, reported significant results on measures that were 
directly related to the aspects targeted during the programme. For example, Hampstead et 
al. (2008) reported improved reaction time and recognition accuracy on the trained face-
name pairs. Similarly, Belleville et al. (2006) demonstrated improvements in the ability to 
learn face-name pairs following face-name association training. Other authors have 
described increased memory strategy knowledge (Troyer et al., 2008) and increased 
compliance with the use of a calendar system after training (Greenaway, Hanna, Lepore, 
& Smith, 2008). These findings of training-related improvements in MCI demonstrated 
that elderly with MCI retained the ability to learn new information with repeated 
exposure, and thus providing support to the view that the brains of people with MCI 
remain highly plastic.  
 




The ultimate goal of cognitive intervention is, however, to produce transfer of the 
trained strategies to untrained tasks and to create improvements in the overall level of 
cognitive functioning. Standardised neuropsychological tests are usually adopted to 
measure the transfer of the training effects. Overall, multi-domain studies (Table 4-3) 
showed stronger evidence of transference to standardised neuropsychological tests than 
studies of pure memory training. For example, Kinsella et al. (2009) provided multi-
domain cognitive training to a group of MCI participants, and reported significant 
changes on a prospective memory task after intervention;  another study described 
improved word list recall following multi-domain cognitive training (Belleville et al., 
2006); and a number of studies revealed that MCI participants reached the level of 
performance of healthy controls after intervention on tests of categorical verbal fluency 
(Olchik et al., 2013), word-list learning (Olchik et al., 2013), story recall (Olchik et al., 
2013), and associative memory (Wenisch et al., 2007). In contrast, only two of the 
reviewed memory strategy training studies (Table 3-1) reported significant improvement 
on standardised memory measures (Kurz et al., 2009; S. Rapp et al., 2002). Furthermore, 
randomised controlled trials of multi-domain cognitive intervention have demonstrated 
positive effects on global cognitive measures, such as the ADAS-cog (Buschert et al., 
2011; Olazaran et al., 2004), the MMSE (Olazaran et al., 2004; Tsolaki et al., 2011), and 
the MoCA (Tsolaki et al., 2011), and no such effects were reported by studies of memory 
strategy training. The limited efficacy of memory strategy training is perhaps because it 
fails to provide broad enriching stimulation for the participants (Gates & Valenzuela, 
2010). Hence, suggesting that cognitive intervention aimed to stimulate a range of 




cognitive functions is perhaps the more promising method to postpone cognitive decline 





Single-Domain Memory Strategy Training in Individuals with MCI  
Author  
(Year) 
Format / Components of 
Intervention 




Outcome Measures Results 
Rapp et al.  
(2002) 
Group Intervention: 
memory strategy training, education, 
relaxation training, and cognitive 
restructuring 
TG: 9 MCI  
 
CG: 10 MCI 




Memory, perception of memory 
impairment, perceived control over 
memory 
Between Group Comparisons: 
TG showed greater perceived memory 
ability and control over memory  
no significant group differences on 
objective memory measures 
 
Hampstead et al. 
(2008) 
Individual Intervention: 
memory strategy training (face-name 
association) 
8 MCI  UC  Three 60-min 
sessions over 2 
weeks 
Face-name associative memory 
(trained and untrained) 
Pre-Post Comparisons: 
improved performance on both trained 
and untrained face-name associations 
 






memory strategy training (training in 
the use of memory support system, a 
calendar and organsiation system) 
20 MCI UC 
 
Twelve 60-min 
sessions over 6 
weeks 
Memory, compliance assessment, 
activities of daily living, caregiver 
burden 
Pre-Post Comparisons: 
increased compliance with the memory 
support system 
no significant effect on other outcome 
measures 
 
Londos et al. 
(2008) 
Group Intervention: 
memory strategy training 
(compensatory strategies) 
 
15 MCI UC Sixteen 150-min 





Memory, visuospatial skills, 
attention, processing speed, 
occupational skills, quality of life 
Pre-Post Comparisons: 
improved in processing speed, 
occupational skills, and quality of life 






Troyer et al. 
(2008) 
Group Intervention: 
memory strategy training, relaxation, 
lifestyle education 
TG: 22 MCI  
 
CG: 27 MCI 
RCT Ten 120-min 
session over 6 
months 
Memory, strategy knowledge and 
use, memory-related affect and 
thoughts 
Between Group Comparisons: 
TG showed increased memory strategy 
knowledge and use 
no significant group differences on other 
outcome measures 
 
Kurz et al.  
(2009) 
Group Intervention: 
memory strategy training, self-
assertiveness training, relaxation 
techniques, stress management and 
motor exercises 
 
TG: 18 MCI, 
10 AD 
 
CG: 12 MCI 
C 22h/week over 4 
weeks 
 
Memory, activities of daily living, 
mood 
Pre-Post Comparisons: 
TG improved in memory, activities of 
daily living and mood 
CG did not show these improvements 
 
Jean et al.  
(2010) 
Group Intervention: 
errorless or errorful learning for face-







RCT Six 45-min 
sessions over 3 
weeks 
Memory, global cognitive function 
face-name associative memory, 
subjective memory questionnaire 
Between Group Comparisons: 
both group showed improved capacity to 
learn face-name associations and were 
more satisfied with memory functioning 
no significant effect on other outcome 
measures 
 
Kinsella et al. 
(2015) 
Group Intervention: 
Memory strategy training  
TG: 53 MCI, 
56 HC 
 
CG: 53 MCI 
,  
57 HC 
RCT Six weekly 
sessions  
Memory, strategy knowledge, 
strategy use, wellbeing, self-
reported memory ability  
Between Group Comparisons:  
for HC participants improvements were 
found in memory ability and prospective 
memory tests 
for MCI participants gains were found in 
strategy use only 
 
Note. C = Controlled Study; RCT = Randomised Controlled Trial; UC = Uncontrolled Study; TG = Treatment Group; CG = Control Group; HC = Healthy Control; MCI = Mild Cognitive 





Multi-Domain Cognitive Intervention in Individuals with MCI 




Outcome Measures Results 
Olazaran et al. 
(2004) 
Group Intervention:  
cognitive exercises (memory, attention, 
language,  visuospatial abilities, calculation, and 
executive function), reality orientation, training 
of activities of daily living, psychomotor 
exercises 
 
12 MCI; 48mild 
AD; 24 moderate 
AD  
 




RCT One hundred 
and three 210-
min sessions 




Global cognitive functioning, 
activities of daily living, mood 
 
Between Group Comparisons: 
TG maintained/improved global 
cognition and mood  
CG declined on these measures 
Wenisch et al. 
(2007) 
Group Intervention:  
memory strategy use (categorisation, mental 
imagery), reality orientation, newspaper review, 
cognitive exercises (executive function) 
 




Memory, executive function, 
mood  
MCI vs HC: 
MCI showed greater improvements 
on measures of memory than HC 
Belleville et al.  
(2006) 
Group Intervention:  
memory strategy training (interactive imagery, 
method of loci, face-name association, 
organisation of text information, verbal 
organisation-semantic proximity, categorisation, 
hierarchisation), computer-assisted divided 
attention and processing speed training 
 
TG: 20 MCI, 9 
HC 
 
CG: 8 MCI, 8 HC 
 




List recall, face-name 
association, story recall, 




TG improved in delayed list recall, 
face-name association, subjective 
memory and well-being   




Kinsella et al. 
(2009) 
Group Intervention:  
memory strategy training (face-name recall, 
verbal categorisation and elaboration, visual 
imagery, errorless learning, spaced retrieval, 
compensatory strategies), strategies for 
improving organisational and attentional skills  
 
TG: 22 MCI  
 
CG: 25 MCI 
 





subjective memory, strategies 
knowledge 
Between Group Comparisons: 
TG improved prospective memory, 
strategies knowledge 
no significant differences on 
subjective memory 
Buschert et al. 
(2011) 
Group Intervention:  
memory strategy training (face-name association, 
errorless learning, compensatory strategies), 
reminiscence, psychomotor and recreational 
tasks,  




TG: 12 MCI, 8 
AD 
 




over 6 months 
 
Global cognitive functioning, 
executive function, memory, 
mood, activities of daily living  
 
Between Group Comparisons: 
TG improved global cognition and 
reduced depressive symptoms 
no significant effect on other 
measures 
Tsolaki et al. 
(2011) 
Group Intervention:  
cognitive training in attention, memory and 
executive function  
TG: 104 MCI  
 
CG: 72 MCI 
RCT Sixty 270-min 




Global cognitive functioning, 
memory, visuospatial ability, 
attention, executive function, 
language  
Between Group Comparisons: 
TG improved global cognition, 
attention, memory, executive 
function, visuospatial function, 
language, daily function 





Olchik et al. 
(2013) 
Group Intervention:  
cognitive training in memory, attention and 
executive function training, plus education or 




16 MCI, 20 HC 
 
Education only:  
17 MCI, 20 HC 
 
CG:  
14 MCI, 22 HC 




Executive function and 
memory  
MCI vs HC: 
MCI showed greater improvements 
than HC, and were comparable to HC 
at baseline 
 
Between Group Comparisons: 
cognitive training resulted in higher 
improvements in executive function 
and memory measures  
 
Note. C = Controlled Study; RCT = Randomised Controlled Trial; UC = Uncontrolled Study; TG = Treatment Group; CG = Control Group; HC = Healthy Control; MCI = Mild Cognitive 
Impairment; AD = Alzheimer’s Disease.




 Rationale for the Current Study 4.3
While multi-domain intervention programmes appeared to demonstrate greater efficacy 
than memory strategies training, the rationale for many of the programme components in 
the former programmes was seldom explicitly stated or linked to models in cognitive 
neuroscience. Some studies have selected techniques or programmes that have 
demonstrated some efficacy in other memory impaired populations such as traumatic 
brain injury (TBI). However, neurobiological deficits seen in patients with TBI can be 
very different from those exhibited by MCI individuals.  
 
The current study proposes an alternative approach to the existing cognitive 
training programmes. The intent here was to provide MCI individuals a cognitively 
stimulating environment using a range of complex and novel cognitive activities. There 
are two lines of evidence to support the utility of cognitive enrichment in this regard. The 
first draws on the concept of cognitive reserve. The term cognitive reserve describes the 
brain’s resilience to neuropathological damages, it was first introduced to explain why 
cognitive decline associated with AD is sometimes absent even when significant AD 
pathology is present (Katzman et al., 1988). The cognitive reserve hypothesis proposes 
that lifelong experiences, including education, work complexity, and engagement in 
cognitively stimulating activities result in a greater reserve, which leads to a more 
efficient use of existing brain networks (Valenzuela, 2008; Valenzuela & Sachdev, 2007). 




Hence, individuals with more cognitive reserve would be more successful than someone 
with less reserve in coping with the same amount of brain pathology.  
 
Studies on cognitive reserve and AD have demonstrated that the risk of dementia 
remained highly modifiable by experience well into late life (Valenzuela & Sachdev, 
2007). Longitudinal studies have also demonstrated that engagement in cognitively 
stimulating activities during late-life was inversely correlated with the incidence of AD, 
and this protective effect typically remains even after adjusting for early life experiences 
and other confounding variables (Fratiglioni, Paillard-Borg, & Winblad, 2004; Scarmeas, 
Levy, Tang, Manly, & Stern, 2001; Valenzuela, Breakspear, & Sachdev, 2007; R. S. 
Wilson, Mendes De Leon, et al., 2002). For example, one study measured past and 
current participation in cognitively stimulating activities of more than 700 elderly 
participants (R. S. Wilson, Scherr, Schneider, Tang, & Bennett, 2007). Past cognitive 
activities included items about activities in childhood (ages 6 and 12), young adulthood 
(age 18), and middle age (age 40). Current activities were those endorsed at study 
baseline and annually thereafter. The authors first demonstrated that both past and current 
activities were associated with reduced incidence of MCI and AD, and less rapid decline 
in cognitive function. However, the effect of past activity attenuated and no longer 
significant when both past and current activities were examined in a single model 
suggesting that current activities is a more important predictor of cognitive functions than 
past activities. Moreover, it appeared that the frequency of participation in late-life 
activities was also related to the risk of AD. An earlier study reported a dose-dependent 




relationship between late-life cognitive activity and the risk of AD, with more frequent 
participation in cognitive activity associated with a lower risk of AD (Verghese et al., 
2003). The risk of AD in a group with moderate level of cognitive activities was 50% 
lower compared with the low-activity group, whilst those with the highest activity levels 
had their risk reduced to 33%. Taken together, these results suggest that increasing the 
cognitive reserve even in elderly persons through cognitively stimulating activities might 
help to preserve cognitive functioning and delay the onset and progression of AD.    
 
The second line of evidence comes from animal research. While caution must be 
employed when comparing human and animal models, it is worth considering how 
successful animal paradigms can better inform the selection of intervention parameters 
when developing novel intervention programmes for humans. The potential effects of 
cognitive activity in the prevention or reduction of age-related cognitive decline have 
been modelled using the environmental enrichment (EE) paradigm in animals. The vast 
majority of such work to date has been conducted in rodents. EE involves changes to the 
animals’ housing condition which offer enhanced cognitive, motor, sensory and social 
stimulation in comparison with standard caging (e.g., Nithianantharajah & Hannan, 2006; 
Will et al., 2004). While different labs have employed different protocols, animals in the 
EE conditions are generally housed in bigger cages to allow room for exploration and the 
introduction of a variety of objects. These objects, varying in shape, size, weight, smell 
and texture, may include tubes, balance platforms, climbing apparatus, balls, or running 
wheels which are changed on a scheduled basis, often daily, to maintain novelty and 




complexity of the animals’ environment. Furthermore, EE increases social stimulation 
through larger number of animals per cage, for example 8 to 12 animals per cage instead 
of the 3 to 6 per cage in standard housing conditions.  
 
These EE conditions have been found to alter a range of cellular, molecular and 
behavioural aspects of pathogenesis in animal models including transgenic AD mouse 
models. At the cellular and molecular level, EE has been associated with decreased 
amyloid deposition and reduced tauopathy in neurofibrillary tangles (Lahiani-Cohen et 
al., 2011; Lazarov et al., 2005), greater neurogenesis and improved synaptic neuronal 
connections (Levi, Jongen-Relo, Feldon, Roses, & Michaelson, 2003), and positive 
effects on growth factors and neurochemicals that promote brain health (Cracchiolo et al., 
2007; Wolf et al., 2006). The positive effects of environmental stimulation extend beyond 
neurobiology. Behavioural studies have also shown that transgenic mice raised in an 
enriched environment showed improved performance in various cognitive tasks, 
including the Morris Water Maze (Costa et al., 2007; Wolf et al., 2006), and the visual 
novel Object Recognition Test (Polito et al., 2014). In a more recent study, it was found 
that EE not only demonstrated beneficial effects when applied before disease onset, when 
it is provided after the disease onset it was also associated with positive effects on 
amyloid pathology (Herring et al., 2011). In their study, transgenic AD mice were 
randomly allocated to 60 days of enriched environment either before disease onset (no 
appearance of Aβ plaques) or 60 days after the appearance of Aβ plaques, thus allowing 
the comparison of the effects of preventative EE (pre-disease-onset) and therapeutic EE 




(post-disease-onset). That study found that the preventative EE reduced the number and 
size of amyloid plaques, which was suggested to reflect an increased degradation and 
clearance of Aβ. Therapeutic EE, on the other hand, reduced the growth and fusion of 
plaque seeds, possibly by inhibiting Aβ aggregation. Findings from this study provided 
an experimental basis for application of EE in the prevention and treatment of AD. 
 
The beneficial effects of EE in transgenic animal models of AD clearly illustrated 
the potential utility of a programme of cognitive, sensory, social stimulation in humans. 
Although animal EE paradigm cannot be readily translated as an intervention programme 
for AD patients, it provides the theoretical basis for the development of an analogous 
intervention programme with the human population. Therefore, aspects of the EE 
paradigm that are responsible for brain and behavioural changes in animal models 
provide pointers when developing an analogue for humans. Nithianantharajah and 
Hannan (2006) concluded that the key feature of EE appears to be the provision of 
novelty and complexity to the animals’ environment, while motor activity potentially 
adds value to the overall EE effects, but has limited beneficial effect when applied on its 
own. Studies that compared rodents exposed to wheel running only with rodents exposed 
to EE have recognised that while enhanced motor activity contributes to some of the 
beneficial effects, cognitive stimulation is essential to the EE paradigm (Pang, Stam, 
Nithianantharajah, Howard, & Hannan, 2006; Pawlowicz, Demner, & Lewis, 2010). In 
addition to cognitive stimulation, social stimulation has also been suggested as an 
important aspect of the EE paradigm. Renner and Rosenzweig (1986) suggested that 




social interaction may have some direct or indirect (e.g. the activity of one animal attracts 
the attention of another) impact on the effects of EE. Extrapolating from these findings, 
the key drivers of neural plasticity found in EE studies appears to include the availability 
of multiple stimuli coupled with novelty in the environment, and opportunity for 
engagement in social interaction.  
 
There have been some attempts to use a variety of cognitively stimulating tasks in 
people with MCI, mostly with computerised software programmes. For example, a recent 
study by Finn and McDonald (2011) used the computerised programme supplied by 
Lumosity Inc, and gave 30 sessions which each contained four to five cognitive exercises 
out of six available exercises. All MCI participants began at the same level of difficulty, 
and once a predetermined criterion of performance was reached for a particular exercise, 
the level of difficulty was increased. These authors reported improved performance on 
trained tasks, but little evidence of generalisation of training to the Cambridge Automated 
Neuropsychological Test Battery (CANTAB; a computerised neuropsychological test 
battery). Also, non-significant effects were found on self-reported measures of everyday 
memory function or mood. In contrast, greater efficacy was demonstrated by a study that 
incorporated social interaction with computer-based cognitive activities. Dannhauser et 
al. (2014) developed an intervention programme which comprised of three components: 
physical activity, group-based cognitive stimulation and individual cognitive stimulation. 
Group-based cognitive activities included activities such as pottery, painting, cooking, 
tap-dancing, playing brass instruments, rope craft, genealogy, sign language, digital 




photography and drawing, whereas individual cognitive stimulation involved computer-
based puzzle-type exercises. These authors reported significant treatment effects on 
several cognitive measures including forward and backwards digit span and category 
fluency (Dannhauser et al., 2014). It is possible that the limited generalisation reported by 
Finn and McDonald (2011) may be attributed impart to the fact that their programme did 
not have any social stimulation. As noted earlier that social interaction has a synergistic 
effect on the overall EE effect, at least in animal studies (Pawlowicz et al., 2010).  
 
Although computer-based cognitive programmes, especially when incorporated 
with social interaction, have demonstrated some efficacy in the MCI population, but it is 
worth noting that aged population often have little familiarity with and sometimes 
aversion to computers and access to computers is still limited in this age group compared 
to younger populations (Goodman, Syme, & Eisma, 2003). Their computer use is further 
impeded by functional deficits such as visual impairments that make reading a computer 
screen more difficult (Bitterman & Shalev, 2004) and dexterity problems that interfere 
with typing and moving a computer mouse (Charness & Holley, 2004). Another barrier is 
financial, as older adults may have limited income to invest in computer equipment, 
software, and service fees (Fisk & Rogers, 2002). Older adults’ sometimes report anxiety 
about their lack of knowledge (Czaja & Sharit, 1998) and lack of confidence in their 
ability to master computers (Marquié, Jourdan-Boddaert, & Huet, 2002).  
 
 




 Functional Brain Networks Relevant to MCI  4.4
Cognitive changes in MCI more often reflect pathological changes in the brain rather than 
psychological variables. Neuroimaging studies have revealed both structural and 
functional changes in MCI with progressive loss of both grey and white matter, as well as 
reductions in cerebral metabolism (Dai & He, 2014; De Santi et al., 2001; Misra, Fan, & 
Davatzikos, 2009; Risacher & Saykin, 2013). Although the medial temporal lobe is 
thought to be the site of early pathology underlying the initial amnestic syndrome in AD, 
current theories of AD have posited that neuropathology and functional changes exist in 
many cortical and subcortical regions in individuals with AD (Andrews-Hanna et al., 
2007; Seeley, Crawford, Zhou, Miller, & Greicius, 2009). The discovery of resting state 
brain networks has suggested that functional communication between anatomically 
distributed, but functionally linked brain regions is likely to play a key role in complex 
cognitive processes (van den Heuvel & Hulshoff Pol, 2010). It has been increasingly 
recognised that cognitive functions are dependent on the integrity of these brain 
networks, so decline in cognitive abilities is likely to be a result of disruption in multiple 
networks, rather than alterations in a single brain region (Andrews-Hanna et al., 2007; 
Brier et al., 2012).  
 
Functional magnetic resonance imaging (fMRI) has allowed the assessment of 
functional connectivity between spatially distant brain regions by measuring the temporal 
correlations in the blood-oxygen-level-dependent (BOLD) signal across the brain. In 
task-related fMRI, MR signal during one cognitive condition (e.g., memory encoding of 




novel stimuli) is often compared to a control task (e.g., viewing familiar stimuli) or to a 
passive baseline fixation (e.g., visual fixation). Comparing the relative changes in the 
BOLD signal at baseline and during the performance of a task or in response to a stimulus 
allows one to infer whether certain areas of the brain are activated or deactivated by the 
task in question. In recent years, there has been an increase in interest in the application 
of fMRI at rest (i.e., in the absence of an explicit task or stimulus). This technique has 
been referred to as the resting-state fMRI (RS-fMRI), which measures the spontaneous 
low frequency fluctuations (<0.1 Hz) in the BOLD signal. Many large-scale resting-state 
networks have been identified using this technique, and several of these networks are 
affected in AD and MCI, including the default mode network (DMN), attention network, 
executive network, and salience network (Agosta et al., 2012). The key nodes in the 
DMN are the medial prefrontal cortex, posterior cingulate cortex/precuneus, inferior 
parietal cortex, lateral temporal cortex and, in some descriptions, the hippocampal 
formation. The attention network includes the lateral prefrontal cortex  and 
temporoparietal regions; the executive network covers several medial and lateral 
prefrontal cortex areas; and the salience network encompasses the inferior frontal cortex, 
insula and the anterior cingulate cortex (Agosta et al., 2012; Buckner, Andrews-Hanna, & 
Schacter, 2008). An interesting feature of the DMN is that, in contrast to the other 
resting-state networks, regions of the DMN are highly active during an idle state (hence 
the term default). The DMN is typically deactivated during externally driven cognitive 
tasks but further activated during internally driven processes, such as mind wandering, 




future planning, taking the perspective of the others, navigation, and autobiographical 
memory (Buckner et al., 2008).  
 
A number of studies have shown that the DMN is particularly vulnerable to the 
pathological processes seen in AD and is affected even in MCI (Bai et al., 2008; Greicius 
et al., 2004). Amyloid burden is often considered to be one of the major 
neuropathological hallmarks of AD. Interestingly, the deposition of the amyloid protein 
shows a high degree of spatial overlap with areas of the DMN, particularly the posterior 
regions of the DMN including the precuneus and posterior cingulate cortex (Buckner et 
al., 2005; Sperling et al., 2009). Furthermore, Adriaanse et al. (2014) found that the 
amyloid load in the DMN was highest in patients with AD, intermediate in MCI and 
lowest in controls, suggesting an inverse relationship between amyloid deposits in the 
DMN and cognitive function in elderly. Studies examining the impact of amyloid 
pathology on the DMN function have shown that the amount of amyloid accumulation is 
significantly associated with reduced network connectivity (Drzezga et al., 2011; Hedden 
et al., 2009; Koch et al., 2014; Mormino et al., 2011; Sheline et al., 2010; Sperling et al., 
2009). While it is likely that multiple factors play a role in the decline to AD, these 
studies suggest that the DMN may play a critical role in the neurodegenerative process of 
AD. 
 
The most consistent finding of DMN impairment in both MCI and AD is the 
decreased functional connectivity during resting state, and decreased task-induced 




deactivation in the DMN (Hafkemeijer, van der Grond, & Rombouts, 2012). For 
example, Sorg et al. (2007) compared resting-state DMN connectivity between healthy 
elderly and MCI, and found that functional connectivity between hippocampus and 
posterior cingulate cortex was absent in MCI. Others studies have suggested a pattern of 
decreased functional connectivity from the posterior to anterior portions of the DMN (Bai 
et al., 2008; Sperling et al., 2010). Furthermore, these alterations were found to be related 
to the severity of the disease and, therefore, may act as a biomarker of future progression 
in MCI (Brier et al., 2012; Petrella, Sheldon, Prince, Calhoun, & Doraiswamy, 2011). A 
recent longitudinal study suggested that functional connectivity between regions 
comprising the DMN was progressively diminished in MCI and AD, with more severe 
decreases observed in AD (Petrella et al., 2011). This study also distinguished individuals 
with MCI who converted to AD from those who remained stable over the 2-3 years, 
reporting that the converters showed more severe loss of DMN connectivity than the non-
converters, which suggested that decreased functional connectivity in the DMN region 
may be a significant predictor of conversion to AD (Petrella et al., 2011). 
 
Comparing MCI to healthy controls, reduced task-induced deactivation in MCI 
was found in the posterior cingulate cortex, precuneus, frontal and parietal regions during 
the performance of cognitively demanding tasks (Hafkemeijer et al., 2012; Rombouts et 
al., 2005). The DMN task-induced deactivation pattern has also been shown to 
progressively decrease along the continuum from normal ageing to MCI to AD 
(Pihlajamaki & Sperling, 2009; Rombouts et al., 2005). Moreover, Celone et al. (2006) 




showed that compared to healthy older controls, less impaired MCI had increased task-
related deactivation in the medial and lateral parietal regions, whereas more impaired 
MCI showed decreased deactivation in these regions. This observation of increased task-
related deactivation in early MCI provided indications of possible compensatory 
mechanisms in early MCI. Another interesting finding is that task-induced deactivation is 
modulated by cognitive reserve in older adults (Bosch et al., 2010), but in an opposite 
manner for healthy elderly and MCI. In healthy elderly, high cognitive reserve was 
related to decreased deactivation of the DMN, which has been suggested as a result of 
more efficient usage of brain networks (Bosch et al., 2010). In contrast, high cognitive 
reserve in MCI was related to increased activity in brain areas involved in the task and 
increased deactivation in DMN regions, which indicate possible increased reorganisation 
of functional compensatory resources in MCI with high cognitive reserve. The finding 
that pattern of brain activity is modulated by cognitive reserve provided further evidence 
for the use of cognitive enrichment in MCI.  
 
 The Current Study  4.5
The current study examined the effectiveness of a novel cognitive enrichment 
programme, in individuals with MCI. Unlike any prior programmes, this programme was 
based on sound theoretical perspectives, as outlined above. It aimed to provide a broad 
range of cognitive stimulation for elderly with MCI. The cognitive activities included the 
current programme were therefore very different from the generally non-specific brain 




exercises in prior studies. In the current programme, the tasks were designed specifically 
to influence multiple brain networks identified in fMRI analyses and in particular to focus 
on changes in the DMN. The novelty of the programme, an idea that was predicated on 
animal EE research, was maintained by having multiple levels within each of many 
varying tasks, and unfamiliar features were added at each level, so that performance of 
the task will remain challenging and not become subject to automation. Moreover, the 
enrichment programme adopted a dyadic approach which involved the inclusion of a 
support person (e.g., social support from a spouse or a family member) in the 
intervention, who becomes instrumental in assisting the person with MCI to carry out the 
enrichment programme. This dyadic approach has the advantage of promoting social 
interaction as well as individualise the treatment by tailoring it to a participant’s 
neuropsychological abilities. A rating scale was implemented at the end of each task to 
permit the user and the research team to evaluate their performance and thus help monitor 
a ‘systematic enrichment plan’. The dyadic approach also offers a possibility of a wide 
scale dissemination of the programme, as participants are able to complete the enrichment 
tasks in their own home and pace, with assistance and encouragement from a support 
person. 
 
The effectiveness of the programme was examined using standardised 
neuropsychological tests. Functional neuroimaging techniques were also incorporated to 
measure enrichment-related changes in the DMN. Changes in the patterns of DMN 
activation or deactivation were measured using standardised fMRI methods, focusing on 




increases and decreases in the BOLD signal during experimental conditions compared to 
the control conditions. Changes in the functional connectivity of the DMN were 
examined using resting-state fMRI. It was expected that the Cognitive Enrichment 
Programme would protect further cognitive decline in MCI through its influence on the 







CHAPTER 5 - The Cognitive Enrichment 
Programme 
 
 Introduction  5.1
The Cognitive Enrichment Programme was developed as a support person based, 
individualised cognitive intervention designed primarily to influence multiple large-scale 
functional networks in the brain, especially the default mode network (DMN) in MCI 
individuals. The goal of the programme was for all MCI participants to engage in 
network-related cognitive stimulating activities for about 45-60 minutes a day, 3-4 times 
a week, for four months at the participant’s home. This equals or exceeds the frequency 
of cognitively stimulating activities that have been associated with reduced dementia risk 
in studies of older population (Verghese et al., 2003; R. S. Wilson, Bennett, et al., 2002). 
The intervention programme was administered by a support person, especially a 
significant other such as spouse, but people without a support person had the intervention 
administered by postgraduate psychology students (including the author).  
 
Given the programme’s emphasis on brain networks and specially the DMN, the 
tasks in the Cognitive Enrichment Programme were different to common non-specific 
‘brain exercise’ activities. They were designed in a specific way to stimulate the DMN or 
inhibit the DMN through influence on other brain networks. The DMN becomes less 




active during engagement in cognitive tasks that demand attention to external stimuli and 
more active during self-referential cognitive processes (Buckner et al., 2008; Spreng, 
Mar, & Kim, 2008). Hence, the enrichment tasks were designed so that some tasks would 
(1) activate the DMN, (2) some deactivate it, while (3) other tasks would require 
switching between activating and deactivating the DMN. The programme was tailored to 
each individual’s cognitive ability and preference, and individuals worked through the 
tasks at their own pace, albeit with encouragement and monitoring by the author and 
other researchers. Participants worked on five to six different tasks at a time, with new 
tasks introduced periodically; some tasks were given on a more regular basis than others. 
Importantly, the tasks were designed so most tasks provided multiple difficulty levels, 
starting with very simple examples and gradually getting more difficult as the person 
progressed through the programme. In addition, several repeats were included in each 
level to give participants the opportunity to practice at any given level. The decision 
when a participant moved on to the next level of a particular task was primarily 
determined by their rating at the end of each level where they signalled it as ‘too easy’, 
‘easy’, ‘okay’, ‘hard’, or ‘too hard’. If a task was rated as ‘too easy’, ‘easy’, or ‘okay’, the 
participant then moved on to the next level of that task; on the other hand, they repeated 
the same level if they gave a rating of ‘hard’ or ‘too hard’. On some occasions the support 
person decided to repeat a particular level, if they considered the participant was having 
difficulties, even if the participant themselves considered the task as ‘okay’. Participants 
and their support person could request additional repeats if they wanted to have more 




attempts at a particular task. Participants were also allowed to skip a level if they were 
finding them ‘too easy’.  
 
 Tasks Designed to Inhibit Activity in the DMN 5.2
Tasks designed to inhibit DMN activities were also referred to as the ‘external’ tasks, as 
these tasks require attention to external stimuli. The ‘external’ tasks were given to 
participants from the beginning of the enrichment programme. The order in which 
participants received these tasks did not differ, but the frequency and speed at which the 
tasks were given was guided by the participants’ ratings. 
 
 Tangram Puzzle 5.2.1
The Tangram Puzzle was designed to enhance participants’ ability to visualise and 
manipulate spatially presented information. Participants were asked to solve puzzles 
using seven flat puzzle pieces of different shapes and colour (Figure 5-1). The difficulty 
of the task was modulated by increasing/decreasing the number of missing puzzle pieces. 
Participants started by completing puzzles with only two pieces missing (Figure 5-1 B) 













Figure 5-1. Examples of the tangram puzzle task. (A) A completed puzzle. (B) An uncompleted puzzle; 
participants were asked to fill the two missing pieces. (C) An uncompleted puzzle with three pieces 
missing. (D) Participants were asked to recreate the puzzle using all seven puzzle pieces. 
 
 Numerical Stroop 5.2.2
The ability to inhibit irrelevant information is a crucial part of the attention system. 
Individuals with MCI frequently exhibit deficient interference control (Wylie, 
Ridderinkhof, Eckerle, & Manning, 2007), so this task was designed to improve their 




ability to withstand distraction. The task was adapted from the procedures described by 
Kaufmann et al. (2006). Their Numerical Stroop task required the participants to compare 
the magnitude of two simultaneously presented Arabic numerals according to their 
numerical values (numerical value comparison), or alternatively their physical size 
(physical size comparison). In the congruent condition the physically larger digit was also 
numerically larger than the other one. In the incongruent condition the physically larger 
digit was numerically smaller than the other one. In addition to the congruency effect, 
two additional levels of interference were included: the distance effect and the physical 
size effect. The distance effect is achieved through presenting numbers that are either 
adjacent to each other (e.g., 2 3) or distant number pairs (e.g., 1 9). The physical size 
difference between digits was manipulated by changing the font size (e.g., 10-point 
difference vs. 20-point difference). For the numerical comparison, maximal interference 
was obtained by a small distance effect (i.e., using adjacent pairs), but a large physical 
size effect (i.e., 20-point difference). Maximal interference for the physical size 
comparison was obtained by a large distance effect (i.e., using distant pairs), but a small 
physical size effect (i.e., 10-point difference). Examples of the task stimuli are presented 






























Figure 5-2. Examples of numerical value and physical size comparisons. 
 
 Global-Local  5.2.3
The Global-Local task was intended to improve participants’ processing speed, mental 
flexibility and visual discrimination abilities. In this task, small (local) letters were 
arranged to form a single large (global) letter. Initially, participants had to answer 
whether a given letter is local or global (i.e., is R global or local?; Figure 5-3 A). In the 
global trials, the instruction was to identify the large letter; for local trials, the instruction 
was to respond to the small letters. Later on, they had to circle either the global or local 
letter in response to the cue given (Figure 5-3 B). The difficulty of the task was 
determined by the frequency that the participant had to switch between the global and 
local trials. In addition, participants were instructed to switch to an ‘internal’ task (see 
2     1 9          1 
2      1 9          1 




below) when they encountered a shaded stimulus (Figure 5-3 B), and switch back to the 






Figure 5-3. Examples of the global-local task. (A) Participants were asked to decide whether the letter 
given in the question is local or global. (B) Participants were asked to circle either the global or local letter 
in response to the stimulus. Shaded stimulus = switch to an ‘internal’ task.  
 
 Mental Rotation  5.2.4
The Mental Rotation task was designed to promote participants’ ability to rapidly and 
accurately rotate a two- or three-dimensional figure. Initially, a variety of two 
dimensional figures (letters, numbers, everyday objects, and abstract shapes) were used. 
The difficulty of the task varied on two levels: the familiarity of the figures (from familiar 
letters, number and symbol, common objects to more abstract shapes), and the degrees of 




rotation (50°, 100°, 150°). Participants started on the task by making yes/no decisions 
(Figure 5-4 A), later on they had to make multi-choice decisions (i.e., selecting the 
correct answer among distractors; Figure 5-4 B). Three-dimensional pictures were 
introduced once the participant had mastered the two-dimensional figures. For this part, 
participants had to decide whether the picture was showing a left or a right hand (Figure 
5-4 C). The pictures were taken from a variety of angles, some with part of the hand 








Figure 5-4. Examples of the mental rotation task. (A) An example of the yes/no mental rotation task. (B) 








 Bells Test  5.2.5
This task was adapted from the Bells Test (Gauthier, Dehaut, & Joanette, 1989), which 
was aimed to enhance attention, speed of processing, and visual searching skills. It 
required the participant to circle pictures of bells surrounded by various distracters 
(Figure 5-5). The difficulty of the task was determined by the area that the participant 
needed to search. Participants started by searching a 8cm x 8cm square and then 
gradually move to searching a A4 sheet of paper.  
 
 









 Mars Money  5.2.6
Mars Money was designed as a mental arithmetic task 
(https://www.gamesforthebrain.com/game/marsmoney/). The aim was to improve 
participants’ attention and working memory by conducting a series of mental calculations 
to ‘balance’ the amount of money held by the two Martians (Figure 5-6). This task varied 
in difficulty by the number of notes displayed which presented the wealth of each Martian 
(harder levels contained more notes).  
 
 
Figure 5-6. An example of mars money. 
 
 Mirror Reverse Reading  5.2.7
This task was developed to enhance the participant’s ability to process novel information. 
Participants were exposed to a perceptual skill learning task requiring them to read 
written information in reserved direction. This task varied in difficulty by introducing the 




text in various fonts, some of which were more difficult to read than others, along with 
the length of material being read. Participants began with single words (Figure 5-7 A) and 
continued to sentences through to whole passages (Figure 5-7 B). Questions directly 





Figure 5-7. Examples of mirror reverse reading. (A) Mirrored reserved words. (B) Mirror reserved 
paragraph.  
 
 Rearranging Muddled Pictures  5.2.8
Rearranging Muddled Pictures was designed to improve participants’ sequencing and 
planning skills by sorting muddled scenes of events into their temporal order. In this task, 
participants were shown muddled photo sequences of an activity (e.g., making a cup of 
coffee; Figure 5-8) and asked to mentally arrange these photos into their chronological 
order. The difficulty of this task was adjusted by the number of available photo 
sequences. 
 





Figure 5-8. An example of rearranging muddled pictures. 
 
 Toy Store 5.2.9
This task was designed to improve performance in associative memory by requiring 
participants to remember names of toys associated with specific children. Participants 
were first introduced to the children and required to learn their names, followed by their 
associated toys (Figure 5-9). The difficulty of this task was varied by the number of 
children and the toys associated with each.  
 
 
Figure 5-9. An example of toy store. 




 Split Words  5.2.10
This task was aimed to promote working memory and attention. In this task, words have 
been cut in half and rearranged, with the first half the words in the first column and 
second half in the second column. Participants were required to match up the split words 
to create whole words. The difficulty of the task varied from matching the split words in 
two columns (Figure 5-10 A), then to three columns in the original order of the word 
(Figure 5-10 B), then to matching the fragments appearing in any column and not 








Figure 5-10. Examples of split words. (A) Word fragments organised in two columns. (B) Word fragments 
organised in three columns. (C) Word fragments appearing not necessarily in the same order as the original 
word. 




 Word Shapes  5.2.11
Word Shapes were designed as a word recognition task to improve attention and 
visuospatial function in participants. Each word is corresponded with a unique shape 
(sometimes called the Bouma shape), which matched the outline of the specific word. 
Tall letters (e.g., h, l) were represented with tall boxes; and shorter letters (e.g., s, o) had 
shorter boxes; while letters that overhang below (e.g., p, g) had boxes which hang lower. 
Participants were required to match each of these unique shapes with the corresponding 
word from a list (Figure 5-11).  
 
 
Figure 5-11. An example of word shapes. 
 
 Tricky Tiles  5.2.12
The aim of this task was to improve visuospatial memory by exercising participants’ 
ability to memorise the location of coloured squares in a grid. Following the 




memorisation trial, participants were required to reproduce the pattern they had just seen 
by placing the coloured squares in their correct location. The difficulty of this task was 
varied by using different grid sizes and the number of colours presented in the patterns 
(Figure 5-12). More difficult trials had a greater number of squares in the grid, along with 




Figure 5-12. Examples of tricky tiles. (A) Pattern made of tiles of the same colour. (B) Pattern made of tiles 
of two different colours. 
 
 Card Game 5.2.13
The Card Game was intended to facilitate mental flexibility, inhibition and speed of 
processing. To encourage inhibition participants flicked through a set of playing cards 
and responded yes or no to each card based on a predetermined rule, but upon seeing an 
ace participants had to change to a new rule. As the person progressed through the task, 




not only the rules got more complex (e.g., same suit as previous card; one value higher or 
lower to previous), they also had to make more frequent switches between the rules.  
 
 Self-Selected Pointing 5.2.14
In Self-Selected Pointing task, participants were presented with a series of pages with an 
array of objects. Objects on each page were always the same but arranged in different 
configurations on different pages. Participants were asked to self-select one object to 
point to on the first page, and then pick a new object every new page and keep track of 
they have pointed to previously. The difficulty of the task increased as the number of 
objects increased from 3 to 4 then eventually to 12 objects. In addition, the objects also 







Figure 5-13. Examples of self-selected pointing. (A) Concrete common objects. (B) Abstract items. 




 Tasks Designed to Elicit DMN Activity 5.3
Accumulating evidence has suggested that several internally directed cognitive processes, 
including remembering the past, envisioning the future, conceiving the view-point of 
others, and spatial navigation are associated with increased activity in DMN (Buckner et 
al., 2008; Buckner & Carroll, 2007; Dixon, Fox, & Christoff, 2014; Spreng et al., 2008). 
Tasks were developed for this enrichment programme based on these cognitive processes 
to elicit DMN activity. These tasks were referred to as ‘internal’ tasks due to the 
involvement of internally directed attention to thoughts, memories and mental imagery. 
The ‘internal’ tasks were introduced approximately 6-7 weeks after starting the 
enrichment programme. These tasks were delivered to the participants in a separate folder 
to the ‘external’ tasks, and participants were instructed to alternate between the ‘external’ 
and ‘internal’ tasks whilst completing the tasks. 
 
 Hebb-Williams Maze  5.3.1
This task was adapted from the Hebb-Williams Maze task (Meunier, Saint-Marc, & 
Destrade, 1986), and involved participants forming a mental imagery of a maze and 
navigating their way through it. Participants were gently blindfolded and were instructed 
to trace with a pen through a wooden maze from the start (positioned in the bottom right 
corner) to finish (positioned in the top left corner) onto a sheet underneath the maze. 
Mazes were always given in pairs, participants traced through each maze five times. After 
tracing through the pair of mazes, participants were instructed to draw free hand on a 




blank piece of paper their mental representation of their path through the first maze only 
from start to finish. Participants were not able to view the maze before blindfolding, and 
remained blindfolded for the duration of the task.  
 
 Autobiographical Memory 5.3.2
Autobiographical memory is referred to as the episodic recollection of personal events 
from one’s own life (Rubin, Schrauf, & Greenberg, 2003). During autobiographical 
recall, individuals must project themselves back in time to re-experience the event, and 
this is often accompanied with by a feeling of reminiscence (Rubin, 2005). Unlike the 
other tasks where the support person assists the MCI participant in completing the task, 
this task was carried out by a research assistant. During the initial session, the researcher 
selected a memory from the Autobiographical Memory Interview (AMI; Kopelman, 
Wilson, & Baddeley, 1989), and prompted the participant to share that memory in as 
much detail as possible, by reflecting on it through mental time travel. The AMI was 
administered at the start of the enrichment programme and involved participants recalling 
nine episodic events across their lifespan (refer to Grenfell, 2013 for more details). In 
approximately fortnightly visits by the research assistant, participants repeated the 
procedure with the memory recalled in the previous session and with a different memory 
recalled on the AMI. During these sessions the researcher used a ‘quilting’ strategy to 
encourage the participants to elicit increasingly detailed recall of each memory. Quilting 
refers technique that has been developed to help patients with dementia to put pieces of 




their personal narratives together by asking more questions or repeating an important 
phrase or sentence in the person’s narrative to elicit additional information of the event 
(Moore & Davis, 2002). 
 
 Moral Decision Making 5.3.3
Moral decision making involves the evaluation of actions that concern norms and values 
established in a social environment (Ciaramelli, Muccioli, Ladavas, & di Pellegrino, 2007; 
Prehn et al., 2008). In order to judge another person’s behaviour as morally right or 
wrong, one must try to infer that person’s intentions and predict the possible outcomes if 
those intentions are acted upon (Knobe, 2005; Moll, de Oliveira-Souza, Bramati, & 
Grafman, 2002). In this task, participants were given a scenario and were forced to 
choose between two different hypothetical statements about how they could react if they 
were a person in the scenario (Figure 5-14).  
 
 
Figure 5-14. An example of the moral decision making task. 




 Faux Pas 5.3.4
Faux pas is a French term, which refers to a socially awkward or tactless act. In this task, 
participants were given brief written scenarios of social situations (Gregory et al., 2002; 
Stone, Baron-Cohen, & Knight, 1998), and they were asked to identify whether a 
character unintentionally said something hurtful to another character, committing what is 
called a ‘faux pas’. An example of a social faux pas is illustrated in Figure 5-15. 
Recognising a faux pas requires both an understanding of false or mistaken belief and an 
empathic inference of the effect it has on someone, and such cognitive processes are 
related to increased DMN activity (Buckner & Carroll, 2007). If a social faux pas had 
been identified in the scenario participants had to say what the faux pas was and who 
committed it and how they thought that person felt. To check understanding of the story 
participants answered two control questions that related to events explicitly stated in the 
scenario. If no faux pas was identified participants did not answer what the faux pas was, 
who committed it and how they thought that person felt, instead skipping to the control 
questions.  
 
A - a social faux pas  
 
Jill had just moved into a new flat. Jill went shopping and bought some new curtains for her bedroom. 
When she had just finished decorating the flat, her best friend, Lisa, came over.  
Jill gave her a tour of the flat and asked, "How do you like my bedroom?" 
"Those curtains are horrible," Lisa said. "I hope you're going to get some new ones!" 
 
B - not a social faux pas  
 
Vicky was at a party at her friend Oliver’s house. She was talking to Oliver when another woman came up 
to them. She was one of Oliver’s neighbours. The woman said, "Hello," then turned to Vicky and said, "I 
don't think we've met. I’m Maria, what's your name?" 
"I’m Vicky." 
"Would anyone like something to drink?" Oliver asked. 
 
 
Figure 5-15. Examples of social faux pas. 




 Reading the Mind in the Eye 5.3.5
The Reading the Mind in the Eye test (Baron-Cohen, Jolliffe, Mortimore, & Robertson, 
1997) was developed to measure ‘Theory of Mind’ or the ability to recognise and 
understand another person’s mental state. This test was adapted for the current study, 
which required the participant to judge an emotion based on pictures of sets of eyes. 
Participants began with choosing between two contrasting emotions (Figure 5-16 A) for 
each set of eyes, progressing to choosing between four emotions (Figure 5-16 B) that 
were similar in nature. Participants were instructed to pick the emotion they thought was 






Figure 5-16. Examples of the reading the mind in the eye. (A) Choosing between two contrasting emotions. 
(B) Choosing between four emotions similar in nature. 




 Envisioning the Future 5.3.6
Prospection or thinking about the future has been linked with an increased activation in 
the DMN (Buckner & Carroll, 2007). In this task, participants were given scenarios and 
instructed to plan their actions in response to these scenarios. Each scenario included both 
a written description and pictures to prompt possible responses (Figure 5-17). Participants 
were instructed to give descriptions as detailed as possible, to visualise the future events 
and situations, and to not limit those descriptions to the picture prompts. 
 
 





CHAPTER 6 - Cognitive Enrichment Outcomes: 
task-related and neuropsychological findings  
 
 Introduction  6.1
This chapter provides an overview of the study design and the feasibility and efficacy of 
the Cognitive Enrichment Programme. Enrichment task-related changes and findings on 
standardised neuropsychological measures are reported and discussed in this chapter. 
Functional MRI (fMRI) procedures and results are reported in the following chapter 
(Chapter 7).  
 
 Method  6.2
Following detailed neuropsychological assessment (described in Chapter 3), 18 MCI 
participants were identified (17 through cognitive screening plus an additional MCI 
referred through a local neurologist). Each MCI participant completed pre- and post-
enrichment assessments, which included standardised neuropsychological tests (Figure 6-
1) and MRI scanning (refer to Chapter 7). For comparison purposes, 11 age and education 
matched healthy controls were also identified, classification criteria included: (1) intact 
functioning on memory tests (i.e., no memory scores below -1.5SD); (2) preserved 
general cognition (i.e., MoCA > 26, DRS-2 scaled score > 9); and (3) normal activities of 
daily living (i.e., a total CDR score of 0). Healthy control participants completed pre-




enrichment assessments only. Table 6-1 provides the demographic and cognitive 
characteristics of the MCI participants and healthy controls at baseline (t1).  
 
 Neuropsychological Assessment Procedure 6.2.1
In addition to the detailed neuropsychological assessment administered at the baseline of 
the study (t1; described in Chapter 4), a briefer assessment was conducted immediately 
prior to the start (t2) of the Cognitive Enrichment Programme, which consisted of a 
subset of tests from the full battery of tests used at baseline (Table 6-2). The primary aim 
of the detailed neuropsychological assessment (t1) was to determine the individual’s 
cognitive status, and to facilitate the selection of individuals into the enrichment 
programme. In contrast, the briefer neuropsychological evaluation was conducted at a 
time much closer to the start of enrichment (87 days prior to the start of enrichment), and 
thus provided an estimation of each individual’s cognitive functioning at that point. Post-
enrichment neuropsychological evaluation was administered, on average, 18 days after 
the completion of the enrichment tasks or the waitlist period. Full battery of cognitive 
tests was given at the end (t3). Table 6-2 details the cognitive tests used at each time 
point.





Baseline Demographic and Cognitive Characteristics of MCI and Healthy Controls; Mean (SD) 
 MCI 
(n = 13) 
Healthy control 
(n = 11) 
t-score 
Demographic Variables     
Age (years) 75.9 (4.72) 75.9 (3.51) 0.01 
Education (years) 12.8 (2.82) 12.6 (2.58) 0.19 
Gender (Male : Female) 9 : 4 6 : 5  
Premorbid IQ 113.4 (11.91) 118.2 (8.02) -1.13 
CDR 0.35 (0.24)   
General Cognitive functions    
MoCA *** 21.8 (2.58) 27.1 (1.76) -5.71 
DRS-2 (scaled score) *** 9.4 (2.29) 13.3 (1.95) -4.42 
ADAS-Cog 11 (raw score) *** 10.1 (2.46) 3.4 (2.02) 7.18 
Executive Function    
Trail Making Test-Part B  0.58 (0.85) 0.98 (0.51) -1.38 
Action Fluency * -0.26 (1.01) 0.59 (0.54) -2.49 
Verbal Fluency 0.36 (1.23) 0.49 (1.35) -0.24 
Category Fluency 0.97 (1.20) 1.79 (0.82) -1.91 
Category Switching  0.08 (1.37) 0.94 (0.83) -1.82 
Stroop Interference 0.15 (1.57)  0.91 (0.37) -1.56 
Design Fluency Filled Dots 0.51 (0.92)  0.55 (0.83) -0.09 
Design Fluency Empty Dots 0.67 (0.94) 0.39 (0.65) 0.81 
Design Fluency Switching 0.38 (1.35) 1.12 (0.79) -1.59 
Attention and Processing Speed    
Trail Making Test-Part A 0.71 (0.62) 1.15 (0.41) -2.01 
Digit Span 0.46 (1.21) 0.97 (0.61) -1.26 
SDMT Written *** -0.54 (0.85) 1.09 (1.00) -4.32 
SDMT Oral *** -0.69 (0.69) 0.91 (0.83) -5.15 
Stroop Colour Naming -0.00 (0.96) 0.39 (0.51) -1.22 
Stroop Word Naming 0.15 (0.98) 0.55 (0.49) -1.22 
Learning and Memory    
BVMT-R Total Recall *** -2.02 (0.61) 0.35 (1.00) -7.11 
BVMT-R Delayed Recall *** -1.91 (0.81)  0.59 (0.82) -7.49 
Story Recall Immediate Recall * 5.31 (3.38) 8.50 (1.83) -2.80 
Story Recall Delayed Recall ** 3.69 (2.55) 6.91 (1.88) -3.45 
CVLT-II SF Total Recall *** -0.15 (0.96) 1.99 (0.42) -6.85 
CVLT-II SF Short Delay *** -0.77 (1.28) 2.09 (1.09) -5.81 
CVLT-II SF Long Delay *** -0.50 (0.89)  1.36 (0.84) -5.25 
RCFT Immediate Recall *** -1.48 (0.79)  1.91 (0.69) -11.14 
RCFT Delayed Recall *** -1.35 (1.03) 1.73 (1.02) -7.32 
RI-48 Immediate Recall (raw score) ** 37.2 (6.92) 45.1 (3.14) -3.47 
RI-48 Delayed Recall (raw score) *** 17.5 (6.29) 29.0 (4.75) -4.99 
Visual Association Test *** -1.06 (0.97) -0.07 (0.24) -3.28 
Visuospatial Function    
Matrix Reasoning 0.18 (0.85)  0.97 (1.09) -2.00 
RCFT copy *** -1.36 (0.99) 0.30 (0.35) -5.32 
Silhouettes (percentile) 30.2 (31.54) 50.6 (28.85) -1.64 
Judgement Of Line Orientation * 0.29 (0.71) 0.82 (0.46) -2.09 
Language    
Boston Naming  0.01 (1.05) 0.40 (0.69) -1.05 
Token Test -0.36 (0.68) -0.12 (0.39) -1.02 
Note. Neuropsychological test values are z scores based on age- and education-adjusted norms, unless 
otherwise stated. SDMT = Symbol Digit Modalities Test; BVMT-R = Brief visuospatial Memory Test-
Revised; MoCA = Montreal Cognitive Assessment; DRS-2 = Dementia Rating Scale-2; ADAS-Cog = 
Alzheimer's Disease Assessment Scale-cognitive subscale; CVLT-II SF = California Verbal Leaning Test-
II Short Form; RCFT = Rey Complex Figure Test; RI-48 = Rappel Indice 48 items. 
* p < 0.05. ** p < 0.01. *** p < 0.00.




 MRI Procedure  6.2.2
Refer to Chapter 7.  
 
 Random Allocation  6.2.3
MCI participants were randomly allocated to either the intervention group or the waitlist 
group (Figure 6-1). Block randomisation was used to achieve balance in the allocation of 
participants. A block size of two was chosen. Each test was assigned with a specific 
weighting, tests of memory functions and general cognitive abilities received higher 
weightings than tests of other cognitive functions. The overall weighted score represents 
the degree of cognitive impairment (higher score = more impaired; lower score = less 
impaired). MCI participants were rank ordered based on the severity of their cognitive 
impairment. The random allocation sequence (1 = intervention; 0 = waitlist) was 
generated by Random Allocation Software version 1.0.0 (http://random-allocation-
software.software.informer.com). To achieve matched groups, the randomisation 












Neuropsychological Tests Administered at Three Different Time Points 
Tests  Baseline (t1) Start (t2) End (t3) 
MoCA  √  √ 
DRS-2  √  √ 
ADAS-Cog  √  √ 
Trail Making Test √  √ 
Letter Fluency √ √ √ 
Category Fluency  √ √ √ 
Category Switching √ √ √ 
Action Fluency √  √ 
Stroop Interference  √ √ √ 
Design Fluency  √ √ √ 
SDMT  √ √ √ 
Digit Span √  √ 
CVLT-II SF  √  √ 
BVMT-R  √ √ √ 
RCFT  √  √ 
Story Recall  √ √ √ 
RI-48  √  √ 
Visual Association Test √  √ 
Matrix Reasoning √  √ 
Silhouettes  √  √ 
Judgment Of Line Orientation  √  √ 
Boston Naming √  √ 
Token Test √  √ 
Note. MoCA = Montreal Cognitive Assessment; DRS-2 = Dementia Rating Scale-2; ADAS-Cog = 
Alzheimer's Disease Assessment Scale-cognitive subscale; SDMT = Symbol Digit Modality Test; CVLT-II 
SF = California Verbal Leaning Test-II Short Form; BVMT-R = Brief Visuospatial Memory Test-Revised; 
















Figure 6-1. Participant flow diagram from randomisation through to study completion. A total of 18 MCI 
(17 Confirmed MCI as mentioned in Chapter 4 plus an addition MCI referred through a local neurologist) 
were randomised into the intervention and waitlist group. One intervention participant had to be moved to 
the waitlist group due to overseas holiday. One intervention participant (increased family commitment) and 
three waitlist participants (discomfort with cognitive testing; lacking motivation) withdrew before 
beginning the intervention, but after randomisation. One intervention participant discontinued within the 
first week of cognitive enrichment due to increased work commitments.  




 Statistical Analyses 6.2.4
The question of interest was whether the decline in scores from pre-intervention (t1 or t2) 
to post-intervention (t3) is greater for the waitlist group than it is for the enriched group. 
A series of analyses of covariance (ANCOVA) were conducted, with the difference score 
between pre- and post-intervention (i.e., primary measures: t2 minus t3; secondary 
measures: t1 minus t3) as the dependent variable, and the pre-test as the covariate. That 
is, this model assessed the differences in the pre-post means after accounting for pre-
intervention values. Unless otherwise noted, statistical effects associated with p <0.05 
were reported as significant, and effects with p <0.20 were reported as indicative on an 
exploratory basis and given the likelihood of type II errors with this sample size (Stallard, 
2012). Data were analysed using Statistica 12 (www.statsoft.com). Cohen’s d, expressing 
the effect size of comparisons, was calculated to gain a better understanding of the range 
of intervention related benefits. The effect sizes and their 95% confidence intervals were 
calculated using the difference score (post minus pre), but did not account for the 
individual’s pre-test performance. The effect size for the intervention effect estimates the 
magnitude of the effect present in the population, expressed in standardised units. In case 
of a null hypothesis (no effect), a zero effect size is expected. The null hypothesis is 
rejected, when the confidence interval of the effect size does not span zero. Effect sizes of 
0.2, 0.5 and 0.8 are considered as small, medium, and large, respectively. Effect sizes 
were calculated using Power and Precision (www.poweranalysis.com).  
 





 Participants vs. Drop-Outs  6.3.1
To determine the representativeness of the participant sample, comparisons were made 
between individuals who completed the study and those who dropped out of the 
programme. The results showed no group differences in sex, age, years of education or 
cognitive scores, with the exception of Design Fluency Empty Dots. The score was 
significantly lower in the drop-out group (M = -0.53, SD = 0.76) than in the participant 
group (M = 0.67, SD = 0.94; t = -2.53, p < 0.05). Overall, the two groups were 
comparable with respects to preclinical stages of AD. On the a priori basis of compliance 
of at least three months continuance in the study, drop-outs were excluded from further 
statistical analyses. 
 
 Intervention vs. Waitlist Participants 6.3.2
Demographic and clinical variables of the intervention and waitlist participants are 
presented in Table 6-3. Intervention participants were slightly older and had more years 
of education than the waitlist group, but none of the variables listed in Table 6-3 showed 
significant differences. Baseline (t1) performances on neuropsychological tests are 
presented in Table 6-4. At baseline, comparable performances were observed between the 
two groups, with the exception of TMT-B (t = -2.64, p < 0.05) and Stroop Colour 
Naming (t = -2.22, p < 0.05), the waitlist controls obtained higher scores than the 
intervention group on both tests.  




Similarly, comparable performances on the neuropsychological tests were 
observed between the two groups at the start of the Cognitive Enrichment Programme 
(t2). Table 6-5 provides the cognitive characteristics of the two groups at the start of the 
cognitive enrichment programme (t2).  
 
Table 6-3 
Baseline Demographic Characteristics of Intervention and Waitlist Groups; Mean (SD) 
 Intervention  
(n = 6) 
Waitlist 
(n = 7) 
Age (years) 78 (3.01) 74 (5.59) 
Education (years) 14 (2.88) 12 (2.33) 
Gender (Male : Female) 4 : 2 5 : 2 
Premorbid IQ 114 (8.44) 113 (14.96) 
CDR  0.33 (0.29) 0.30 (0.27) 
Note. CDR = Clinical Dementia Rating.  
 
 Feasibility and Acceptance of the Cognitive Enrichment Programme 6.3.3
The randomised controlled trial (RCT) was conducted from August 2013 to February 
2014. Due to individual variability, the length of the intervention programme ranged from 
four months to six months. One participant progressed through the enrichment tasks at a 
much slower pace than the others; in order for him to be exposed to a good variety of 
tasks his programme was extended to approximately six months. All intervention 
participants and their caregiver were able to use the programme independently and 
successfully after initial instruction from the research team. Of the people that started the 
programme, 83% completed the intervention, with one participant discontinuing after the 
first week of cognitive enrichment, due to lack of time and work commitment, not 




because of difficulty using the programme. No adverse events were reported from either 
group.  
 
 Performance on Cognitive Enrichment Tasks 6.3.4
It is postulated that an effective Cognitive Enrichment Programme must provide varied 
cognitive activities that require continuous effort by the participants. Thus, the difficulty 
of the enrichment tasks was manipulated, so that each task contained multiple levels that 
would continue to challenge participants’ abilities. Furthermore, rating scales were 
implemented at the end of each level to avoid distress in participants and at the same time 
to provide continual cognitive challenges (i.e., if they rated the task as ‘too difficult’ they 
can repeat that level again, but if they rated as ‘too easy’ then they can skip a level).  
 
Tangram Puzzle and Mirror Reverse Reading provided good illustrations of how 
the tasks were manipulated and participants’ progression through the tasks (Figure 6-2 
and 6-3). For Tangram Puzzle, as the number of missing puzzle pieces increased from 
two to seven (Figure 6-2 A), participants rated the task as more difficult (Figure 6-2 D) 
and required more repeats before progressing onto the next level (Figure 6-2 B). 
However, participants were still able to maintain a high level of performance, between 
85% - 100% of correct responses (Figure 6-2 C), despite the increased mental load, which 
suggested an improvement in their cognitive abilities during the intervention. The 











Figure 6-2. Tangram puzzle performance. Example of manipulated parameters and performances during 
enrichment (A), number of attempts (B), percentage of correct responses (C), and difficulty rating (D). 
Error bars represent 95% confidence intervals.  
 
Another example of task-related improvements was illustrated by Mirror Reverse 
Reading (Figure 6-3). There were no data available on the accuracy of performance, as it 
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Nonetheless, participants rated the task as more difficult (Figure 6-3 B) as they 
progressed through the task and required more attempts at the same level before feeling 
confident to move onto the next level (Figure 6-3 A). The drop in the number of attempts 
at level six was due to participants reaching the end of the enrichment programme, and 
not having a chance to repeat that particular level despite finding it more difficult than 




Figure 6-3. Mirror reverse reading performance. Number of attempts (A), and difficulty rating (B). Error 
bars represent 95% confidence intervals.  
 
 Performance on Standardised Neuropsychological Tests 6.3.5
Primary outcome measures consisted of tests that were administered at both the start (t2) 
and the end (t3) of the enrichment programme (Table 6-4). A significant group difference 
was observed for BVMT-R Delayed Recall, [F (1, 10) = 4.97, p < 0.05, d = 0.63], with a 
greater decline observed in the waitlist group. In addition, the group difference for 
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(1, 10) = 3.09, p = 0.11, d = 0.73] approached significance in favour of the intervention 
group. Medium to large effect sizes were also observed for Verbal Fluency [F (1, 10) = 
0.32, p = 0.59, d = 0.58] and SDMT [F (1, 10) = 1.38, p = 0.27, d = 0.81].  
 
Secondary outcome measures consisted of additional tests that were only 
administered at baseline (t1) and at the end of enrichment (t4). Although none of these 
measures reached statistical significance (Table 6-5), medium effects were observed on 
tests of general cognitive function (e.g., MoCA [F (1, 10) = 0.48, p = 0.50, d = 0.50]; 
DRS-2 [F (1, 10) = 0.78, p = 0.40, d = 0.60]). Additionally, CVLT-II SF Short Delayed 
Recall approached statistical significance in favour of the intervention group [F (1, 10) = 
2.72, p = 0.13, d = 0.80]. On tests measuring visuospatial abilities, a large effect size was 
observed for RCFT Copy [F (1, 10) = 3.33, p = 0.10, d = 1.10]. Furthermore, a medium 
to large effect size was found for Digit Span [F (1, 10) = 0.01, p = 0.95, d = 0.56], Boston 






Performance on Primary Outcome Measures at Pre- and Post-Intervention  
 Pre-Intervention  Post-Intervention  Difference Score p-value Effect Size (95% CI) 
#
 
      
 Intervention 
(n = 6) 
Waitlist 




(n = 6) 
Waitlist 




(n = 6) 
Waitlist 
(n = 7) 
  
Executive Function           
Verbal Fluency -0.11 (1.62) 0.76 (1.24)  0.67 (1.81) 0.95 (0.73)  0.78 (0.72) 0.19 (1.20) NS 0.58 (-0.60 – 1.77) 
Category Fluency -0.06 (1.51) 0.19 (0.92)  1.00 (1.44) 1.29 (1.18)  1.06 (0.44) 1.10 (1.10) NS -0.05 (-1.23 – 1.14) 
Category Switching  -0.11 (1.56) -0.14 (1.15)  -0.06 (1.90) -0.19 (1.34)  0.06 (0.39) -0.05 (1.32) NS 0.11 (-1.08 – 1.30) 
Stroop Interference -0.22 (1.34) 0.81 (0.57)  0.06 (1.67) 0.76 (0.69)  0.28 (0.58) -0.05 (0.30) 0.11 0.73 (-0.45 – 1.92) 
Design Fluency Filled Dots 0.67 (0.99) 0.38 (1.48)  1.00 (1.27) 0.48 (0.96)  0.33 (0.76) 0.10 (0.86) NS 0.28 (-0.91 – 1.47) 
Design Fluency Empty Dots 0.39 (1.12) 0.33 (1.31)  0.67 (1.37) 0.67 (0.88)  0.28 (0.44) 0.33 (1.06) NS -0.06 (-1.25 – 1.13) 
Design Fluency Switching 0.22 (1.66) -0.29 (1.52)  0.67 (1.49) 0.29 (1.03)  0.45 (0.66) 0.57 (0.69) NS -0.18 (-1.36 – 1.01) 
Attention and Processing Speed           
SDMT -0.83 (0.75) -0.29 (0.57)  -0.50 (0.77) -0.43 (0.89)  0.33 (0.52) -0.14 (0.63) NS 0.81 (-0.38 – 1.99) 
Stroop Colour Naming -0.06 (1.02) 0.52 (0.33)  -0.11 (1.29) 0.43 (0.76)  -0.06 (0.75) -0.10 (0.54) NS 0.06 (-1.13 – 1.25) 
Stroop Word Naming 0.22 (0.66) 0.52 (0.69)  0.28 (1.10) 0.57 (0.71)  0.05 (0.77) 0.05 (0.36) NS 0.00 (-1.19 – 1.19) 
Learning and Memory           
BVMT-R Total Recall  -1.52 (1.15) -1.34 (1.13)  -1.53 (0.96) -1.99 (0.56)  -0.02 (0.66) -0.64 (0.93) 0.13 0.76 (-0.43 – 1.94) 
BVMT-R Delayed Recall  -1.33 (1.36) -1.20 (1.28)  -1.53 (0.82) -1.90 (0.54)  -0.20 (0.70) -0.70 (0.86) 0.05 0.63 (-0.56 – 1.82) 
Story Immediate Recall -0.22 (1.60) -0.38 (0.70)  0.00 (1.96) -0.43 (1.12)  0.22 (0.65) -0.05 (1.25) NS 0.26 (-0.92 – 1.45) 
Story Delayed Recall -0.06 (1.22) -0.67 (0.67)  0.00 (1.05) -0.81 (0.98)  0.06 (0.54) -0.14 (0.86) NS 0.27 (-0.91 – 1.46) 
Note. Neuropsychological test values are z scores based on age- and education-adjusted norms. SDMT = Symbol Digit Modalities Test; BVMT-R = Brief Visuospatial 
Memory Test-Revised.  
#







Performance on Secondary Outcome Measures at Baseline and Post-Intervention  
 Baseline  Post-Intervention  Difference Score p-value Effect size  (95% CI) 
#
 
     
 Intervention 
(n = 6) 
Waitlist 




(n = 6) 
Waitlist 




(n = 6) 
Waitlist 
(n = 7) 
  
General Cognitive Function           
MoCA (raw) 21(3.46) 23 (1.40)  23 (4.22) 23 (3.68)  1.83 (3.87) 0.14 (2.85) NS 0.50 (-0.68 – 1.69) 
DRS-2 (scale) 9 (2.45) 10 (2.29)  10 (4.18) 9 (2.31)  1.33 (2.42)  -0.71 (4.07) NS 0.60 (-0.59 – 1.78) 
ADAS-Cog 11 (raw) 10 (3.20) 11 (1.72)  11 (7.12) 12 (4.01)  -1.33 (5.15)  -1.62 (2.85) NS 0.07 (-1.12 – 1.26) 
Executive Function           
TMT-B  0.03 (0.92) 1.05 (0.43)  0.49 (0.59) 1.02 (0.62)  0.46 (0.73) -0.03 (0.48) NS 0.81 (-0.38 – 2.00) 
Action Fluency  -0.25 (1.41) -0.26 (0.64)  0.22 (0.78) 0.29 (0.64)  0.47 (1.34) 0.55 (0.40) NS -0.08 (-1.27 – 1.10) 
Attention and Processing Speed           
TMT-A 0.56 (0.66) 0.85 (0.60)  0.45 (0.75) 1.00 (0.85)  -0.11 (0.42) 0.16 (0.45) NS -0.62 (-1.81 – 0.57) 
Digit Span -0.11 (1.22) 0.95 (1.05)  0.11 (1.00) 0.81 (0.77)   0.22 (0.72)  -0.14 (0.57) NS 0.56 (-0.63 – 1.75) 
Learning and Memory           
CVLT-II SF Total Recall -0.28 (1.14) -0.03 (0.84)   0.17 (1.55) 0.36 (0.83)  0.45 (0.95) 0.39 (0.47) NS 0.08 (-1.10 – 1.27) 
CVLT-II SF Short Delay  -0.75 (1.81) -0.79 (0.76)  0.50 (1.41) -0.50 (1.08)  1.25 (1.44) 0.29 (0.95) 0.13 0.80 (-0.39 – 1.99) 
CVLT-II SF Long Delay -0.42 (1.11) -0.57 (0.73)  0.00 (1.05) -0.57 (0.84)  0.42  (1.16) 0.00 (0.71) NS 0.45 (-0.74 – 1.63) 
RCFT Immediate Recall -1.38 (0.78) -1.57 (0.84)  -0.50 (1.28) -1.11 (1.19)  0.88 (1.17) 0.46 (1.14) NS 0.36 (-0.82 – 1.55) 
RCFT Delayed Recall -1.42 (0.73) -1.30 (1.29)  -0.97 (1.45) -1.00 (1.17)  0.45 (1.39) 0.30 (1.31) NS 0.11 (-1.08 – 1.30) 
RI-48 Immediate Recall  39.33 (8.50) 35.43 (5.22)  38.00 (9.53) 35.14 (5.27)  -1.33 (2.34) -0.29 (2.69) NS -0.41 (-1.60 – 0.78) 
RI-48 Delayed Recall 19.67 (7.15) 15.57 (5.26)  19.00 (10.71) 15.14 (6.89)  -0.67 (4.80) -0.43 (4.12) NS -0.05 (-1.24 – 1.13) 
Visual Association Test -1.13 (1.05) -1.00 (0.98)  -1.17 (1.11) -1.20 (1.07)  -0.03 (0.37) -0.20 (0.61) NS 0.33 (-0.86 – 1.52) 
Visuospatial Function           
Matrix Reasoning 0.33 (1.01) 0.05 (0.73)  0.50 (1.07) -0.14 (1.20)  0.17 (1.21) -0.19 (0.61) NS 0.39 (-0.80 – 1.57) 
RCFT Copy  -1.29 (1.18) -1.42 (0.88)  -0.86 (1.16) -1.68 (1.06)  0.43 (0.90) -0.26 (0.43) 0.10 1.10 (-0.18 – 2.19) 
Silhouettes (percentile) 29.95 (33.77) 30.37(32.23)  40.88 (38.24) 35.27 (35.70)  10.93 (33.15) 4.90 (22.58) NS 0.22 (-0.97 – 1.40) 




Language           
Boston naming -0.11 (1.19) 0.11 (1.01)  -0.25 (0.97) -0.66 (1.55)  -0.15 (0.82) -0.76 (0.89) NS 0.71 (-0.48 – 1.90) 
Token test -0.56 (0.86) -0.19 (0.49)  -0.22 (0.53) 0.00 (0.00)  0.34 (0.67) 0.19 (0.49) NS 0.26 (-0.93 – 1.45) 
Note. Neuropsychological test values are Z scores (except where specified) based on age- and education-adjusted norms. MoCA = Montreal Cognitive Assessment; 
DRS-2 = Dementia Rating Scale-2; ADAS-Cog = Alzheimer's Disease Assessment Scale-cognitive subscale; TMT = Trail Making Test; CVLT-II SF = California 
Verbal Leaning Test-II Short Form; RCFT = Rey Complex Figure Test; RI-48 = Rappel Indice 48 items; JLO = Judgement of Line Orientation.  
#
 Effect sizes were calculated based on the difference score, and did not take into account of pre-intervention performance.




 Discussion  6.4
The goal of this chapter was to assess the feasibility and efficacy of the Cognitive 
Enrichment Programme in persons with MCI. Participants of the programme were faced 
with cognitively stimulating tasks that called upon a range of cognitive functions.  
 
 Feasibility of the Cognitive Enrichment Programme  6.4.1
One important aspect of a successful cognitive intervention programme is whether it is 
able to retain participants’ interest and motivation to such a degree that extensive 
amounts of the tasks can be completed. Completion rates are one way to evaluate these 
issues. The current study achieved a high level of participation in both intervention and 
waitlist participants. The attrition rate was relatively low in spite the fact that the 
programme was relatively demanding and involved a substantial time commitment (45-60 
min/d, 3-4 d/wk for at least 4 months), not only for the participants but also for their 
caregivers. The involvement of a caregiver could be an important factor in the high 
completion rate; the dyadic interaction between MCI participants and their support people 
is likely to have facilitated participants’ motivation and effort. Most previous cognitive 
intervention programmes were professional-led, but we found that a support person based 
programme is also possible and well-accepted by individuals with MCI and their families. 
This finding is consistent with a study by Margrett and Willis (2006), which showed that 
older adults could successfully implement a cognitive training programme at home 
without a formal trainer. Hence, suggests that support person based cognitive intervention 




may be a valuable alternative to group formats. Support person based cognitive 
intervention also offers the advantage of tailoring the programme to each individual’s 
need.  
 
 Enrichment Task-Related Improvements  6.4.2
In the present study, the enrichment tasks were designed in a fashion so that the tasks 
tailored each participant’s cognition, but at the same time provided continual challenges 
and offered variety. Although no formal testing was conducted on the enrichment tasks, 
task-related improvements can be inferred using a number of measures. Firstly, the 
parameters of the tasks were manipulated to produce increments in difficulty at each 
level, and the increments were adjusted according to the subjective rating of the 
participant. Therefore, advancing to the next level usually indicated that the person had 
shown improved performance on the previous level with repeated exposure. Furthermore, 
improvements can be measured through the percentage of correct responses at each level. 
Although this information is not always available for all the tasks and is dependent on the 
accurate recording of such information by the support person, nonetheless it provides 
valuable information on a person’s progression on the enrichment tasks. It was found in 
the present study that even with increased cognitive load, participants were still able to 
achieve a high level of accuracy on the tasks. It is important to note that a stabilised 
performance should be interpreted as an improvement in performance since the 
complexity of the enrichment tasks was gradually increased. These results are thus in line 




with previous findings of improvements on measures that are directly related to the 
trained tasks (Belleville et al., 2006; Greenaway et al., 2008; Hampstead et al., 2008; Jean 
et al., 2010; Troyer et al., 2008).  
 
 Beneficial Effects on General Cognitive Status 6.4.3
The Cognitive Enrichment Programme produced a medium effect size for two of the 
global cognitive measures, namely the MoCA and DRS-2. Although these effects did not 
reach statistical significance, but they were in the expected direction, and their sizes 
suggest that a larger trial may be warranted. Previous studies using multi-domain 
cognitive intervention have reported significant intervention effect on global cognitive 
measures such the ADAS-cog (Buschert et al., 2011) and MMSE (Buschert et al., 2011; 
Olazaran et al., 2004). We also included the ADAS-cog as a measure of global cognitive 
status. However, we failed to find a significant intervention effect on the ADAS-cog. 
Taken together, our results combined with results from previous studies indicated that 
cognitive intervention involving multi-domain stimulation has the potential to induce 
generalised cognitive benefits. 
 
 Beneficial Effects on Memory  6.4.4
It was found that the Cognitive Enrichment Programme had a significant beneficial effect 
on the BVMT-R Delayed Recall. This beneficial effect of long-term retrieval of visual 
information was shown by a greater decline of the BVMT-R Delayed Recall in the 




waitlist participants, suggesting cognitive enrichment may protect against further memory 
decline in MCI individuals. In contrast, no significant differences were found on the 
RCFT Immediate Recall and Delayed Recall, which are also measures of visuospatial 
memory. Although both intervention and waitlist group showed improved recall of the 
complex figure, greater improvements were observed in the intervention group than the 
waitlist group. The lack of significance may be partly attributed to a practice effect. 
While alternate forms were used at each occasion for the BVMT-R, the same RCFT 
complex figure was administered at each point, which presents a problem in the 
evaluation of memory when participants are asked to memories the same information on 
more than one occasion. A number of our participants reported that they remembered 
seeing the complex figure on repeated examinations. It is possible that following the 
initial exposure, the RCFT has lost its novelty thereby inflating the recall test score. 
Examination on a related measure (RCFT Copy) revealed that intervention participants’ 
ability to copy the complex figure was greatly improved, while the waitlist group 
declined. This effect approached significance and resulted in a large effect size. Sullivan, 
Mathalon, Ha, Zipursky, and Pfefferbaum (1992) argued that the copy score not only 
provides information about drawing accuracy of the complex figure, it also reflects 
planning and organisation abilities, which may also influence stimulus encoding and 
retrieval processes involved in the subsequent recall trials. A different study examined the 
effects of different types of encoding strategies reported that organised copying strategies 
resulted in better recall performance of the visual design than disorganised strategies 
(Newman & Krikorian, 2001). Furthermore, Meyers and Meyers (1995) also noted 




moderate correlations between RCFT Copy and RCFT Recall performance. The greater 
improvements seen in the recall trials of the intervention group, thus could be attributed 
to a more efficient constructing and organisation strategies during the copy trial and this 
improved approach had potentially assisted in the subsequent recall of the complex 
figure. 
 
In terms of verbal memory performance, the gain score of the intervention 
participants on CVLT-II Short Delayed Recall approached significance, along with a 
large effect size. No significant intervention effect was observed for the RI-48 and Story 
Recall. The lack of significance on these tests may be partly due to a relatively intact 
performance on pre-intervention assessments. Despite previous studies suggesting that 
RI-48 and Story Recall as sensitive measures for early AD (Adam et al., 2007; Rabin et 
al., 2009), most our MCI participants performed within the normal range compared to 
others of similar age (i.e., did not fall below a z-score of -1.5).  
 
 Beneficial Effects on Other Cognitive Domains 6.4.5
The Cognitive Enrichment Programme was employed to stimulate a range of cognitive 
functions, hence it was expected that the programme would show beneficial effects on 
measures of non-memory functions. Neuropsychological results revealed that a number 
of these measures showed a non-significant trend favouring the intervention group, long 
with a medium to large effect size. As mentioned, the group difference on the gain score 




of RCFT Copy approached significance, which suggests a beneficial effect of the 
programme on visuospatial and visuoconstruction abilities in MCI. Medium to large 
effect sizes were observed on several other outcome measures, namely TMT-B, Verbal 
Fluency, Stroop Interference, SDMT, Digit Span, and Boston Naming. These results 
suggest positive effects of the programme on executive function, attention and processing 
speed and language abilities. Larger studies with more power are needed to determine 
whether these observations are real or due to random variation.  
 
 Summary and Conclusion 6.5
Using an RCT design, the current study revealed positive, although generally non-
significant, intervention effects in persons with MCI. In general, participants in the 
intervention group demonstrated reduced cognitive decline compared to the waitlist 
group. Although most differences between the intervention and waitlist group were not 
statistically significant, we observed a pattern in which effect sizes for cognitive 
measures consistently favoured the intervention group. The significant improvement 
found in BVMT-R Delayed Recall suggests that cognitive enrichment increased the 
ability to encode and retain visuospatial information in MCI individuals. Delayed recall 
has been suggested as a reliable neuropsychological marker of detecting MCI at risk for 
dementia. Thus, improvements in delayed recall following intervention are likely to have 
clinical validity in MCI by protecting those cognitive functions that are most likely to 
deteriorate. In summary, findings of our randomised controlled pilot study suggest 




positive effects of the Cognitive Enrichment Programme in elderly with MCI, and that 
cognitive enrichment could be a valuable method for supporting cognition in MCI, 







CHAPTER 7 - Cognitive Enrichment Outcomes: 
Magnetic Resonance Imaging 
 
 Introduction  7.1
This chapter explored enrichment-related changes in default mode network (DMN) 
activity and connectivity in older adults with MCI. As mentioned in Chapter 3, the DMN 
is defined as a set of brain regions that show a high level of activity when the mind is not 
engaged in specific behavioural tasks. Its activity is increased during internally directed 
self-referential cognitive processes (e.g., tasks that require awareness of a personal past, 
present, and future), but deactivated during tasks that demand external attention (e.g., 
working memory tasks) (Buckner et al., 2008; Dixon et al., 2014). Neuropathology in the 
DMN have been repeatedly shown in AD as well as MCI (Bai et al., 2008; Greicius et al., 
2004; Hedden et al., 2009; Rombouts et al., 2005; Sorg et al., 2007). The most consistent 
functional DMN impairment in both MCI and AD is decreased resting-state functional 
connectivity within the posterior DMN, especially the posterior cingulate cortex (Agosta 
et al., 2012; Hafkemeijer et al., 2012; Sorg et al., 2007), and a decreased ability to 
suppress activity within the DMN when performing cognitively demanding tasks 
(Rombouts et al., 2005). Furthermore, these alterations were found to be related to the 
severity of the disease and conversion of MCI to dementia (Binnewijzend et al., 2012; 
Greicius et al., 2004; Petrella et al., 2011).  




The Cognitive Enrichment Programme was developed so as to restore (i.e., return 
to a normal state) or to compensate for (i.e., reduce further decline) functional decline of 
the DMN in MCI participants. As DMN integrity is marker of cognitive dysfunction of 
early AD, we used DMN activity and connectivity as an objective measure to assess 
whether the Cognitive Enrichment Program would have a positive effect on brain 
function. Two types of functional Magnetic Resonance Imaging (fMRI) procedures were 
used to examine enrichment-related changes in DMN. One explored task-related 
activations and deactivations within regions of the DMN (task fMRI), and the other 
focused on the degree of connectivity of the DMN at rest (resting-state fMRI).  
 
 Method  7.2
While all participants (13 MCI and 11 healthy controls) received an MRI scan prior to the 
start of the Cognitive Enrichment Programme, only the MCI participants were scanned at 
the end of their enrichment/waitlist period (demographic characteristics of the MCI and 
HC participants are presented in Table 6-1). Funding was not available for repeat scans 
on the healthy controls. All scans included structural, functional, diffusion, and arterial 
spin labelling MR imaging of the brain. Data collection and analyses for the functional 
MRI scans are described below; structural, diffusion imaging and arterial spin labelling 
components of this study have not been included in this thesis. 
 
 




 MRI Acquisition  7.2.1
MR images were acquired on a 3 tesla General Electric HDxt scanner with an eight 
channel head coil. Structural MR images included a T1-weighted, three-dimensional 
spoiled gradient recalled echo (SPGR) acquisition (TE/TR = 2.84/6.7ms, TI = 400ms, flip 
angle = 15°, acquisition matrix = 256×256×184, FOV = 250mm, slice thickness = 1mm, 
voxel size = 0.98×0.98×1.0mm
3
). A T2-weighted fluid-attenuated inversion recovery 
(FLAIR) sequence for classification of white matter hyperintensities (TE/TR/TI = 
105/9000/2250ms, 3mm slices with 1.5mm gap, 33 slices, FOV = 220mm, acquisition 
matrix = 320×320).  
 
Functional images (both resting state and task) were acquired using a two-
dimensional gradient echo, echo planar imaging (EPI) sequence (TE/TR = 35/3000ms, 
flip angle 90°, acquisition matrix = 64×64×44, FOV = 220mm, slice thickness = 3mm, 
number of slices = 44, space between slices = 0mm, voxel size = 3.4×3.4×3mm
3
, 
interleaved bottom to top, angled 20° above the anterior commissure-posterior 
commissure line to improve signal form the temporal lobe). A gradient echo field map 
acquired at two different echo times (TE1/TE2 = 5.3/7.6ms, TR = 475ms) was used to 
minimise distortion due to susceptibility in homogeneity in the fMRI EPI acquisitions. 
Resting-state images were acquired over 8 minutes 12 seconds during which time 
participants were instructed to relax and close their eyes, but stay awake. Task fMRI 
images were acquired over two 10 minutes 12 seconds sessions; participants were 
instructed to make yes/no decisions using the MR-safe response pad in the scanner.  




 Task fMRI Paradigms  7.2.2
Participants were asked to perform two tasks: one to deactivate the DMN (n-back), and 
the other to activate the DMN (self-reflection).  Participants practiced these tasks on a 
standalone computer before going into the scanner. Each task consisted of an active 
condition (e.g., two-back; self-reflection) and a control condition (x-not-x; short or long) 
presented in blocks. Participants were prompted with an instruction screen to inform them 
about the task/condition to which they should respond on each trial (refer to Figure 7-1 
and Figure 7-2). Each task/condition had a different colour border to aid discrimination 
between tasks/conditions. Participants performed six blocks of each condition, within 
which they alternated between the active condition and the control condition. Each block 
(i.e., active or control) started with an instruction screen shown for 9 seconds and ended 
with 15 seconds of fixation, and contained nine stimuli, presented one at a time for 2.7 
seconds, followed with a brief dot shown for 0.3 seconds. The tasks were designed using 
E-Prime 2.0 software (Psychology Software Tools, www.pstnet.com). The order of runs 
(the tasks as well as the conditions within the tasks) was counterbalanced across 
participants. Responses were made with a two-button response device held in the right 
hand; participants were instructed to use the index finger for yes responses, the middle 
finger for no responses. 
 
N-Back Task. In the n-back task, fragmented capital letters (70% completed) were 
presented one at a time in each block (Figure 7-1). Fragmented letters ensured that the 
precise visual stimulus for any given letter was never repeated while simplifying the task 




for the participant. In the active condition (two-back), participants had to remember the 
letters appearing on a screen and indicate through a button press response if the currently 
shown letter was identical to the letter presented two trials previously. In the control 
condition (x-not-x), participants were asked to indicate whether the current fragmented 
capital letter shown was an x or not, and again indicate yes/no with a button press. Refer 
to Appendix E for task instructions.  
 
Self-Reflection Task. In the active condition of the self-reflection task, participants 
responded to a variety of adjectives in each block requiring knowledge of and reflection 
of their own personalities (e.g., casual, demanding, irritating; Figure 7-2). Participants 
were instructed to make the decision based on their own opinion of themselves, not 
someone else’s view. In the control condition (short/long), participants made decisions 
about whether the word shown was a short or a long word. In both conditions, yes/no 
responses were required by a button press. Trait adjectives presented were obtained from 













Figure 7-2. Design of the fMRI self-reflection task, with the active condition (self-reflection) on the left and the control condition (short/long) on the right 




 MRI Pre-Processing  7.2.3
Image pre-processing was performed using Statistical Parametric Mapping software 
(SPM12b v5581; http://www.fil.ion.ucl.ac.uk/spm/) implemented in Matlab (R2010a, 
Mathworks Inc., MA, USA).  
 
For each MCI individual, pre- and post-intervention structural images were 
aligned to a subject-specific halfway space between the two using the longitudinal 
registration utility with default parameters (Ashburner & Ridgway, 2012). The mid-point 
average image for each individual was then segmented and grey matter (GM) atrophy rate 
images produced by multiplying the native space GM segments (both pre- and post-
intervention) by the Jacobian rate. We then ran DARTEL (existing template) using the 
DARTEL template provided with the VBM8 toolbox (http://dbm.neuro.uni-
jena.de/vbm/). This template is in MNI space and is derived from 550 individuals across a 
wide age range, which is a more representative template than one that could be created 
from our 24 subjects.  
 
As opposed to MCI, healthy controls underwent only a single imaging session. To 
ensure control images underwent the same processing and interpolation steps as the MCI 
scans, which had two time-points, an additional pre-processing step was performed for 
the healthy control scans. A mirror reversed image was created from the baseline 
structure image of each healthy control participant and this mirrored image was then used 




as the post-intervention structural image and the subsequent processing steps processed as 
per the MCI processing (Bernal-Rusiel et al., 2013). This method allowed us to evaluate 
healthy control scans in the longitudinal stream (instead of cross-sectionally), reducing 
bias and allowing for more faithful comparisons between the groups. 
 
Both task fMRI sessions and the resting-state sessions were processed in a similar 
fashion, as follows. The FieldMap utility in SPM was used to create a fieldmap and voxel 
displacement map. A mean functional image was also produced. Functional images were 
then realigned (motion-corrected to the first functional volume) and unwarped (to 
minimise susceptibility distortions). This was followed by slice timing correction. At 
each time point, functional images were then coregistered to the individual’s structural 
brain image using the mean functional image as the source image (mean pre-intervention 
functional image to pre-intervention structural and mean post-intervention functional to 
post-intervention structural). In each individual, deformation fields mapping either pre-
intervention or post-intervention structural images to the mid-point average were 
combined with the DARTEL flow fields to normalize the coregistered, slice timing-
corrected, realigned, and unwarped functional images at each time point. Lastly, these 








 Analysis of DMN Activations and Deactivations 7.2.4
In the first-level (the subject-level), the following parameters were used; inter-scan 
interval 3s, Microtime Resolution 44, and Microtime Onset 22s. Low frequency drifts 
were removed using a temporal high-pass filter with a cut-off of 128s. Serial 
autocorrelation was also corrected using autoregressive model. Six contrast images were 
created for each subject (control condition > active condition; active condition > control 
condition; control condition > fixation; fixation > control condition; active condition > 
fixation; fixation > active condition). These subject-specific summaries of 
activation/deactivation were then taken to second-level analyses. Given the sample size, a 
height threshold of p < 0.001, uncorrected for multiple comparisons across the whole 
brain was applied, with k > 10 voxels.  
 
 Analysis of the Resting-State DMN Functional Connectivity 7.2.5
To identify the DMN, smoothed, normalized resting state images for all participants were 
entered into a group Independent Component Analysis (ICA) using the Group ICA fMRI 
Toolbox (GIFT; http://icatb.sourceforge.net) implemented in Matlab. Twenty 
independent components were estimated using the infomax algorithm, with default 
parameters. All components were then spatially correlated with a healthy control template 
provided by S. M. Smith et al. (2009) (Figure 7-3). The component with the highest 
spatial correlation to the DMN template was selected for further analysis. The individual 
DMN component maps were transformed to z-scores, using the following formula:  




𝐶𝑧(𝑋) = (𝐶(𝑋) − 𝜇𝑐)/𝜎𝑐 
where 𝐶(𝑋) are the component weightings within each selected DMN image, 𝜇𝑐 is the 
mean and 𝜎𝑐 is the standard deviation of component weightings in the map, and 𝐶𝑧(𝑋) 
represents the z scored component weighting (Greicius et al., 2004; Petrella et al., 2011). 
 
   
Figure 7-3. DMN template from Smith et al., (2009). 
 
  A goodness-of-fit (GOF) index was then calculated. The GOF index reflected the 
degree to which each individual’s DMN matched the healthy DMN template provided by 
S. M. Smith et al. (2009). For each individual’s DMN component, the GOF was 
calculated as the difference between the mean z-score of all voxels that fell inside the 
DMN template (z inside) and the mean z-score of all voxels outside the DMN template (z 
outside); that is GOF = mean (z inside) – mean (z outside) (Greicius et al., 2004; Petrella 
et al., 2011).  
 
 Statistics on GOF 7.2.6
GOF values were compared across time and group using linear mixed-effects models 
with the nlme package in R (v3.0.0). Baseline age, sex and time between scans were 
included in the model.  




 Results  7.3
 
 Task fMRI: N-Back (Baseline Scans: Healthy Control and MCI) 7.3.1
Repeated measure t-tests were conducted to examine the task effect within the heathy 
control and MCI group.  
  
Two-Back vs. X-not-X. For the two-back > x-not-x contrast, increased activation 
was observed in the inferior parietal lobule, middle frontal gyrus, inferior frontal gyrus, 
fusiform gyrus, thalamus and cerebellum (red regions in Figure 7-4; Table 7-1). For the 
x-not-x > two-back contrast, the only region that showed more activation during the x-
not-x condition was the superior temporal gyrus (blue regions in Figure 7-4; Table 7-1). 
 
two-back vs. x-not-x 
 
Figure 7-4. Brain regions showing significant fMRI response to two-back relative to x-not-x. Axial slices z 
= 35, 45, 55, 65, 75, 85. Red = areas of activation (two-back > x-not-x). Blue = areas of deactivation (x-not-
x > two-back). Uncorrected p < 0.001; k >10. 
 
Two-Back vs. Fixation. The two-back > fixation contrast revealed increased 
activation in the supplementary motor area, inferior parietal lobule, middle occipital 
gyrus, middle temporal gyrus, supramarginal gyrus and cerebellum (red regions in Figure 




7-5; Table 7-1). For the contrast of fixation > two-back, increased activation was 
observed in the posterior cingulate gyrus and precuneus (blue region in Figure 7-5; Table 
7-1). The posterior cingulate gyrus and precuneus are known to be part of the DMN.  
 
two-back vs. fixation  
 
Figure 7-5. Brain regions showing significant fMRI response to two-back relative to fixation. Axial slices z 
= 50, 55, 60, 65, 70, 75. Red = areas of activation (two-back > fixation). Blue = areas of deactivation 
(fixation > two-back). Uncorrected p < 0.001; k >10. 
 
X-not-X vs. Fixation. The x-not-x > fixation contrast revealed increased activation 
in the postcentral gyrus, middle occipital gyrus, middle temporal gyrus, supramarginal 
gyrus, superior parietal gyrus, inferior frontal gyrus, putamen and cerebellum (red regions 
in Figure 7-6; Table 7-1). As above (fixation > two-back), there were activations in 
regions that overlapped with the DMN for the contrast of fixation > x-not-x, including the 
precuneus, posterior cingulate gyrus and hippocampal formation (blue regions in Figure 









x-not-x vs. fixation 
 
Figure 7-6. Brain regions showing significant fMRI response to x-not-x relative to fixation. Axial slices z = 
35, 45, 55, 65, 75, 85. Red = areas of activation (x-not-x > fixation). Blue = areas of deactivation (fixation 
> x-not-x). Uncorrected p < 0.001; k >10. 









x y z 
Two-Back vs. X-not-X     
two-back > x-not-x     
R inferior parietal lobule  47 -51 44 5.97 
L middle frontal gyrus  -36 3 50 5.85 
L inferior fontal gyrus -45 42 -9 3.99 
R cerebellum  32 -51 -27 3.65 
L fusiform gyrus  -39 -62 -21 3.33 
L thalamus -11 -6 -3 3.26 
x-not-x > two-back     
R superior temporal gyrus  40 21 -30 4.25 
L superior temporal gyrus  -44 9 -18 3.64 
Two-Back vs. Fixation      
two-back > fixation      
L supplementary motor area  -6 1 51 7.27 
L inferior parietal lobule  -50 -33 45 6.55 
R middle occipital gyrus  33 -80 3 5.98 
R middle temporal gyrus 42 -71 0 5.39 
R cerebellum 30 -50 -24 4.90 
R supramarginal gyrus  59 -36 24 3.51 
fixation > two-back     
L posterior cingulate gyrus  -5 -50 32 4.13 
L precuneus   -2 -61 20 4.15 
X-not-X vs. Fixation      
x-not-x > fixation     
L postcentral gyrus  -39 -29 54 6.77 
R middle occipital gyrus  39 -74 2 5.98 
L middle occipital gyrus  -38 -77 -1 5.72 
R middle temporal gyrus  50 -63 5 5.47 
L cerebellum  -35 -47 -27 5.22 
R supramarginal gyrus  57 -23 39 5.15 
R superior parietal gyrus  41 -51 59 4.39 
L putamen  -33 -15 -6 4.17 
R inferior frontal gyrus  49 42 -10 3.81 
fixation > x-not-x     
L precuneus  -6 -48 38 4.28 
L lingual gyrus  -9 -44 -1 4.03 
L posterior cingulate gyrus  -6 -50 24 3.95 
R calcarine gyrus 6 -78 17 3.71 
L hippocampus -20 -17 16 3.54 
L angular gyrus -50 -72 32 3.38 
L parahippocampal gyrus  -18 -30 -13 3.24 
Note. Peak z-scores, corresponding to uncorrected p-values and MNI coordinates (x, y, z) of deactivated 
brain regions; L = left; R = right; threshold for statistical significance p < 0.001, uncorrected for multiple 
comparisons, k > 10 voxels. 
 




 Task fMRI: Self-Reflection (Baseline Scans: Healthy Control and MCI) 7.3.2
Repeated-measure t-tests were conducted to examine the task effect within the heathy 
control and MCI group.  
 
Self-Reflection vs. Short/Long. For the contrast of self-reflection > short/long, 
there were activations in regions that overlapped with the DMN (Red regions in Figure 7-
7; Table 7-2). These regions included the precuneus, angular gyrus, posterior cingulate 
gyrus, and medial frontal gyrus. Additional areas of activation included the fusiform 
gyrus, inferior frontal gyrus, superior frontal gyrus, lingual gyrus, middle temporal gyrus, 
superior temporal gyrus and supramarginal gyrus. For the short/long > self-reflection 
contrast, only three regions exhibited increased activity, the superior parietal gyrus, the 
superior occipital gyrus, and middle temporal gyrus (blue region in Figure 7-7; Table 7-
2).  
 
self-reflection vs. short/long  
 
Figure 7-7. Brain regions showing significant fMRI response to self-reflection to short/long. Axial slices z 
= 50, 55, 60, 65, 70, 75. Red = areas of activation (self-reflection > short/long). Blue = areas of deactivation 
(short/long > self-reflection). Uncorrected p < 0.001; k >10. 
 




Self-Reflection vs. Fixation. The contrast of self-reflection > fixation showed 
increased activation in the supplementary motor area, putamen, supramarginal gyrus, 
inferior parietal lobule, superior parietal gyrus, and middle occipital gyrus (red regions in 
Figure 7-8; Table 7-2). The fixation > self-reflection contrast revealed increased 
activation in the precuneus (blue regions in Figure 7-8; Table 6-2).  
 
self-reflection vs fixation  
 
Figure 7-8. Brain regions showing significant fMRI response to self-reflection relative to fixation. Axial 
slices z = 50, 55, 60, 65, 70, 75. Red = areas of activation (self-reflection > fixation). Blue = areas of 
deactivation (fixation > reflection). Uncorrected p < 0.001; k >10. 
 
Short/Long vs. Fixation. For the short/long >fixation contrast, increased activation 
was observed in the superior parietal gyrus, superior occipital gyrus, middle temporal 
gyrus, superior temporal gyrus, middle temporal gyrus and cerebellum (red regions in 
Figure 7-9; Table 7-2). The fixation > short/long contrast revealed increased activation in 
regions that are known to be part of the DMN. These regions included the posterior 
cingulate gyrus, precuneus, angular gyrus, medial frontal gyrus, and hippocampus (blue 
regions in Figure 7-9; Table 7-2).  
 
 




short/long vs. fixation  
 
Figure 7-9. Brain regions showing significant fMRI response to short/long relative to fixation. Axial slices 
z = 35, 45, 55, 65, 75, 85. Red = areas of activation (short/long > fixation). Blue = areas of deactivation 
(fixation > short/long). Uncorrected p < 0.001; k >10. 





Regions of Activations and Deactivations Associated with the Self-Reflection Task (baseline scans: healthy 
control and MCI) 
 Regions Coordinates 
z-score 
x y z 
Self-Reflection vs. Short/Long     
self-reflection > short/long      
R angular gyrus  59 -60 30 3.56 
L angular gyrus  -44 -59 29 5.42 
L posterior cingulate gyrus  -3 -46 30 5.59 
L fusiform gyrus -44 -50 -24 4.01 
L inferior frontal gyrus  -53 22 -6 4.86 
R lingual gyrus  29 -68 -3 3.41 
L middle temporal gyrus -44 -54 14 4.61 
L precuneus -6 -51 18 5.31 
L superior frontal gyrus  -3 3 62 5.07 
L medial frontal gyrus  -3 60 -4 4.39 
R superior temporal gyrus  54 17 -24 4.99 
L superior temporal gyrus  -45 16 -33 3.57 
L supramarginal gyrus  -65 -39 24 3.33 
short/long > self-reflection      
R superior occipital gyrus  33 -71 41 3.64 
R superior parietal gyrus  38 -65 54 3.60 
R middle temporal gyrus  54 -48 -3 3.70 
Self-Reflection vs. Fixation      
self-reflection > fixation     
R middle occipital gyrus  30 -63 36 3.59 
L putamen -17 4 3 6.95 
R supplementary motor cortex 8 4 57 7.16 
R supramarginal gyrus  47 -33 42 4.78 
R superior parietal gyrus  33 -62 57 3.59 
fixation > self-reflection     
R precuneus  8 -54 38 4.32 
L precuneus -11 -75 28 3.52 
Short/Long vs. Fixation      
short/long > fixation      
R supplementary motor area 9 -11 65 6.40 
R superior parietal gyrus 33 -62 53 5.24 
L superior parietal gyrus -27 -65 48 6.28 
R superior occipital gyrus  32 -69 41 5.34 
R middle temporal gyrus  54 -45 -4 5.12 
R superior temporal gyrus  60 -33 23 3.34 
R middle frontal gyrus  28 53 -6 3.28 
fixation > short/long      
R angular gyrus  48 -65 29 3.92 
L angular gyrus  -48 -74 32 3.77 
L posterior cingulate gyrus  -6 -47 3 4.85 
R precuneus  2 -54 35 4.71 
R medial frontal gyrus  9 -6 51 5.31 
R superior occipital gyrus  24 -69 21 3.35 
L hippocampus  23 -15 -15 3.31 
Note. Peak z-scores, corresponding to uncorrected p-values and MNI coordinates (x, y, z) of the activated 
brain regions; L = left; R = right; threshold for statistical significance p < 0.001, uncorrected for multiple 
comparisons, k > 10 voxels.




 Task fMRI: Group Effect (Baseline Scans: Healthy Control vs. MCI)  7.3.3
Two-sample t-tests were conducted to examine the group difference between the heathy 
control and MCI participants. For the both tasks (n-back and self-reflection), there were 
no significant differences in patterns of brain activation or deactivation between healthy 
control and MCI participants for any of the contrasts of interest.  
 
 Task fMRI: Enrichment-Related Changes (Pre- and Post-Scans: MCI only)  7.3.4
In order to investigate enrichment induced changes in DMN activation/deactivation, 
repeated-measure ANOVA (i.e., flexible factorial model in SPM 12) with within-subject 
factor time (pre, post) and between-subject factor group (intervention, waitlist) was 
performed. The results [intervention (post > pre) > waitlist (post > pre)] showed no 
significant enrichment-related changes in brain activity during the n-back or the self-
reflection task.  
 
 Resting-State fMRI: Group Effect (Baseline Scans: Healthy Control and MCI) 7.3.5
GOF analysis of DMN functional connectivity at baseline showed no group difference 
between healthy control and MCI participants [F (1, 9) = 0.10; p = 0.33]. The means were 
1.54 (SD = 0.25) for the healthy control group and 1.40 (SD = 0.23) for the MCI group 
(Figure 7-10).  
 





Figure 7-10. Box whisker plot of GOF of HC and MCI participants at baseline. GOF = Goodness of Fit; 
HC = Healthy Control. Plot depicts the median, interquartile range, and range of values for each group. 
 
 Resting-State fMRI: Enrichment-Related Changes (Pre- and Post-Scans: MCI 7.3.6
only)  
Linear mixed effects modelling was conducted to determine the effects of the Cognitive 
Enrichment Programme on the DMN functional connectivity using the GOF value. The 
primary finding was an interaction between group and time, which just failed to reach 
statistical significance, after controlling for age, sex and time between scans [F (1, 11) = 
2.19, p = 0.051]. Compared to pre-intervention, an increase in DMN functional 
connectivity (indicated by higher GOF) was found for the intervention group, while a 
decrease was observed for the waitlist group (Table 7-3 and Figure 7-11). Figure 7-12 
shows changes in individual GOF scores over time. Baseline GOF values did not differ 




significantly between the intervention waitlist groups [F (1, 9) = 0.54, p = 0.60]. 
Additionally, there was no significant main effect of sex [F (1, 9) = 1.26, p = 0.24], or 
age [F (1, 9) = 0.79, p = 0.45].  
 
Table 7-3 
Group Mean (SD) GOF Values Pre-and Post-Cognitive Enrichment  
 Pre-Intervention GOF Post-Intervention GOF 
Mean (SD) Mean (SD) 
Intervention MCI (n = 6) 1.26 (0.30) 1.50 (0.32) 
Waitlist MCI (n = 7) 1.54 (0.34) 1.21 (0.42) 






Figure 7-11. GOF values at baseline and follow-up for intervention and waitlist participants. GOF = 
Goodness of Fit; MCI = Mild Cognitive Impairment. Plot depicts the median, interquartile range, and range 


























Figure 7-12. Changes in individual GOF scores over time. Red dots = Healthy Control; Green dots = 
Intervention MCI; Blue dots = Waitlist MCI. GOF = Goodness of Fit. Line between dots 
indicates changes in GOF values over time. The variation in time between scans was included 
as a covariate in the statistical model.  
 
 Correlation Between GOF Changes and Cognitive Performance 7.3.7
We determined whether the GOF changes that occurred between pre- and post-
intervention scans were associated with changes on primary neuropsychological 
measures. Changes in GOF were found to be significantly correlated with the 
improvement on the Verbal Fluency test (r = 0.57, p < 0.05; Figure 7-13). None of the 
other tests correlated significantly with changes in GOF (Table 7-4), but the correlation 
approached significance for Stroop Interference (r = 0.53, p = 0.06; Figure 7-14). 
 





Correlation between Neuropsychological Measures and Changes in GOF 
 r p 
Executive Function   
Verbal Fluency 0.57 0.04 
Category Fluency 0.07 NS 
Category Switching  0.36 NS 
Stroop Interference 0.53 NS 
Design Fluency Filled Dots -0.18 NS 
Design Fluency Empty Dots -0.44 NS 
Design Fluency Switching -0.44 NS 
Attention and Processing Speed   
SDMT 0.41 NS 
Stroop Colour Naming -0.25 NS 
Stroop Word Naming -0.02 NS 
Learning and Memory   
BVMT-R Total Recall  0.19 NS 
BVMT-R Delayed Recall  0.20 NS 
Story Immediate Recall -0.30 NS 
Story Delayed Recall 0.06 NS 
Note.  SDMT = Symbol Digit Modalities Test; BVMT-R = Brief Visuospatial Memory Test-Revised.  
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Figure 7-14. Correlation between the changes in GOF indices and changes in Stroop Inference performance 
in MCI.  
 
 Discussion  7.4
In this chapter we investigated the effect of cognitive enrichment on brain function, with 
a focus on its effect on the DMN. The results demonstrated that cognitive enrichment was 
associated with an outcome of enhanced resting-state functional connectivity within 
regions of the DMN by comparison with MCI participants who remained on a waitlist. 
Following cognitive enrichment the intervention group showed an increase in the mean 
GOF, while that the waitlist group decreased. It should be noted that the group x time 
interaction only just failed reach statistical significance, and despite the small sample 
size. Previous research has indicated that GOF indices lie in a continuous range with the 
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individuals with MCI who progress to AD and in AD patients (Petrella et al., 2011), 
suggesting that changes in GOF indices may correspond to changes in cognitive clinical 
stages. Hence, the Cognitive Enrichment Programme may represent a viable intervention 
option to prevent decline of the DMN in individuals with MCI. However, studies with 
larger sample sizes are required to validate this finding.  
 
To understand the relevance of changes in functional connectivity to cognition, 
we assessed the association between changes in GOF and performance on standardised 
neuropsychological measures. In contrast to previous studies suggesting a close 
association between DMN and episodic memory processes (Greicius et al., 2004; 
McCormick et al., 2014; Sestieri, Corbetta, Romani, & Shulman, 2011), we did not find a 
significant relationship between changes in resting-state DMN functional connectivity 
and memory performance in our MCI participants. Our results suggested that changes in 
GOF were correlated with improved performance on the Verbal Fluency test and with the 
Stroop Interference test. Both tests are measures of executive function, and the successful 
completion of these tasks requires a high degree of cognitive control. It is assumed that 
the extent of DMN activity reflects the ability of the brain to redirect its activity from 
internal (self-focused) to external (goal-directed) processes (Raichle et al., 2001). 
Impairments in the DMN have been suggested to associate with deficits in interference 
control, commonly interpreted as a failure to fully and effectively transition from an 
internal state to an active processing mode during performance of cognitive tasks 
(Sonuga-Barke & Castellanos, 2007), which results in an intrusion of task-non-specific 




cognition (typically seen at rest) into periods of active task-specific processing, producing 
periodic fluctuations in attention that compete with goal-directed activity. Thus, the 
correlation between changes in DMN functional connectivity and executive function may 
be interpreted as a result of improved ability of the DMN to transition between its 
‘internal’ and ‘external’ state following cognitive enrichment.  
 
In terms of task fMRI, we found patterns of activation (via the self-reflection task) 
and deactivation (via the n-back task) that included regions of the DMN in some of the 
contrasts. However, the extent and intensity of DMN activations/deactivations were lower 
than what we had initially anticipated. For the n-back task, both task conditions (two-
back and x-not-x) produced deactivation in regions of the DMN when compared to 
fixation, but it was surprising to find in the current study that the two-back > x-not-x 
contrast did not produce significant DMN deactivation. Even more to our surprise,  
stronger DMN deactivation was observed in the contrast of x-not-x > fixation than two-
back > fixation. Previous studies suggested that increased working memory load is 
associated with stronger DMN deactivation (Leech & Sharp, 2014; Sambataro et al., 
2010). However, this association was not found in the current study. In contrast, our 
results suggested that a simple discrimination task (i.e., x not x) may be sufficient to elicit 
DMN deactivation. For the self-reflection task, increased DMN activation was observed 
in the self-reflection > short/long contrast. This suggests that the self-reflection paradigm 
used by the current study led to detectable BOLD signal changes in the DMN and is 




therefore compatible with previous research suggesting that self-reflection leads to 
increased DMN activation (Buckner & Carroll, 2007; Ries et al., 2012; Ries et al., 2006).   
 
Cognitive training in MCI has resulted in greater activation within regions of the 
DMN in previous studies. For example, Hampstead et al. (2011) reported greater 
activation in within the posterior cingulate cortex, medial frontal cortex and left 
temporoparietal junction following explicit-memory training. Another study of mnemonic 
strategy training reported increased activation in the frontal, temporal and parietal areas 
after episodic memory training (Belleville et al., 2011). In contrast, we did not find such 
effect with the Cognitive Enrichment Programme. The interpretation of the task fMRI in 
the current study may be limited by the fact that task performance was not included in the 
statistical model. Previous studies have reported significant correlations between task 
performance and levels of brain activity (Fleisher et al., 2009). Resting-state fMRI, in 
contrast, is not dependent on differential task performance, and thus does not suffer from 
variability related to task performance.  
 
Although prior studies have demonstrated differences in brain 
activation/deactivation and resting-state functional connectivity in the DMN in MCI 
participants compared to healthy controls, we did not find such between-group 
differences in the current study. There are a number of possible explanations for this lack 
of difference in our study. First, the relatively small sample size may have attenuated the 
statistical power to reveal the between-group differences. Second, the differences in 




disease characteristics (e.g., level of cognitive impairment) may contribute to increased 
variability in brain pathology, so it may be useful for future studies to include grey matter 
in the DMN as a covariate (not measured here). It is likely that many of our MCI 
participants were in a relatively early stage of MCI, because all of them were recruited 
from screenings of healthy individuals from the community, rather than from a medical 
centre or hospital. A study of normal ageing, MCI, and AD demonstrated a nonlinear 
trajectory of functional MR imaging activation across the continuum of impairment 
(Celone et al., 2006), which suggests that patients in the late stage of MCI or patients 
with mild AD are more likely to show distinct patterns of DMN impairments. Third, 
when running the ICA analysis, we used an independent template of the DMN from S. M. 
Smith et al. (2009), rather than a template created from our healthy control, as was done 
in previous studies (Greicius et al., 2004; Petrella et al., 2011). Using a template created 
from own control subjects is likely to artificially amplify any between-group differences, 
because the control data would be used to create the template in the first place and 
therefore would better match the template and produce a higher GOF value.  
 
 Summary and Conclusion 7.5
Previous literature suggests that the DMN is impaired with ageing. Our results 
demonstrated that an intervention program could strengthen the connectivity between 
regions of the DMN. To our knowledge, this study provides the first evidence of the 
beneficial effects of cognitive enrichment, as opposed to focused memory training, on the 




DMN in individuals with MCI. Our findings are by no means definitive, but rather should 
serve as a starting point for future research on the relationship between cognitive 





CHAPTER 8 - Concluding Summary and Outlook 
 
 Main Findings 8.1
The first contribution of this thesis was that the screening study provided valuable 
information about the selection of tests and appropriate cut-off scores of potential 
screening tools for MCI individuals. Our results showed that while MoCA, RCFT Copy 
and RCFT Recall provided good accuracy for the identification of MCI, TMT-A 
performed poorly as a screening test. Furthermore, logistic regression analysis revealed 
that the combination of MoCA and RCFT (copy and 3-min recall) exhibited more useful 
diagnostic indicators than either the MoCA or RCFT in isolation. The combined model 
provided excellent discrimination between MCI from normal cognition, plus added 
diagnostic utility when discriminating MCI from possible MCI. These findings suggest 
that health professionals should consider including the RCFT as an adjunct test to the 
more routinely used MoCA when screening for MCI. The use of cognitive screening 
instruments can have a significant impact on the early detection and treatment of MCI 
because of the possibility of wide-spread use at the primary care or community level. 
However, it is important to recognise that the primary purpose of screening is not to 
confirm diagnosis but to establish the need for an in-depth assessment. Thus, it is 
necessary to follow up any positive results with comprehensive neuropsychological 
assessments.  




The second contribution of the thesis was the development of the Cognitive 
Enrichment Programme. The Cognitive Enrichment Programme used a novel approach to 
cognitive intervention in that enrichment tasks were designed to influence multiple brain 
networks. Results from the cognitive enrichment study indicated that the enrichment 
programme we developed is both feasible and has a high potential for reducing further 
cognitive declines in persons with MCI. The neuropsychological results revealed an 
intervention effect on a measure of delayed recall of visuospatial information. Although 
this result might be taken as a chance finding, as other neuropsychological outcome 
measures did not reach statistical significance. However, the resulting effect sizes were 
generally in favour of the intervention group, suggesting that a larger sample size might 
obtain statistical significance. In terms of fMRI results, the enrichment programme was 
found to improve the functional connectivity of DMN at rest in intervention participants, 
while the waitlist group showed a reduced connectivity. And, this improved functional 
connectivity was associated with an improved performance on the Verbal Fluency test in 
intervention participants. However, no task-related brain activation and deactivation 
changes were found. Taken together, these results suggest some positive effects of the 
Cognitive Enrichment Programme on the DMN in MCI, but further studies are required 








 Critique of the Study and Future Direction 8.2
 Sample Size 8.2.1
Some limitations of the study should be acknowledged. Firstly, this study has a smaller 
sample size in comparison to other studies, despite an initial large number of screened 
participants. Thus, a lack of statistical power may be suspected for the non-significant 
results. Conversely, the small sample size also precluded more rigorous statistical 
analysis with control of multiple comparisons. Given the small sample size and the 
number of statistical analyses conducted, the possibility of a Type I error (e.g., delayed 
recall) cannot be excluded. Hence, these results should be regarded as promising but 
preliminary, awaiting confirmation, and as a starting point for further research.  
 
The MCI population, particularly the amnestic subtype, seems difficult to recruit 
for intervention purposes. Large study samples were scarce in studies reviewed in 
Chapter 3. Participants with MCI are not easy to find possibly because a large proportion 
of these individuals is still functionally independent and active (Petersen, 2004), therefore 
they do not come to the attention of physicians or other health care professionals. In 
addition, some of them despite acknowledging a cognitive decline could be feeling 
ambivalent about engaging in such research studies. We also found that when such 
individuals are interested in the study, their busy social schedules often interfered with 
their ability to participate in the study. Relatively younger people with MCI may still be 




working, thus it could be difficult for them to find enough time in their daily schedule to 
participate in this kind of research study. 
 
 Control Condition  8.2.2
A further limitation of the study was the lack of an active control group. Without a 
control intervention, we cannot determine with certainty whether the observed outcomes 
were due to the specific components of the intervention or simply as a result of engaging 
in any forms of activities. However, prior studies have shown that it is difficult to devise 
an active control condition for this type of study. Barnes et al. (2009) included an active 
control condition in their study of computer-based cognitive training for MCI. Their 
intervention programme required participants to determine whether two sounds were 
sweeping upward or downward; identify a target syllable when it interrupted a repeated, 
similar sounding syllable; distinguish between two similar sounds/similar sounding 
words; match sounds on a spatial grid; follow a series of instructions that increased in 
complexity and identify the picture that correspond to the sentence. The active control 
condition consisted of listening to audio books, reading online newspaper, and playing a 
visuospatially oriented computer game. They later found that a few of the outcome 
measures were in favour of the active control condition, which they attributed this effect 
to the type of exercises included in their control condition. Therefore, careful planning of 
the active control group is required to reduce the risk of the condition being too active 
and thus diluting the intervention effect. Future studies should consider the use of a three-




arm design (an intervention group, an active control group, a no-contact control group), 
and confirm that any active control activities are, in fact, inert before commencing a trial.  
 
 Generalisation of the Results  8.2.3
There are a few concerns regarding generalisability of the intervention effects. It is 
possible that those who enrolled and participated differed from those who declined 
participation. First, approximately a third of the initial screened sample was excluded 
based on medication and medical condition reasons. Thus, participants included in the 
current study are likely to have a better physical health than the general elderly 
population. That is, it is unclear whether the current results would generalise to 
individuals with more chronic health conditions. Intervention programmes may be less 
effective for individuals with chronic health conditions, as these individuals tend to face 
more demands including managing numerous health appointments, adhering to 
medications and self-monitoring their conditions (Bohlen, Scoville, Shippee, May, & 
Montori, 2012; Gallacher, May, Montori, & Mair, 2011; Jani et al., 2013), along with 
needing to practice important health behaviours, such as maintaining a healthy diet and 
physical activity. These demands may limit their ability to engage in cognitive 
intervention programmes. Moreover, motivation to engage in such programme may be 
further complicated by mental health disorders, especially depression and anxiety 
disorders (Clarke & Currie, 2009; Katon, Lin, & Kroenke, 2007).  
 




Second, it is likely the enrichment population included primarily highly motivated 
subjects, thus it is unclear whether our results would generalise to less motivated subjects. 
Troyer et al. (2008) reported that the number of sessions attended and at-home 
assignments completed by the participant positively predicted the observed changes in 
memory. Thus, suggesting that the individual’s motivation plays a crucial role in 
cognitive intervention. Furthermore, the lack of motivation or apathy has been suggested 
to correlate with greater memory impairment and predicted the progression to dementia 
(Robert et al., 2008). This thus creates a paradox for intervention studies, in that ideally 
intervention studies would want to capture these individuals as they may be at higher risk 
than the general elderly population. However, these individuals are less likely to respond 
to participant requests in advertisements and even when they do respond they are less 
likely to carry through and complete such programme. Future studies would benefit from 
careful analysis of potential biases in the recruitment and retention of study participants.  
 
 Follow-Up  8.2.4
One issue concerns the long-term, disease modifying effects of the Cognitive Enrichment 
Programme. Due to time constrains, we only examined the immediate short-term effects 
of enrichment in MCI. Future studies should also include follow-up sessions to ascertain 
any maintenance effects and rate of conversion to AD. Evidence of long-term 
maintenance of benefits in MCI due to intervention is crucial given the neurodegenerative 




nature of the condition. A delay of symptom progression and conversion to dementia 
should be considered as an ultimate efficacy outcome.  
 
 Concluding Remarks and Future Direction 8.2.5
Despite these limitations, this study represents the first attempt to evaluate a novel 
cognitive enrichment programme designed to enhance DMN activity and connectivity, 
and therefore cognition in elderly with MCI, who are a vulnerable group with high risk of 
developing dementia. Our preliminary results provided support for the feasibility of this 
type of intervention programme in MCI. For example, we did not know in advance 
whether older adults with MCI and their partner would be willing and able to commit to 
an intervention programme over a 4-6-month period. Furthermore, we demonstrated that 
cognitive enrichment is associated with positive effects on DMN connectivity at rest. 
However, results from the present study must be interpreted with great care due to the 
small sample size. The next step would be to boost the current sample size up either with 
the waitlist group, or to replicate the study with a larger sample size. It is important for 
future studies to evaluate the long-term benefits and real-world generalisation of such 
intervention programme. Furthermore, the present study had a particular emphasis on the 
changes in the functional integration of the DMN in patients with MCI. A recent study 
indicated that AD is associated with an alteration of large-scale functional brain networks 
that extend beyond the DMN (He et al., 2014; R. Li et al., 2012; Weiler et al., 2014; 
Zhang et al., 2015). Thus, it would be useful for future studies to examine whether the 




Cognitive Enrichment Programme show beneficial effects on other brain networks in 
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CHAPTER 10 - Appendices 
 
 Appendix A – Descriptions of Standardised Neuropsychological Tests Used 10.1
 
 Pre-Morbid Intelligence 10.1.1
The Test of Premorbid Functioning (TOFP; Pearson, 2009) provides an estimate of an 
individual’s level of intellectual functioning before the onset of injury or illness. It 
involves asking the participants to read out loud a list of 70 words that have atypical 
grapheme to phoneme translations. The total score is the number of words read correctly.  
 
 Activities of Daily Living 10.1.2
In the current study, participants’ ability to perform activities of daily living was 
evaluated through the Clinical Dementia Rating (CDR). The CDR is a semi-structured 
interview with the participants and informants. It consists of six domains of functioning: 
memory, orientation, judgement and problem solving, community affairs, home and 
hobbies, and personal care of the participant. Each domain is rated on a five-point scale: 
CDR 0 = no cognitive impairment, CDR 0.5 = very mild dementia, CDR 1 = mild, CDR 
2 = moderate, and CDR 3 = severe. In this study, the global CDR score was computed 
using the Washington University online algorithm 
(http://www.biostat.wustl.edu/intrnet/broker). MCI participants had a global CDR of 0 or 




0.5, participants with a CDR score ≥ 1 were classified as demented and excluded from the 
cognitive enrichment study. 
 
 Global Cognitive Functioning  10.1.3
General cognitive status was assessed with the use of the Montreal Cognitive Assessment 
(MoCA; Nasreddine et al., 2005), the Alzheimer’s Disease Assessment Scale-cognitive 
subscale (ADAS-cog; Graham, Cully, Snow, Massman, & Doody, 2004) and the 
Dementia Rating Scale-2 (DRS-2; Jurica, Leitten, & Mattis, 2001).  
 
The Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005) is a brief 
screening test that was developed specifically for the detection of MCI. It assesses a 
number of different cognitive domains, including attention and concentration, executive 
function, memory, language, visuospatial abilities, working memory, and orientation. To 
adjust for education levels, one point is added for participants with 12 years or fewer of 
formal education, for a possible maximum score of 30 points. A final total score of 26 
and above is considered normal.  
 
The modified version of the Alzheimer’s Disease Assessment Scale-cognitive 
subscale (ADAS-cog; Mohs et al., 1997) was used. The ADAS-modified version consists 
of 13 tasks, including 9 performance-based assessments and 4 rater-based items. The 
performance items include word recall, following commands, constructional praxis, 




naming, ideational praxis, orientation, delayed recall, word recognition, and number 
cancellation. The rater-based items include remembering test items, comprehension, word 
finding ability, and spoken language ability. The total score has a range of 0 to 85, higher 
scores indicated greater severity. 
 
The Dementia Rating Scale -2 (DRS-2; Jurica et al., 2001) was constructed to 
assess cognitive abilities in dementia patients, differentiate levels of ability in these 
patients, and track their cognitive status over time. The scale provides a global measure of 
cognitive functioning as well as five subscales scores (attention, initiation/perseveration, 
construction, conceptualisation, and memory). A scaled score of 9 and above is described 
as ‘intact’, with scores between 6 and 8 described as mildly impaired, 4 to 5 as 
moderately impaired, and 3 or less as severely impaired (Jurica et al., 2001). In this study, 
the orientation items (date, month, year, day, place, and city) were crossed-scored with 
the MoCA, as both tests were completed within the same session.  
 
 Attention and Processing Speed  10.1.4
Attention and processing speed was assessed using the Digit Span Test (Wechsler, 2008a, 
2008b), Stroop Colour Naming and Word Reading (Delis, Kaplan, & Kramer, 2001), and 
Trail Making Test-Part A (Mitrushina et al., 2005).  
 




The Digit Span Test (Wechsler, 2008a, 2008b) measures auditory attention, 
immediate span of learning, and working memory. In this test, participants are asked to 
listen carefully to a series of random numbers, which are presented at a rate of one per 
second. The Digit Span is composed of three tasks: Digit Span Forward (DSF), Digit 
Span Backward (DSB), and Digit Span Sequencing (DSS). In the DSF, the participants 
are asked to repeat the numbers in a forward order, while in the DSB task, the numbers 
are recalled in reserve order. For the DSS task, the participants are required the recite the 
numbers in sequence starting with the lowest number.  
 
The Stroop Colour Naming and Word Reading tests (Delis et al., 2001) require 
the participants to read aloud the colour/word as fast as they can. The Stroop Interference 
test is included under the executive function domain.  
 
The Trail Making Test consists of two parts: A and B (Mitrushina et al., 2005). 
Part A examines visual scanning, numeric sequencing, and visuomotor speed, whereas 
Part B of the test involves more cognitive flexibility from the participants, hence it is 
included as part of the executive function domain. For Part A of the test, participants are 
asked to use a pencil to link together numbers presented in circles (1 to 25) in the 
ascending sequence. If the participant makes an error, the examiner is to correct them 
before the participant moves on to the next dot.  
 




 Executive Function 10.1.5
Executive function was assessed using the Verbal Fluency Test (Delis et al., 2001), 
Action Fluency Test (Piatt, Fields, Paolo, & Troster, 1999; Piatt et al., 2004), Trail 
Making Test-Part B (Mitrushina et al., 2005), Stroop Interference (Delis et al., 2001), 
Symbol Digit Modalities Test (A. Smith, 1982), and Design Fluency Test (Delis et al., 
2001).  
 
The Verbal Fluency Test (Delis et al., 2001) measures participants’ ability to 
generate words, in response to a single letter and categorical stimuli, as well as generating 
words whilst alternating between two separate category stimuli. Participants are asked to 
name as many words as possible in 60 seconds.  
 
The Action Fluency Test is a measure of verbal fluency in which participants are 
instructed to generate as many verbs (i.e., things that people do) as possible in 60 seconds 
(Piatt et al., 1999, 2004).  
 
Part B of the Trail Making Test (Mitrushina et al., 2005) requires the participants 
to connect numbers and letters in an alternating numeric and alphabetic sequence (i.e., 1-
A-2-B-3-C, etc) as fast as possible. The task is timed and the score represents the amount 
of time required to complete the task. 
 




The Stroop Interference Test (Delis et al., 2001) requires the participant to name 
the colour of the ink in which the word was printed rather than read the actual word.  
 
The Symbol Digit Modalities Test (SDMT; A. Smith, 1982) is a simple 
substitution task using a reference key with nine different digit-symbol pairs. It captures 
divided attention and processing speed. Each participant was given 90 seconds to pair 
specific numbers with given abstract symbols.  
 
The Design Fluency Test (Delis et al., 2001) consists of three conditions in which 
participants are required to create as many novel designs as possible within one minute by 
connecting the dots using four straight lines. The three conditions are referred to as filled 
dots (connecting filled dots), empty dots (connecting empty dots while filled dots 
function as distractors), and switching (alternating between connecting filled and empty 
dots).  
 
 Visuospatial Function 10.1.6
Visuospatial function was assessed using the Silhouettes (Warrington & James, 1991), 
Judgement of Line Orientation (Benton et al., 1983), Matrix Reasoning (Wechsler, 2008a, 
2008b), and Rey Complex Figure Test (Meyers & Meyers, 1995).  
 




The Silhouettes, part of the Visual Object and Space Perception Battery (VOSP; 
Warrington & James, 1991), consists of 15 silhouettes of animals and 15 of common 
objects, drawn from varying degrees of angular rotation. Participants are required to 
identify the drawings.  
 
Judgement of Line Orientation (JLO; Benton et al., 1983) is a 30-item test of 
visuospatial perception. The JLO is presented in flip-book style where two lines appear at 
the top page, and a standard fan-shaped array of 11 lines appears at the bottom. 
Participants must identify the two lines from the bottom page that match the angles of the 
two lines of the top page.  
 
Matrix Reasoning (Wechsler, 2008a, 2008b) involves participants viewing an 
incomplete matrix or series and select the response option that completes the matrix or 
series from a set of five alternatives.  
 
The Rey Complex Figure Test (RCFT; Meyers & Meyers, 1995) evaluates 
visuospatial and constructional abilities and organisational strategy in the copy stage and 
visual memory in the recall stage. The copy trial involves participants drawing a complex 
geometric figure, there is minimal demand placed on memory during the copy condition. 
Whilst the participant is copying the drawing the examiner copies the participant’s 
drawing using different coloured pens to capture organisational and sequential aspects of 
the participant’s copy. The recall trails are included in the learning and memory domain.  




 Learning and Memory 10.1.7
Learning and memory was assessed using the California Verbal Learning Test – Second 
Edition (Delis et al., 2000), Rey Complex Figure Test (Meyers & Meyers, 1995), Brief 
Visuospatial Memory Test–Revised (Benedict, 1997), story recall from the Rivermead 
Behavioural Memory (B. A. Wilson, Cockburn, & Baddeley, 2003; B. A. Wilson et al., 
2008), Rappel Indice 48 Items (Adam et al., 2007), and Visual Association Test 
(Lindeboom & Schmand, 2003; Lindeboom et al., 2002).  
  
The Short Form of the California Verbal Learning Test – Second Edition (CVLT-
II SF) measures participant’s ability to learn and recall a list of nine words, the words are 
taken from three semantic categories (Delis et al., 2000). The word list is orally 
administered to the participants over four acquisition trails. Participants are asked to 
recall those words after a short delay of counting backwards from 100 for 30 seconds. 
The long-delay free recall is administered after a 10-minute delay filled with non-verbal 
tasks.  
 
The short-delay recall of the Rey Complex Figure Test (RCFT; Meyers & 
Meyers, 1995) requires the participants to recall and reproduce the figure and is 
administered after a 3-minute interval filled with a short conversation. The participants 
are asked to reproduce the complex figure again after a further 30-minute delay.  
 




The Brief Visuospatial Memory Test–Revised (BVMT-R; Benedict, 1997) 
consists of six geometric designs on an A4 size page. The page is shown to the 
participants for 10 seconds. There are three acquisition trials, and participants are asked 
to reproduce the designs immediately after each trial. Approximately 25 minutes 
following the acquisition trials, participants are again asked to reproduce the designs. 
 
In the Story Recall subtest from the Rivermead Behavioural Memory Test (B. A. 
Wilson et al., 2003; B. A. Wilson et al., 2008), a brief fact-laden passage is read to the 
participants and they are asked to memorise it for immediate recall and recall in 20 
minutes. The story from the RBMT-second edition was used at baseline assessment, 
while the RBMT-third edition was used at the start and end of the enrichment 
programme.  
 
The Rappel Indice 48 Items (RI-48 Task; Adam et al., 2007) is a simplified and 
shortened form of the original selective reminding test developed by Buschke (1997). It 
comprises of 48 items belonging to 12 different semantic categories. The items are 
presented to participants as written words on 12 consecutive cards, each card containing 
four items with each item from a different category. Participants are asked to identify and 
encode each item when its category is presented by the examiner. The card is then 
removed from the participant, and immediate cued recall is performed for these four 
words. If participants are unable to give an item in response to its category, the card is 
presented again and the procedure of identification and cued recall is repeated for this 




item alone. Once the immediate cued recall for a card is completed, the next card with 
four new items is presented and encoded in the same way. After the recall of the last card, 
participants are asked to count backward for 20 seconds. Participants are then asked to 
recall the four items from each category.  
 
The Visual Association Test (VAT; Lindeboom & Schmand, 2003; Lindeboom et 
al., 2002) consists of six cue cards showing only one of the objects (cue) and six 
association cards showing two interacting objects (cue and target). The participants are 
asked to name the objects on the cue cards and then the pairs of interacting objects on the 
association cards. Immediately after naming, the person is presented with the cue cards 
again and is asked to recall the corresponding targets.  
 
 Language 10.1.8
The language domain was assessed using the Boston Naming Test (Lansing et al., 1999) 
and Indiana University Token Test (Unverzagt et al., 1999).  
 
The Boston Naming Test (BNT) measures participants’ ability to name objects 
following visual representations of the objects. The current study used the 15-item 
version, which has been shown to be comparable to the 60-item version in discriminating 
between AD and healthy controls (Lansing et al., 1999).  
 




In the Indiana University Token Test (Unverzagt et al., 1999), participants are 
presented with an A4 size sheet of paper, with an array of 16 items, that varied in shape 
(circle and squares), colour (red, black, yellow, and green), and size (large and small). 
Participants are read a series of 12 commands graded in complexity. Items passed on the 






 Appendix B – Cross-Tabulation Tables for Confirmed MCI vs. Non-MCI 10.2
Table 10-1 
Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 15 
 






Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 16 
 






Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 17 
 






Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 18 
 






Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 19 
 






Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 20 
 






Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 21 
 






Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 22 
 






Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 23 
 






Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 24 
 





Table 10-11  
Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 25 
 






Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 26 
 






Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 27 
 






Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 28 
 






Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 29 
 






Confirmed MCI vs. Non-MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 30 
 




 Appendix C – Cross-Tabulation Tables for Confirmed MCI vs. Probable HC 10.3
Table 10-17 
Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 15 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 16 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 17 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 18 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 19 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 20 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 21 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 22 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 23 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 24 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 25 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 26 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 27 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 28 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 29 
 






Confirmed MCI vs. Probable HC: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 30 
 




 Appendix D – Cross-Tabulation Tables for Confirmed MCI vs. Possible MCI 10.4
Table 10-33 
Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 15 
 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 16 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 17 
 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 18 
 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 19 
 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 20 
 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 21 
 T = 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 22 
 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 23 
 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 24 
 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 25 
 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 26 
 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 27 
 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 28 
 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 29 
 






Confirmed MCI vs. Possible MCI: Cut-Off Scores for RCFT Copy and RCFT Recall when MoCA Score of 30 
 
Note. T = Confirmed MCI; F = Possible MCI. z-score ranges from +3 to -3.   




 Appendix E – Instructions for Task fMRI 10.5
 
 
Figure 10-1. Instruction screen for the x-not-x task. 
  






Figure 10-2. Instruction screen for the two-back task. 
  






Figure 10-3. Instruction screen for the short/long task. 
  






Figure 10-4. Instruction screen for the self-reflection task. 
 
